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ABSTRACT 
In Hawai'i, type 2 diabetes is prevalent among Native Hawaiians and thus is a burden to their 
well-being, since there is an increased risk for health complications such as cardiovascular 
disease, kidney disease, and neuropathy.  The terms “Native or Part Hawaiian” in this study 
refers to individuals who self identified one as their racial category.  Individuals with type 2 
diabetes should implement recommended daily self-management strategies to promote better 
health outcomes and possibly delay associated complications.  The concept of self-management 
is found in chronic illness and Native Hawaiian health literature.  The literature reveals that 
complementary and alternative medicine (CAM) serves to improve well-being through culturally 
accepted health and lifestyle practices.  This study scrutinizes the process of recruiting and 
interviewing Native Hawaiians and Part Hawaiians with type 2 diabetes complication of diabetic 
peripheral neuropathy (DPN) and explores reasons these individuals use complementary and 
alternative medicine.  A quantitative research method is conducted using two survey instruments: 
the CAM use survey and the SF-36 survey to assess reasons for CAM use, perceived general 
health, and bodily pain.  A descriptive statistical analysis is performed to identify frequency data 
in a sample of 21 Native Hawaiians with DPN.  The frequency data reveal factors that contribute 
to the use of CAM for diabetic peripheral neuropathy self-management, such as education, 
income, marital status, and religious beliefs.  Knowledge and assessment of complementary and 
alternative medicine use may assist health care professionals in treating and caring for Native 
Hawaiians and Part Hawaiians with type 2 diabetes. 
 Keywords: Native Hawaiian, type 2 diabetes, diabetic peripheral neuropathy, CAM	
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CAM – Complementary and Alternative Medicine 
CAM is defined as “a group of diverse medical and health care systems, practices, and products 
that are not generally considered to be a part of conventional medicine” (NCCAM, 2012). 
CSDPN - Chronic Sensorimotor Diabetic Peripheral Neuropathy  
Chronic sensorimotor diabetic peripheral neuropathy (CSDPN) is a common presentation 
compared to acute diabetic peripheral neuropathy (DPN) (Hartemann et al., 2011).   
DPN – Diabetic Peripheral Neuropathy 
DPN is the loss of sensation in the periphery and progression in a symmetrical stocking-glove 
pattern with proximal progression (Lindsay, Rodgers, Savath, & Hettinger, 2010). 
DPNP – Diabetic Peripheral Neuropathy Pain 
Diabetic peripheral neuropathy pain (DPNP) is exhibited by a discomfort of burning, tingling, or 
aching feeling with increased intensity at night (Barrett et al., 2007). 
NH – Native Hawaiian  
“Any individual who is a descendent of the aboriginal people who, prior to 1778, occupied and 
exercised sovereignty in the area that now constitutes the State of Hawai'i” (U.S. Public Law 
103-150, 1993, p. 1513). 
T2D - Type 2 Diabetes 
Type 2 diabetes may be a combination of insulin resistance and insulin insufficiency (CDCP, 
2014). 
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CHAPTER 1. INTRODUCTION 
 
Chapter 1 is an introduction and overview of a feasibility study assessing the background, 
significance, purpose, and summary of the research done on CAM use by Native Hawaiians with 
DPN.  The general overview of DPN, a common problem, is reviewed highlighting the 
prevalence, treatment options, and quality of life burden.  In Chapter 2, the literature reviews 
information on the evolving challenges a Native Hawaiian individual with type 2 diabetes may 
encounter with self-management.  Native Hawaiian cultural values, social support systems, and 
distrust are topics found in the literature that could provide insight for health care professionals 
recommending conventional methods of treatment and self-management for diabetic peripheral 
neuropathy symptoms.  Chapter 3 details feasibility research methodology conducted with 
insight for future Native Hawaiians studies, a population with poor health outcomes.  The 
demographic racial categorical survey data selections reviewed were Native Hawaiian and Part-
Hawaiian.  Research results in chapter 4 attempt to answer the research questions (1) are Native 
Hawaiians and Part-Hawaiians with type 2 diabetes and DPN using CAM, (2) what are the 
reasons CAM are being used, (3) do Native Hawaiians and Part-Hawaiians combine CAM 
therapies, (4) are CAM therapies being used for type 2 diabetes self-management, and (5) What 
are the characteristics of Native Hawaiian and Part-Hawaiian CAM users.  A discussion in 
chapter 5 compares research findings to relevant studies from the literature providing new 
knowledge for the potential improvement of Native Hawaiian well-being and health outcomes. 
A common complication of type 2 diabetes is Diabetic Peripheral Neuropathy (DPN) and 
could result in chronic pain.  This chronic pain contributes to changes in quality of life, mental 
health, and potential substance abuse.  Chronic pain is difficult to manage and may impact 
physical, social, and economic aspects of an individual’s life.  Individuals with DPN may 
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experience anxiety, depression, and sleep disturbances (Bair, Robinson, Katon, & Kroenke, 
2003; Gore, Dukes, Rowbotham, Tai, & Leslie, 2007; McDermott, Toelle, & Rowbotham, 
Schaefer, & Dukes, 2006).  For more information on CAM treatment for DPN see Appendix A. 
 DPN is the loss of sensation in the periphery and progression in a symmetrical stocking-
glove pattern with proximal progression (Lindsay, Rodgers, Savath, & Hettinger, 2010).  
Diabetic peripheral neuropathy pain (DPNP) is exhibited by a burning, tingling, or aching 
discomfort feeling with increased intensity at night (Barrett, Lucero, Robinson, Dworkin, & 
Chappell, 2007).  Individuals with DPN may experience pain and loss of sensation with impact 
on their functional status, mood, and sleep pattern (Lindsay et al., 2010).  Clinical findings such 
as type of pain (burning sensation, electric shock-like sensation, and aching coldness in the lower 
limbs), time of occurrence (at rest or at night), and abnormal sensations (tingling and numbness) 
assist in the diagnosis of painful diabetic neuropathy (Hartemann et al., 2011) 
 Symptoms diabetic individuals with DPNP may experience are limited mobility, extreme 
discomfort, and numbness (Barrett, Lucero, Robinson, Dworkin, & Chapppell, 2007).  These 
symptoms present activity limitations for those with diabetes to maintain an active lifestyle and 
functional status.  In addition to activity limitations there are challenges to maintain quality of 
life and adhere to recommended diabetic treatment regimens.  
Quality of life (QOL) domains are altered by DPN.  In one study, health related QOL 
domains (energy, sleep, pain, physical mobility and emotional reactions) presented lower scores 
for those with painful DPN (Benbow, Wallymahmed, & MacFarlane, 1998).  Van Acker et al. 
(2009) found painful symptoms of DPN affected the physical and mental aspects of QOL 
associated with age, body mass index, diabetes duration, female gender, and smoking.  In 
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contrast, painless Chronic Sensorimotor Diabetic Peripheral Neuropathy (CSDPN) had no 
significant impact on QOL (Hartemann et al., 2011).   
Prevalence and incidence estimates of DPN vary based on select study criteria and 
population (Hartemann et al., 2011).  Centers for Disease Control and Prevention (2011) 
estimates DPN as one of the most prevalent complication of diabetes mellitus at 60-70%.  
Painful diabetic peripheral neuropathy affects approximately 10-20% of patients with type 2 
diabetes (Lindsay et al., 2010) and five percent in patients with type 1 diabetes (2011).  Constant 
daily pain was experienced by 53% of diabetic neuropathy patients (Galer, Gianas, & Jensen, 
2000).  
 Treatment of diabetic peripheral neuropathy is conventional treatment options established 
and recommended by national guidelines to manage pain.  The American Society of Pain 
Educators provide a consensus guideline for DPN treatment with a collaborative plan between 
patient and provider to discuss pharmacological therapies to reach a goal of decreased pain, 
increased functional measures and quality of life (Argoff et al., 2006).  Conventional 
pharmacological therapies are antidepressants, anticonvulsants, opioids, topical agents, and other 
therapies such as spinal cord stimulation, frequency-modulated electromagnetic neural 
stimulation, acupuncture, transcutaneous electrical nerve stimulation, and magnetic insoles 
(Argoff et al., 2006).  Individuals and providers should consider comorbidities, other medication, 
treatment goals, potential side effects, drug interactions, cost, and availability of conventional 
DPNP treatment (Argoff et al., 2006).   
These individuals with painful DPN may not achieve adequate pain management, 
functionality, and quality of life with conventional treatment.  They may choose to explore other 
therapies, such as CAM.  Complementary alternative therapies may provide pain relief, eliminate 
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potential side effects from conventional treatment, increase function, and improve quality of life 
for those with DPN.  There is a need for healthcare providers to assess types of CAM treatments 
for DPN to provide more complete care (Lindsay et al., 2010). 
CAM therapies are unconventional therapeutic options used independent of traditional 
treatments or as an adjunct therapy.  The National Center for Complementary and Alternative 
Medicine (NCCAM) used the term “complementary and alternative medicine” to describe 
unconventional medicine (NCCAM, 2008).  According to NCCAM (2012), therapy used in 
conjunction with conventional medicine was termed “complementary medicine” and a therapy 
used instead of conventional medicine was “alternative medicine”.  CAM use was the 
implementation of diverse medical and health care systems, practices, and products that are not a 
part of conventional medicine (NCCAM, 2012).  In 2014, NCCAM’s name was changed by 
congress and signed by President Obama to National Center for Complementary and Integrative 
Health (NCCIH) (NCCIH, 2014).  This new name represents data from large population based 
surveys that the use of complementary therapy was used in combination with conventional 
treatment (NCCIH, 2014).  The use of CAM as an element of self-care was increasing (Canaway 
& Manderson, 2013). 
CAM includes natural products, mind and body medicine, manipulative and body-based 
practices, and other CAM practices.  Approximately 40% of Americans use nonconventional 
health care for general well-being or a particular condition.  It is common for complementary 
therapies to be used together with conventional medicine rather than the complete replacement of 
conventional therapies with alternative therapies (NCCAM, 2012).  
The purpose of CAM is to promote health and well-being through body, mind, and 
environment.  Types of CAM are alternative-medical systems (acupuncture, Ayurveda medicine, 
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homeopathic, naturopathy), biologically-based therapies (chelation, folk medicine, herbal, 
special diets, and megavitamins), manipulative/body-based therapies (chiropractic and massage), 
biofeedback, relaxation, hypnosis, yoga, tai chi, qi qong, and prayer (NCCAM, 2012).  See 
Appendix A for samples of CAM types for treatment of DPNP.   
A variety of complementary alternative therapies found in the literature were initially 
used by specific cultures.  For example, acupuncture implemented by the Chinese culture was an 
option for diabetic peripheral neuropathy pain relief (Tong, Guo, & Han, 2010).  Historical 
cultural CAM practices and purposeful cultural assessment may provide healthcare providers 
with insight to an individual’s CAM preferences and uses. 
The benefits from the use of complementary alternative therapy for DPN in other cultures 
may be applicable to Native Hawaiian diabetic individuals in Hawai'i.  The review of the 
literature explores the use of complementary alternative therapy and the ability to translate 
benefits for DPN through cross-cultural connections.  There is a need for healthcare providers to 
be culturally competent and increase their awareness of complementary alternative therapies 
used within various cultures (Lindsay et al., 2010).  In addition, healthcare providers may 
consider adding cultural practice and preference questions to routine health assessments.  
Improved communication about CAM use between healthcare providers and patients can lead to 
consideration for CAM referrals from conventional healthcare providers (Ben-Arye & Frenkel, 
2008). 
Self-management was the concept for this feasibility study and is found frequently in 
chronic illness literature.  Diabetes, a chronic illness, contributes to increases in the chronic 
illness population.  Patients with diabetes are expected to implement recommended self-
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management strategies daily to promote better health outcomes and delay diabetes-associated 
complications.   
 In chronic illness, self-management is the patient’s daily responsibility and includes 
health-promoting activities for disease management (Lorig & Holman, 2003).  A patient with 
diabetes faces daily health challenges to maintaining wellbeing and minimizing the burden of 
illness.  Implementing multiple daily self-management behaviors presents barriers when the 
individual feels overwhelmed (Chlebowy, Hood, & LaJoie, 2010). 
 Those living with diabetes may be required to perform blood sugar monitoring in order to 
maintain optimal glycemic control.  There are recommended daily self-management practices 
such as reducing nutritional intake of refined carbohydrates and saturated fat, increasing physical 
activity, and reducing weight (Hoerger, Gregg, Segel, & Saaddine, 2008).  Lifestyle changes 
may be considered to effectively implement these recommendations. 
 Individuals can experience a feeling of shock and additional burden when diagnosed with 
type 2 diabetes.  They may minimize the severity of type 2 diabetes based on their healthcare 
provider’s response.  Sometimes individuals blame themselves for poor choices over the years.  
They may feel a lack of support or a sense of loss on what to do to manage their diabetes (Crowe 
et al., 2017). 
Self-management for successful health promotion includes many skills: learning to 
problem solve, making decisions, utilizing resources, taking action, and developing partnerships 
between the patient and healthcare provider (Center for the Advancement of Health, 2002).  Self-
management education curriculum may incorporate recommended lifestyle changes.  
Recommended standards of diabetes self-management education from the American Diabetes 
Association could provide more guidance in relation to the effects of education and the 
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individual’s health status.  Despite healthcare professionals recommendations for individuals 
with diabetes to practice self-management Lorig & Holman (2003) found the healthcare system 
is not supportive of self-management education. 
 DPN is a complication of diabetes with multifactorial self-management concerns 
pertinent to access and utilization of health care.  The current recommended strategies include: 
(1) tricyclic antidepressants, (2) serotonin and noradrenalin re-uptake inhibitors, (3) 
anticonvulsants, (4) local analgesics, (5) N-methyl-D-aspartate receptor antagonists, (6) aldose 
reductase inhibitors, (7) sodium channel blockers, and (8) non-steroidal anti-inflammatory drugs, 
antiarrhythmics, and opioids for DPN self-management provide minimal improvement in pain 
management, functionality, and quality of life (Gilron, Watson, Cahill, & Moulin, 2006;  
Lindsay et al., 2010).  CAM may be a self-management option for individuals with DPN.  There 
is little research on CAM therapies used for self-management in Native Hawaiians with DPN.  
There is a need for exploration of CAM options for those who experience little relief from 
conventional therapies and seek other forms of DPN management and treatment.			
Purpose 
The objective of this feasibility study was to scrutinize the process of recruiting and 
interviewing Native Hawaiians and Part-Hawaiians in Hawai'i with DPN and explore reasons 
these individuals use CAM for self-management.  There were two specific aims: (1) to describe 
the process of conducting a feasibility study for Native Hawaiians and Part-Hawaiians with type 
2 diabetes and DPN and, (2) to describe reasons, experiences, and types of CAM used by Native 
Hawaiians and Part Hawaiians with type 2 diabetes and diabetic peripheral neuropathy. 
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Background: Information on Diabetes 
 In the United States, there are 29.1 million people or 9.3% of the population of all ages 
with diagnosed or undiagnosed diabetes.  These numbers are inclusive of all ages and types of 
diabetes.  A total of 1.7 million newly diagnosed diabetes cases were reported in 2012.  Pre-
diabetes diagnosis accounts for 86 million Americans aged 20 years or older (CDCP, 2014).  The 
focus of this study was type 2 diabetes in an adult, age 18 or older, Native Hawaiian population. 
Native Hawaiians have a higher risk of developing diabetes and diabetes complications 
compared to other ethnic groups in Hawai'i (King et al., 2012).   
 There are several types of diabetes: type 1 diabetes limits or eliminates insulin 
production, type 2 diabetes may be a combination of insulin resistance and insulin insufficiency, 
and Gestational diabetes is glucose intolerance during the third trimester of pregnancy.  Type 1 
diabetes occurs in five percent of diagnosed diabetic cases as compared to Type 2 diabetes 
present in 90-95% of diagnosed diabetic cases (CDCP, 2014).  Gestational diabetes prevalence 
estimates are from 4.6% to 9.2% (DeSisto, Kim, & Sharma, 2014). 
 There are reported racial and ethnic differences for people over 20 years old who are also 
diagnosed with diabetes.  The following adjusted percentages are 7.6% Non-Hispanic Whites, 
9% Asian Americans, 12.8% Hispanics, 13.2% Non-Hispanic blacks, and 15.9% American 
Indians/Alaska Natives (CDCP, 2014).   In the United States, diabetes prevalence and incidence 
trends increased from 1990 to 2008.  From 2008 to 2012, diabetes prevalence and incidence 
trends plateaued (Geiss et al., 2014). 
The term Native Hawaiian is defined as “any individual who is a descendent of the 
aboriginal people who, prior to 1778, occupied and exercised sovereignty in the area that now 
constitutes the State of Hawai'i” (U.S. Public Law 103-150, 1993, p. 1513).  Native Hawaiians 
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have high rates of diabetes, obesity, and metabolic syndrome (Aluli, et al., 2009; Grandinetti, et 
al., 1998; Grandinetti et al., 2007; Grandinetti, Kaholokula, Mau, & Chow, 2010; Kaholokula, et 
al., 2014; Mau, Sinclair, Saito, Baumhofer, & Kaholokula, 2009).  On the islands of Hawai'i, 
Kaua'i, and Moloka'i, prevalence of type 2 diabetes in Native Hawaiian adults are 19-24% in a 
population 30 years or older (Grandinetti, et al., 1998; Grandinetti, et al., 2010).  The comparison 
of this data with the National Health and Nutrition Examination Survey (NHANES), Native 
Hawaiians had a fourfold increase in type 2 diabetes prevalence compared to non-Hispanic 
whites (Grandinetti et al., 1998). 
Diabetes Management 
Management of diabetes is dependent on the daily lifestyle practices of those with 
diabetes (Adejoh, 2014).  Recommended daily lifestyle practices include healthy eating patterns, 
regular physical exercise, taking medication as prescribed, monitoring blood glucose level, 
maintaining regular clinic visits, and managing stress.  Balanced daily lifestyle practices are 
recommended for diabetes management (CDCP, 2014). 
 Unmanaged diabetes has been associated with heart disease, kidney failure, blindness, 
stroke, premature death, amputation of toes, feet, or legs and diabetic neuropathy (CDCP, 2014).  
These serious health complications contribute to total medical costs as well as lost work and 
wages estimated at $245 billion (CDCP, 2014).   The rise in medical costs doubles for those with 
diabetes compared to those not diagnosed with diabetes, and the risk of death is 50% higher for 
adults with diabetes (CDCP, 2014). 
 Unmanaged diabetes individuals may contribute to high rates of medical complications, 
high mortality rates, and preventable hospitalizations. Native Hawaiians were diagnosed at a 
younger age and died at a higher rate compared to other ethnic groups (Humphry, Jameson, & 
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Beckham,1997). There were efforts to evaluate culturally adapted community-based diabetes 
self-management interventions with Native Hawaiians and Pacific Islanders resulting in short-
term improvement on glycemic control (Sinclair et al., 2013). 
Geographically isolated, Native Hawaiians were a healthy population.  With little illness, 
Native Hawaiians promoted hygiene, consumption of good food, and rest (Dunford, Andrews, 
Ayau, Honda, & Williams, 2013).  A kahuna lapa'au, or healing priest, provided assistance to 
the sick and was viewed as a doctor.  The forms of healing included assessing the etiology of the 
illness through a process inclusive of the whole family.  Kahuna lapa'au had knowledge about 
many types of medicine from plants, shells, and fish.  Heiau is a Hawaiian temple.  These 
temples were constructed for a variety of purposes such as human sacrifices, fishing, and 
honoring Hawaiian Gods and healing.  Special temples or heiau for healing were erected.  
Hawaiians prayed to their gods for healing.  A few of the specific items of use for healing 
included taro, coconut, breadfruit, sweet potato, sugar cane, 'awa, and salt water to help heal 
wounds, manage ailments, and relieve pain (Dunford et al., 2013).  In a study, modern Native 
Hawaiians used a healer for adolescent Native Hawaiians in Hawai'i if they identified with the 
Hawaiian culture supportive of health and wellness through a holistic and spiritual approach 
(Bell et al., 2001).  Native Hawaiians in Hawai'i with a cancer diagnosis used CAM at a rate of 
30% (Maskarinec, Shumay, Kakai, & Gotay, 2000).  Maskarinec and colleagues (2000) in the 
same study found the most selected types of CAM used by Native Hawaiians with a cancer 
diagnosis in Hawai'i were religious healing/prayer (60%), vitamins/supplements (37.5%), and 
massage/body work (31%). 
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Significance of the Study 
This feasibility study is interested in seeking new knowledge about the reasons for use 
and types of CAM and factors that may contribute to DPN self-management in a Native 
Hawaiian sample population.  Harrigan et al. (2006), investigated practitioner provider-delivered 
CAM use in Hawai'i amongst the general population.  The study findings identified a number of 
factors for provider-delivered CAM use in the general population of Hawai'i.  These factors 
included a higher education level, higher income, and very good or good health status.  60% of 
poor health status respondents used CAM, 51.4% of overweight respondents used CAM, and 
52.1% of women respondents used CAM.  Demographic factors such as age and race/ethnicity 
reflected trends in CAM use.  The youngest and oldest respondents less frequently reported 
CAM use.  Caucasians reported the highest percentage at 60% of CAM users, Filipinos reported 
the lowest percentage at 37.1% of CAM use, and those without health insurance reported the 
highest portion of CAM usage at 53.7%.  Those with extreme pain that interfered with normal 
work were the highest percentage of people 78.3% that used alternative health care services 
(Harrigan et al., 2006).  Hawai'i has significantly higher percentages of provider-delivered CAM 
use than the whole United States.  This assumption is based on results of 49.9% in Hawai'i and 
75% corrected for prayer use compared to 25% National Health Interview Survey (NHIS).   
These results suggest the need for more exploration of factors of ethnicity, potential health 
complications, and economic consequences of provider-delivered CAM use (Harrigan et al., 
2006). 
Studies conducted in Hawai'i reveal the diabetic care provided met minimum nationally 
recommended diabetes standards.  But, the health outcomes for Native Hawaiians and Pacific 
Islanders remain poor.  It is evident that recommended diabetic care is not adequate for Native 
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Hawaiians and Pacific Islanders.  Hawai'i has a diabetic population that may practice CAM for 
treatment of DPN.   
The practitioner provided-delivered CAM use in a Hawai'i study, revealed most users of 
CAM did not use Lomilomi, Ho'oponopono, La'au Lapa'au or other traditional Hawaiian health 
practices (Harrigan et al., 2006).  These results may reflect a mistrust and reluctance to disclose 
use of Native Hawaiian Care system practices. An exploratory descriptive feasibility study could 
provide new knowledge of how best to study self-management with a Native Hawaiian and Part 
Hawaiian type 2 diabetic peripheral neuropathy population, to include identification of reasons 
CAM used or non-used in a Native Hawaiian DPN population. 
 Research is a needed to explore other self-management options such as CAM access and 
utilization for DPN people in Hawai'i.  In addition, there needs to be special attention placed on 
examining self-management options like CAM usage in the Native Hawaiian population 
experiencing a higher prevalence of diabetes compared to other ethnic groups found in Hawai'i.  
This feasibility study contributed by adding new information about the reasons of self-
management CAM therapies used in a Native Hawaiian DPN population on the island of O'ahu, 
Hawai'i. 
Summary 
Chapter 1 presented background on diabetes peripheral neuropathy (DPN) as a 
complication of chronic illness type 2 diabetes.  The prevalence rate of DPN was up to 50% of 
diabetics.  The national and state statistics show a high prevalence of diabetes in ethnic 
subgroups and those with low levels of education.  Native Hawaiians in Hawai'i have a high rate 
of diabetes prevalence as evident by a disproportion in the reported statistics.  This researcher 
scrutinized the process and feasibility of this study to provide insight for future studies. 
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Diabetes self-management is complex to manage, and delays complications.  The current 
literature highlights conventional treatment for DPN, a painful complication of type 2 diabetes, 
and provides limited or poor outcomes. CAM treatment options for DPN are presented in the 
literature and detailed in Appendix A.  Although CAM options are presented, the studies do not 
discuss utilization and access reasons for those with DPN or recommendations for healthcare 
providers.  The purpose of this feasibility study is to scrutinize the process of recruiting and 
interviewing the Native Hawaiian and Part-Hawaiian with type 2 diabetes complication DPN in 
selected Hawai'i outpatient clinics and the self-management reasons Native Hawaiians and Part-
Hawaiians accessed and utilized CAM. 
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CHAPTER 2. REVIEW OF THE LITERATURE 	
 Chapter 2 is a review of the literature of self-management for Native Hawaiians with type 
2 diabetes.  A critical review of the literature reveals what self-management Native Hawaiian 
data is evident to provide high quality care and conduct future research.  The concept of self-
management in daily life experiences for a Native Hawaiian person with chronic illness like type 
2 diabetes complication DPN is explored to attain knowledge on maintaining optimal health and 
quality of life.  The review of the literature examines type 2 diabetes and Native Hawaiians self-
management themes. 
Self-Management 
According to Thorne, Paterson, and Russell (2003), self-management is the ability and 
process an individual uses in a conscious effort to gain control over their disease as opposed to 
being controlled by their disease.  Self-management is defined by Wilkinson and Whitehead 
(2009) as the ability one has, together with family, community, and healthcare professionals, to 
manage symptoms, treatments, lifestyle changes, as well as the psychosocial, culture, and 
spiritual consequences of chronic diseases.  These definitions are a result of a concept analysis 
and the reflection of the burden experienced by the individual with chronic illness. 
Self-management is defined as the “ability of the individual, in conjunction with family, 
community, and healthcare professionals, to manage symptoms, treatments, lifestyle changes, 
and psychosocial, cultural, and spiritual consequences of health conditions (particularly chronic 
diseases)” (Richard & Shea, 2011, p.  261).  Self-management is often found in the chronic 
disease literature.  In the context of chronic disease, “chronic disease self-management is a fluid, 
iterative process during which patients incorporate multidimensional strategies that meet their 
self-identified needs to cope with chronic disease within the context of their daily living” (Miller, 
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Lasiter, Ellis, & Buelow, 2015, p.  158).   
A Chronic Illness Type 2 Diabetes Self-Management 
The term diabetes self-management is an expression of abstracted characteristics 
associated with a specific phenomenon (Rodgers & Knalf, 2000).  Nursing, education, public 
health, and social work literature promotes empowering the individual living with diabetes to 
provide self-management by creating a personalized plan supportive of the individual’s culture, 
priorities, goals, lifestyle, and resources (Funnell & Anderson, 2004; Boren, 2007).  The 
personalized plan is a tool to implement self-management.  An individual is able to identify 
support needs to create a personal plan to implement and maintain self-management. 
 The position statement by the American Diabetes Association (ADA) standards of 
Medical Care in diabetes (2007) focuses on diabetes care treatment goals and identifies 
diagnosis, access to self-management diabetes education, physical and cognitive skills, support 
for people living with diabetes and a realistic diabetes treatment plan as critical. The ADA does 
not specify guidelines for the diabetes treatment plan.  It is unclear if the plan is a collaborative 
effort between the healthcare provider, the individual living with type 2 diabetes and the support 
system.  The implementation of patient partnerships with health care professionals could be 
clarified. 
 Diabetes self-management involves a partnership between the individual living with 
diabetes and their health care professional in order to promote a healthy lifestyle and reduce 
diabetes complications (Skinner et al., 2006).  The relationship between an individual living with 
diabetes and their family members or significant other may also be the barrier for proper diabetes 
self-management and may lead to an incidence of diabetes complications.  Chronic disease 
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requires lifetime management from healthcare providers, families, and patients.  Diabetes is an 
example of a chronic disease that presents daily complex self-management decisions. 
Chronic illness literature focuses on the implementation of self-management strategies, 
adherence to plan, and ongoing support (Cook, Larsen, Sakraida, & Pedro, 2012; Kawi, 2012; 
Leake, 2003; Miller et al., 2015; Rasmussen, Maindal, & Lomborg, 2012; Rothenberger, 2011; 
Udlis, 2011).  Based on these attributes, self-management is complex and multidimensional.  
Although the word “self” is present, there are multiple factors not controlled by the individual.  
According to Udlis (2011), the social construct of self-management consists of person, family, 
society, and healthcare professionals.  The individual’s perception is an important part of self-
management concept.  The mutual investment antecedent is lost when clinical outcomes are self-
management success indicators based on healthcare provider’s outcomes (Udlis, 2011).  If self-
management outcomes are based on healthcare provider goals, then the concern for short-term 
implementation of self-management strategies may continue with no collaborative goal setting 
(Miller et al., 2015).  Nursing and healthcare goals are primarily focused on improvement in self-
care and symptom management (Richard & Shea, 2011).  These self-management goals could 
have better rates of implementation if the individual was consulted to set priority goals. 
Self-management in Native Hawaiians with Diabetes 
 Native Hawaiians face some of the greatest health challenges in the State of Hawai'i 
(Office of Hawaiian Affairs, 1998).  Diabetes contributes to the poor health status of Native 
Hawaiians and is one of the leading causes of death (Hawai'i State Department of Health, 2004).  
Other factors contributing to the high mortality rate, specifically from complications due to 
diabetes, are the accessibility to health care and the integration/acceptance of traditional health 
care beliefs and practices to support self-management. 
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Prior to European contact in 1778, Native Hawaiians maintained a complex social 
structure governed through a kapu system to sustain the health and wellness of self-sufficient 
communities (Casken, 2001; Dunford et al., 2013).  The land belonged to all and provided life 
for all those who lived in Hawai'i.  The Native Hawaiian social structure exemplified the concept 
of self-management.  In a sociocultural context self-management valued environmental 
processes.  Native Hawaiian spiritual wellness is linked to land, water, and atmosphere (Oneha, 
2001).   
Westerners brought new illnesses and imposed a new set of values on Native Hawaiians.  
The decline in Native Hawaiian health began as societal change took place.  The sense of 
community was replaced by Western views to promote individual possessions and land 
ownership.  The result is a most landless Native Hawaiian class with no access to the land or 
sense of place (Kent, 1983).   
The changes brought about by Western settlers altered both the cultural environment and 
the values of Native Hawaiian individuals.  A stable cultural environment may reduce diabetic 
complications and support community health.  The environmental alteration may have led to 
contributing factors for the high incidence of diabetes.  These alterations included financial, 
political, and cultural structure with direct impact on personal well-being.  The Native Hawaiian 
culture promotes health through a connection with body, mind, and spirit.  Diabetes wellness 
strives to achieve a balance between body, mind, and spirit through self-care.  Native Hawaiians, 
though, achieve balance through a link between individual and the environment.  Thus, the ADA 
(2007) established, recommendations for individual self-care management interventions, 
inferring that they may not be valued or effective with Native Hawaiians and non-white 
individuals living with type 2 diabetes in Hawai'i.  Diabetes affects the whole person and their 
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community.  A comprehensive and culturally competent approach to diabetes care may provide 
balance for individuals who value cultural practices. 
 A historical perspective focused on Native Hawaiian culture, diabetes, and self-
management guided the review of the literature. Medicine has been a driving force in early 
diabetes medical discoveries and management.  In the 1930’s, diabetes self-management was 
incorporated into clinical management (Bartlett, 1986).  The high incidence of indigenous 
populations such as Native Hawaiians with diabetes highlighted the issue of cultural competence 
in diabetes self-management.  The term “self” may not be a priority for indigenous populations 
who practice interdependence. 
 Diabetes care may be provided by a variety of disciplines interested in the concept of 
self-management.  There are the selected disciplines for the analysis of self-management; 
nursing, medicine, psychology, education, and sociology.  In the literature, disciplines were 
selected as recognized authorities for the concept of self-management and cited by other 
scholars. The goal of this concept analysis was to provide a rigorous design to clarify the concept 
of self-management in Native Hawaiians living in Hawai'i with type 2 diabetes. 
An inductive approach to collecting data consistent with the evolutionary method concept 
analysis was utilized in a review of the literature.  Online search engines used included Cochrane 
Library, Cumulative Index to Nursing Allied Health Literature (CINAHL), Native Hawaiian 
Health Database, Pub Med MEDLINE, PsycInfo and Science Direct.  Government and 
organizational websites such as Center for Disease Control, U.S. Census Bureau, Hawai'i State 
Department of Health, American Diabetes Association, and International Diabetes Federation 
were reviewed.  An interdisciplinary data analysis approach included nursing, medicine, 
education, sociology, and psychology provided self-management concept information.   
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 The literature review search strategy started with a selected timeline between 2012 and 
2017 with the purpose to gather current data from the past five years.  Refined keyword search 
terms included: self-management, type 2 diabetes, and Native Hawaiians. Twenty-nine articles 
resulted.  However, four articles contained essential key words and met the inclusion criteria to 
provide knowledge on how best to conduct research with a Native Hawaiian population and type 
2 diabetes self-management.  Native Hawaiians with type 2 diabetes and self-management are 
underrepresented in the literature providing opportunity for future research. 
Self-Regulation Factors 
 The first article utilized a cross-sectional design to survey the daily dietary assessments, 
social support, and self-regulation factors (cognitive and behavioral) related to diet and physical 
activity.   “Talk story” sections were employed in this survey (McEligot et al., 2010).  According 
to McEligot et al. (2010), the condition of Native Hawaiians with type 2 diabetes may be 
influenced by several factors: diet, body mass index (BMI), psychosocial issues and cultural 
issues.  There were 62 consenting participants for the original sample.  The measurement 
outcomes were focused on socio-demographic elements, pre-existing health conditions, dietary 
assessments, a psychosocial questionnaire, and “talk story”.  The results revealed a BMI category 
of obese (>30 Kg/m2) for more than 50% of participants as well as low fruit and vegetable intake 
of one to three servings per day.  Psychosocial factors influencing self-management behaviors 
such as diet, exercise, and preparation of healthy food with family and friends were significantly 
low in participants with type 2 diabetes (p< 0.05).  The “talk story” sections mentioned the 
concern about diabetes associated with weight, diet, and exercise in the Hawaiian population and 
barriers to implement self-regulatory factors such as regular exercise and food portions.  
Psychosocial concerns were individual change and community change (McEligot et al., 2010). 
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 McEligot et al. (2010) described feasibility research strategies for work with Native 
Hawaiians.  These strategies included meetings with community advisory board (CAB) and key 
organizational partnerships.  Organizational partnerships established were with 'Āinahau O 
Kalepoi Civic Club and Pacific Islander Health Partnership (PIHP).  The CAB had a pivtol role 
in study protocol development, questionnaire review, and recruitment.  Recruitment methods 
were forming partnerships with Native Hawaiian groups, culturally appropriate fliers, 
recruitment via telephone and in person and cultural gatherings (McEligot et al., 2010). 
Culturally Adapted Self-Management  
 The second article randomized assigned participants to the Partners in Care culturally 
adapted self-management intervention (n=48) or wait list (delayed intervention control group) 
(n=34) (Sinclair et al., 2013).  The Partners in Care intervention was a culturally adapted 
community-based diabetes self-management intervention among Native Hawaiians and Pacific 
Islanders.  Focus groups content utilized included diabetes self-management and diabetes related 
complications, group-based educational format to enable social support, and a delivery method 
by a Native Hawaiian in a convenient community location.  Several self-management content 
areas of type 2 diabetes participant’s interest were medication and side effects, dietary intake 
related to blood glucose, and healthcare provider expectations related to specific examinations.  
Sociocultural relevant strategies included trained peer educators from the participants 
community, used “local” language, and integrated cultural values of family and community 
working together were implemented.  The outcome measures included A1c (a measured 
percentage of glycated hemoglobin) diabetes self-management understanding, self care activities 
performance, and diabetes-related distress.  The Partners in Care intervention decreased A1c by 
1%, and improved self-management understanding, self-management performance, and glycemic 
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control.  The conclusion was a community-based program with cultural aspects and community-
based peer educators showed improvements in type 2 diabetes self-management in Native 
Hawaiians and Pacific Islanders. 
 Feasibility issues addressed by Sinclair and colleagues (2013) for the Native Hawaiians 
were the demands of their time related to work and family resulting in not completing 
participation in the study.  Partners in Care, recruited participants from community-based health 
clinics and a Native Hawaiian community organization.  Community leaders, health advocates, 
and researchers served Native Hawaiians and connected with the PILI 'Ohana project for 
Partners in Care.  A concern these community entities shared, was evidence of diabetes-related 
complications in their communities.  The role of community leaders and health advocates was to 
provide guidance, planning and intervention (Sinclair et al., 2013).   There was evidence of 
community partnerships to support feasibility of Native Hawaiian research. 
Social Support and Self-Management 
 The third article, Ing et al. (2016), examined Native Hawaiian and Pacific Islander 
participants and the effects of a diabetes specific social support maintenance component with 
community-academic partnership through the PILI 'Ohana Project (POP).  In a randomized 
controlled trial, participants (N=25) were in semi-structured support groups randomly assigned 
with six meetings over three months and a standard follow-up group (N=22) received six 
postcards over three months.  The semi-structured positive support group reinforced positive 
changes.  The outcome measures were self-management self-care behaviors and A1c control.  
Trained community facilitators and health professionals led semi-structured support sessions.  
Community facilitators provided appraisal and emotional support for participants in order to help 
them assemble added support from family and friends for diabetes self-management.  Healthcare 
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professionals provided information and appraisal related to self-management activities.  The 
baseline results for demographic and clinical measures were primarily a high school educated 
Native Hawaiian obese female with type 2 diabetes sample with elevated A1c.  This study 
concluded that social support had modest improvement in type 2 diabetes self-management 
understanding and frequency of self care activities.  However, improvements for glycemic 
control were not statistically significant. 
 Feasibility efforts were supported by community partners Kula No Na Po'e Hawai'i (a 
nonprofit serving urban Hawaiian Homesteads), Hawai'i Maoli (a nonprofit serving the Hawaiian 
Civic Clubs), Ke Ola Mamo (the Native Hawaiian Health Care system for Oahu), and Kōkua 
Kalihi Valley (a health clinic serving low-income Pacific Islanders) recruiting participants, 
delivered interventions, and conducted baseline assessments (Ing et al., 2016).  Community 
researchers had a belief that social support groups promoted building relationships outside of the 
intervention (Ing et al., 2016).  These supportive relationships may contribute to feasibility of 
Native Hawaiian research. 
Distrust and Self-Management 
 Distrust in Native Hawaiian communities was a significant barrier to participation in 
epigenetic studies, which was stated in a community-based participatory research (CBPR) 
approach randomized control trial interventional testing and epigenomic analyses study by 
Townsend et al. (2016).  The purpose of the study was to describe the community-based 
participatory research approach and research process employed to integrate behavior and 
biological sciences with community health priorities.  Diabetes self-management interventions 
for A1c, self-care activities, and diabetes distress and understanding in a sample of (N=65) were 
examined.  Community, behavioral, and epigenomic expertise were used to understand diabetes 
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self-management intervention outcomes.  Community-based organization Kula No Na Po'e 
Hawai'i had a responsibility to protect the community members they serve and was skeptical 
about biospecimen collection.  Prior to conducting research, there were efforts made by a Native 
Hawaiian investigator to build relationships and community trust with open communication and 
accessibility to information.  The Native Hawaiian researcher was invited to attend monthly PILI 
'Ohana (POP) meetings with community members, principal investigators, project coordinators, 
and research assistants to present an overview of his epigenetic research.  A mutual benefit to 
both the community and the science for type 2 diabetes self-management was evident.  
Community participant priority was met through collaborative, culturally sensitive, physically 
safe, comfortable, and convenient protocols such as biospecimen collection accepted by 
community and participants and taking place in the community. The researchers recommended 
ongoing open communication, committed time for relationship building, support indigenous and 
minority researchers to improve research and relationships in these communities, and mutual 
benefits to both science and the community (Townsend et al., 2016). 
A self-management characteristic found in the Native Hawaiian population with type 2 
diabetes is a trusting relationship with healthcare team members (Humphry et al., 1997).  The 
provision of medical care through a community-based health care worker who can coordinate 
health services, is a method that reflects the social, economic and political interest of Native 
Hawaiians.  This was found to be preferred in a multiethnic community over the traditional 
office-based health care system (Humphry et al., 1997).  In the literature, self-management 
resulted in better health and wellness that improved.   
Native Hawaiians living with type 2 diabetes may choose to have an active role in 
creating a partnership with healthcare providers in order to determine a culturally appropriate 
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diabetic care plan.  A partnership between the individual with type 2 diabetes and the healthcare 
provider may improve quality of life and decrease symptoms of depression.  The integration of 
cultural values such as a connection to the land in some form is evident in successful self-
management and wellness (Oneha, 2001).  Native Hawaiians value connections between 
political, economical, and social integration in healthcare.  In summary, these connections may 
provide a sense of trust and diabetes self-management implementation. 
Research implementation with a Native Hawaiian population was dependent on 
developed relationships with community gatekeepers.  Potential research contributions and 
benefits were heard and discussed in a community meeting format.  Through a concerted effort 
community leaders execute an evaluative system to prevent research that was not mutually 
beneficial or perceived as harmful to their community.  These variables contribute to the 
feasibility of Native Hawaiian community-based participatory research. 
Self-management Definition in Native Hawaiians 
The definition for type 2 diabetes self-management in Native Hawaiians based on the 
literature and was a dynamic participatory daily process during which a choice of self-
determined multidimensional strategies were employed to cope with type 2 diabetes and 
complications of type 2 diabetes while being supported by both social relationships and 
collaborative partnerships.  This definition recognizes the self-determining actions of the 
individual and importance of support.   
Native Hawaiians living with type 2 diabetes may choose to collaborate and create 
partnerships with 'ohana (family), community, and healthcare providers.  These collaborations 
and partnerships may help in decision-making, achieving and maintaining glycemic control, 
enacting a healthy diabetic lifestyle, and developing preferred cultural values.  Townsend et al. 
		 25	
(2016) described the importance of trust in Native Hawaiian research by forming collaborative 
partnerships to support identified community health priorities.  Diabetes-related social support 
groups were made up of individuals, family members, physicians, and other diabetes experts, a 
method preferred by the Native Hawaiian communities to reinforce culturally adapted 
recommended American Diabetes Association interventions and National Diabetes Education 
Program guidelines for a health diabetic lifestyle (Ing et al., 2016).  Diabetes self-management 
interventions were culturally adapted for a Native Hawaiian population to assess effect on 
understanding of diabetes self-management, glycemic control, self-care activities, and diabetes 
related distress (Sinclair et al., 2013).  After three months improvement of glycemic control was 
evident with diabetes self-management interventions in a Native Hawaiian population (Sinclair 
et al., 2013).  Native Hawaiians with diabetes may have improved outcomes supported by socio-
cultural values through 'ohana, “talk story” discussion groups, and community gatherings 
(McEligot et al., 2010).  Through a culturally accepted method of group discussion Native 
Hawaiians share concern regarding diabetes (McEligot et al., 2010).  Diabetes self-management 
outcomes and research with Native Hawaiians supports integration of culturally accepted 
interventions such as preliminary meetings prior to conducting research, inclusion of community, 
and identification of Native Hawaiian health priorities. 
The concept of self-management is theoretically applicable to a variety of ethnic groups.  
The daily dynamic participatory process and recommended diabetic self-management activities 
may not be culturally accepted by individuals from ethnic groups who prefer a group approach 
instead of an individual-focused approach.  The Western view on self-management is to promote 
the individual primarily without a connection to community (Kent, 1983).  The concept of self-
management is determined and defined by the individual.  Medication adherence plays an 
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important role in diabetes self-management. 
 Native Hawaiians and Part Hawaiians represent the diversity in type 2 diabetic patients.  
A review of diabetes data in Asians, Native Hawaiians, and other Pacific Islanders, focused on 
understanding the differences in diabetes pathophysiology, suggests a need to increase Native 
Hawaiian clinical research.  Current clinical guidelines were based on a limited Native Hawaiian 
representation with a possible need for different treatment guidelines (Hsu et al., 2010).   Studies 
on diabetes treatment, prevention, and dietary guidelines are needed to support the recommended 
Western medicine approach in diabetes self-management.  
Summary 
 Chapter 2 presents a review of the literature of self-management utilizing the 
evolutionary method as a framework.  The systematic review of the literature in nursing, 
medicine, education, psychology, and sociology was conducted. Self-management could be used 
for both acute and chronic conditions.  There was also agreement that the person with type 2 
diabetes should be the center of self-management.  
 Self-management attributes reveal a dynamic process.  A process with multidimensional 
strategies implemented daily to improve health outcomes. The implication of a perceived sense 
of control, guided by evidence-based treatment and guidelines should be given attention in order 
to promote self-management. 
 Native Hawaiians have shown significant improvement with type 2 diabetes self- 
management.  They have an understanding and practice self-management skills for a short 
duration with culturally tailored self- management programs to meet their individual and 
community needs.  Important cultural values of families working together to support community 
were described to promote type 2 diabetic self-management support.  However, social support 
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did not have a significant impact on type 2 diabetes self-management understanding and self-
care behaviors.  The development of relationships in the Native Hawaiian community was 
critical to engaging participation in research.   Self-management practices in Native Hawaiians 
with type 2 diabetes may be known to this population, despite distrust due to previous 
mistreatment of scientific research performed in an effort to protect their community.  There was 
concern that recommended diabetes-care guidelines might not be effective for the Native 
Hawaiian population due to limited Native Hawaiian representation in clinical research.  The 
review of the literature revealed Native Hawaiian type 2 self-management research efforts that 
could be helpful for future research. 
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CHAPTER 3. METHODOLOGY 	
Chapter 3 describes the specific aims, conducted feasibility study processes, and methods 
of analysis.  There were two specific aims in this study.  The first specific aim was to describe 
the process of conducting a feasibility study for Native Hawaiians and Part-Hawaiians with type 
2 diabetes and DPN.  The second specific aim was to describe reasons for CAM use, experience 
of CAM use, and types of CAM used by Native Hawaiians and Part-Hawaiians with type 2 
diabetes and DPN self-management.  
After the type 2 diabetes Native Hawaiian background review of the literature identified a 
problem of increased rates of diabetes in the Native Hawaiian community and the challenges 
individuals experience with diabetic complications such as DPN.  Several research questions 
were formulated to reflect the knowledge gap.  
1. Are Native Hawaiians and Part-Hawaiians with type 2 diabetes and DPN using 
CAM? 
2. What are the reasons CAM are being used? 
3. Do Native Hawaiians and Part-Hawaiians combine CAM therapies? 
4. Are CAM therapies being used for type 2 diabetes self-management? 5. What are the characteristics of Native Hawaiian and Part-Hawaiian CAM users?	
Feasibility Study Process 
Feasibility study is defined as “research conducted to determine whether something can 
or should be done and, if so how” (Morris & Rosenbloom, 2017, p. 39).  The feasibility study 
framework was used for this study.  To gain insight in the use and process of a feasibility study 
framework a review of current information on type 2 diabetes self-management feasibility 
studies was done in the Cumulative Index to Nursing and Allied Health Literature (CINAHL) 
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database.  As a strategy, refined search words used were feasibility study, self-management, and 
type 2 diabetes.  This search strategy resulted in 16 studies.  There were 10 studies out of the 16 
studies published within the past five years and reviewed. 
The feasibility studies on type 2 diabetes self-management shared a similar purpose, to 
evaluate effectiveness, acceptability, and sustainability of self-management interventions.  There 
was evaluation of interventions such as adapted patient centered educational intervention for type 
2 diabetes self-management (Brunk, Taylor, Clark, Williams, & Cox, 2017), culturally tailored 
digital storytelling educational self-management intervention (Wieland et al., 2017), telephone 
and text-messaging diabetes self-management intervention (Wu, Sung, Chang, Atherton, 
Kostner, & McPhail, 2017; Haddad et al., 2014), web-based self-management intervention 
(Ramadas, Chan, Oldenburg, Hussien, & Quek, 2015; Nes, Eide, Krisjánsdóttir, & van Dulmen, 
2013) and integrated self-management interventions (Kaltman et al., 2016).  In the web-based 
self-management intervention for type 2 diabetes, Nes et al. (2013) recommended booster 
sessions for prolonged promotion of self-management.  These studied self-management 
interventions were found to be feasible, effective and accepted by participants with type 2 
diabetes.  
Savage et al. (2014) feasibility study focused on the ability to retain subjects in a diabetes 
self-management intervention for adults experiencing homelessness.  The results revealed 9 
subjects recruited, 5 retained, and 2 of 3 completing the full diabetes self-management 
intervention (Savage et al., 2014).  These finding may indicate future implementation of 
alternative retention strategies for subjects experiencing homelessness.   
In a feasibility study with a mixed-methods design approach, Sell (2013) discovered 
older adults made type 2 diabetes self-management behavior changes by being accountable to 
		 30	
someone and having a health coach.  The health coach method and accountability to someone 
other than a peer or family was preferred by older adults to avoid being a burden to family 
members or children (Sell, 2013).  Another mixed-methods design feasibility study used type 2 
diabetes self-management semi-structured interviews and a nurse-led or standard care (Hegney, 
Patterson, Eley, Mahomed, & Young, 2013).  It was concluded that nurse-led care was 
acceptable, feasible, and sustainable (Hegney et al., 2013).  These mixed-method feasibility 
studies provide insight for consideration to restructure the process of future research in type 2 
diabetes self-management.  In these feasibility studies the aim was to evaluate if the conducted 
could and should be done.  The feasibility framework provides an opportunity to develop 
research processes. 
The components of this feasibility study process included the setting, sample, 
recruitment, procedures, response rate, quality of responses, instruments, formulation and 
implementation of the protocol, and qualities of researcher.   
Setting 
 This feasibility study was carried out at two outpatient clinics of The Queen’s Medical 
Center (QMC) in Honolulu, Hawai'i.  The QMC is an urban medical center with a mission to 
provide quality health care services to improve the well-being of Native Hawaiians.  The 
selected clinics provide diabetic care.  One of the clinics provided diabetic wound care.  This 
nurse researcher contacted and met with the manager and medical director of the clinics to assess 
the feasibility of conducting a study with a Native Hawaiian with type-2 diabetes. Managers and 
medical directors stated that the Native Hawaiian population was not a large group receiving 
services at these clinics, which presented a possible challenge for the nurse researcher.   
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This setting was selected because the nurse researcher was familiar with the general medical 
center and had preexisting professional relationships with clinic managers, physicians, and staff.  
The nurse researcher was knowledgeable of policies, procedures, and how to access basic 
support in this medical center.  These attributes could have been a possible advantage to conduct 
research in this facility.  
Sample 
 Clinic patient record staff, and the clinical staff of two clinics, screened patients based on 
inclusion and exclusion criteria.  The list of eligible patients was given to the nurse researcher.  
These 128 patients including Asian Americans, Pacific Islanders, and Native Hawaiians were 
convenience samples that met the inclusion and exclusion criteria.  The inclusion and exclusion 
criteria included being at least age 18 years old, having been diagnosed with DPN, able to 
understand the English language, and able to verbalize understanding of the purpose and 
procedure of the study.  The sample was Native Hawaiians and Part Hawaiians with DPN living 
on the island of O'ahu, Hawai'i receiving health care at an urban hospital-based outpatient clinic. 
Recruitment 
The recruitment process was approved by the clinic manager, medical director, and 
research and institution review committee. The Queen’s Medical Center Research and 
Institutional Review Committee identification number for this study was RA-2014-315. The 
University of Hawai'i at Mānoa Human Studies Program institutional review board number was 
CHS 22591.  Recruitment process was done at two outpatient clinics.  The medical director of 
the outpatient primary care clinic recommended to start with a list provided by clinic patient 
records staff based on diagnosis of type 2 DPN.  A preliminary scripted phone call was made to 
patients with type 2 DPN in which a request to meet was made at their next scheduled clinic visit 
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or in person at the clinic visit.  A study recruitment brochure was posted in clinics to recruit 
study participants. 
 The manager for the wound care clinic, requested that potential participants be 
approached in person at their clinic visit, specifically at the face-to-face clinic appointment.  This 
was the portion of the recruitment process in which the inclusion and exclusion criteria for 
participation in the study was confirmed.  
Procedures 
Both clinic managers and the medical director agreed to have clinics serve as research 
sites and completed the form letter of agreement that was submitted to the chairperson of the 
hospital institutional review committee.  Physician’s permission in providing service to DPN 
patients was required by the hospital institutional review committee and obtained by the nurse 
researcher prior to conducting research.  An email was sent out to physicians from both clinics. 
Physicians confirmed support by email reply.  These emails were forwarded to the researcher 
and the hospital institutional review committee as part of the institutional review board 
requirements.  
 The procedures were similar for both clinics: eligibility was determined at the clinic 
appointment, informed consent was obtained and a copy of signed forms was faxed to the 
Queen’s Medical Center’s department of research and development (see Appendix E).  On the 
same day, the face-to-face interview with structured questionnaires of CAM and 36-Item Short 
Form Survey Instrument (SF-36) survey was conducted.  Queen Emma Clinics and Wound Care 
Clinic Staff provided support by informing the nurse researcher when it would be the best time to 
meet with the potential participant.  Data collection process occurred when: (1) the physician 
was done with the appointment, (2) the patient was waiting for their next appointment, or (3) the 
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physician was delayed and the patient was waiting.  These interludes provided opportunities for 
the nurse researcher to confirm eligibility and start the face-to-face interviews.  This method of 
interviewing required extensive preparation and considerable time to collaborate with patients 
and staff.  The complexity of a multiservice primary care unit required the nurse researcher to 
collaborate with staff to schedule the interview before, after, or between appointments.  The staff 
of the primary care clinic supported the nurse researcher with a private examination room for the 
interview process.  The Queen Emma Clinic Manager communicated the importance of not 
disrupting the workflow involved with patient care.  The nurse researcher worked closely with 
staff, responsible for both checking patients in and providing care to minimize disruption of the 
clinic workflow.  In the wound care clinic, a patient appointment might take up to an hour 
because of wound care treatments. Patients consented to participating in the research.  
Participants were given a choice to either be interviewed with clinic physician and staff in the 
room during the interview or, for privacy, to wait until they were alone.  It was only in the 
Wound Care Clinic that staff or a physician would be present in the private examination room for 
a portion of the interview.  
Response Rate 
 The nurse researcher attempted to recruit in person at the participant’s clinic appointment 
in cases where they were not reachable by phone.  The nurse researcher tried to contact potential 
participants who were not present for clinic visits by both home phone numbers and alternate 
phone numbers, which were provided by clinic staff.  Response rate was calculated with the 
following formula, the number of participants who completed the face-to-face interview divided 
by the number of eligible participants who met the inclusion criteria and went through the face-
to-face interview. 
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Quality of Responses 
The quality of responses was an important part of this feasibility study (Morris & 
Rosenbloom, 2017).  The method of face-to-face interviews was referred to as the best method to 
collect survey data and obtain quality information (Polit & Beck, 2008).  The participants might 
have planned to meet with the nurse researcher at their scheduled clinic visit because of the 
preliminary phone call and verbal confirmation by both the patient and the nurse researcher.  
Most of them were excited to meet, interested in hearing more about the study, and ready to 
participate.  For those who were approached in person at the primary care clinic visit concerns 
about missing a scheduled transportation pick-up, and the amount of time it would take to 
participate were mentioned.   These patients may have had multiple appointments scheduled on 
the same day and verbalized being tired.  These reasons may potentially have compromised the 
quality of responses.   
Patients at the wound care clinic experienced a longer appointment, which often required 
them to lie on an examination table for more than 30 minutes.  They were interested in having 
someone to talk to during this visit.  Participating in the study might have served as a positive 
distraction during their weekly clinic appointment and this may have provided quality responses.  
The advantages was that patients had time to answer each question, because their appointment 
may be scheduled for an hour compared to the Queen Emma Clinic visits, which are estimated to 
be 15 minutes long.   
 The nurse researcher stated questions from of the aforementioned surveys during the 
face-to-face interaction.  This may be a bias because the nurse researcher may have used certain 
vocal tones unconsciously or individuals may have responded to the way they thought the nurse 
researcher wanted them to respond.  For example, for CAM users the researcher asked, “What 
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was the advice of the healthcare professional after you discussed about CAM use?”  The 
respondent might not have disclosed a quality response because a healthcare professional was 
asking this question.  Another question for CAM users was, “How do you use your Western 
medication when you are using CAM?” Participants might choose, “no change,” because the 
care received from this clinic recommended that participants take Western medications.  With 
some individuals, the nurse researcher showed them the questions and responses if they could 
not remember the available answer selections.  The estimated completion time for both surveys 
was 15-30 minutes.  However, for patients who did not understand the question and requested 
the nurse researcher to repeat or explain the question or a particular word, the interview may 
have lasted longer than 30 minutes and there may be biases.  The percentage of participants that 
asked the researcher to repeat questions or clarify words was not tallied.  An estimate, though, 
would be about 50% or more participants requested that at least one question or word to be 
clarified.   
Instruments 
The selected instruments were the Hsiao-Yun Annie Chang CAM Use Survey and 36-
Item Short Form Survey Instrument (SF-36).  A search of the literature was performed to find an 
instrument to assess the CAM use in Native Hawaiians with type 2 diabetes.  There were no 
instruments found for CAM use in a Native Hawaiian type 2 diabetic population.  The 
demographic data was collected with the CAM Use survey.  This CAM survey was selected to 
capture diabetic clinical data and reasons for CAM use and non-use in a type 2 diabetic 
population. 
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Hsiao-Yun Annie Chang CAM Use Survey 
 The Hsiao-Yun Annie Chang CAM Use Survey was previously used in a diabetic 
outpatient clinic population in Taiwan (Chang, Wallis, & Trialongo, 2011).  The CAM survey 
contained 133 questions with multiple responses created for use in Taiwan diabetic clinics 
servicing a type 2 diabetes population (Chang, et al., 2011).  This instrument was selected for the 
focus on the reasons for CAM and previous use in a type 2 diabetic population. There was no 
specific CAM instrument found for Native Hawaiians.  This instrument was developed for a 
Chinese population in Taiwan.  Please see Hsiao-Yun Annie Chang CAM Use Survey in 
Appendix F. 
The 36-Item Short Form Survey 
 The 36-Item Short Form Survey Instrument (SF-36) was used to assess general health 
with a focus on eight health concepts: physical functioning, role limitations due to physical 
problems, social functioning, bodily pain, mental health, role limitations due to emotional 
problems, vitality, and general health perception (Ware, Snow, & Kosinski, 1993).  These 
instruments were selected because the content-assessed general health with a focus on bodily 
pain and CAM. 
 The SF-36 was previously used in a study focused on Native Hawaiians with diabetes 
(Kaholokula et al., 2014).  The SF-36 was selected to assess perceived general health and bodily 
pain for individuals with DPN.  There were a total of 36 questions with answer selections 
ranging from two to six.  Please see 36-Item Short Form Survey Instrument (SF-36) in Appendix 
G. 
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Formulation and Implementation of the Protocol 
 The protocol formulated in collaboration with two outpatient clinics leadership groups 
was feasible.  Each clinic had a different workflow, which required a different recruitment 
protocol.  The ability to recruit potential participants was present at both sites.  The Queen Emma 
Clinics presented more opportunities because it serviced a larger patient population compared to 
the Wound Care Clinic.  For both sites, clinic staff and physicians were supportive of the nurse 
researcher by informing patients that the nurse researcher was there to discuss an opportunity to 
be a part of a research study or if previous arrangements were made, that the nurse researcher 
was there to meet with them.  In the busy clinic environment, time with participants and a space 
to meet were made available. 
Method of Analysis 
All of the collected data was presented in frequency and percentage.  Collected data for 
both the CAM use and SF-36 instrument was inserted into an Excel workbook spreadsheet.  The 
research ID codes were entered on the y-axis and the questionnaire item on the x-axis.  Each item 
response code or text response was entered into the corresponding cell of the specific research 
ID.   
Once all of the responses from the questionnaires were entered into the Excel workbook 
spreadsheet, IBM SPSS statistical software version 22.0 (henceforth referred to as SPSS) was 
used to analyze the data.  Descriptive statistics analysis was used with special attention to 
frequencies and percentages in the data entered.  The frequencies were helpful to the nurse 
researcher for identifying the total sample and subset groups within the sample.  The percentages 
assisted with the analysis of impact in relation to the group.  Frequency and percentage data 
output from SPSS was placed into tables for reference and review. 
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The initial analysis identified the sample of Native Hawaiian and Part-Hawaiian 
participants from the original sample of N=71.  The subgroup of Native Hawaiians (n=6) and 
Part-Hawaiians (n=15) represented the sample for this dissertation.  The method of analysis to 
examine collected data required the nurse researcher to think about the specific aims and 
potential new knowledge.  Descriptive characteristics and clinical data collected from the CAM 
use instrument were retrieved and analyzed after the establishment of the studied Native 
Hawaiian and Part-Hawaiian population frequencies and percentages.   
To explore Aim 2: the CAM reasons for CAM use, experience of CAM use, and CAM 
types used by Native Hawaiians and Part-Hawaiians with type 2 diabetes and diabetic peripheral 
neuropathy, the respondents were codified into 2 groups.  Those reporting CAM usage were 
grouped as CAM users and those not using CAM were grouped as Non-CAM users.  The 
analysis revealed one participant was a CAM user and then proceeded to stop using CAM.  This 
participant was counted in both categories: of the CAM users and the non-CAM users.  Further 
analysis of CAM users and non-CAM user data was done in order to examine the reasons for 
CAM use or non-use, experience of CAM use, and types of CAM use. 
SF-36 Instrument 
The SF-36 assessed perceptions of general health and bodily pain.  These two areas were 
examined for CAM use.  The discovery of data in the general health and bodily pain groups 
guided the researcher to implement additional analysis. The researcher attempted to examine 
these groups with more depth and detail by comparatively analyzing the descriptive 
characteristics. See Figure 1 for Methodology Analysis. 
The descriptive statistical analysis of a feasibility study process and CAM use by Native 
Hawaiian and Part-Hawaiian type 2 diabetics with diabetic peripheral neuropathy was helpful in 
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providing insight for the design of future studies.  The limitation of the inability to generalize or 
make conclusions was considered.  However, this contribution opens the possibility for future 
researchers interested in CAM use in the aforementioned populations.  
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Figure 1. Methodology Analysis 
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Summary 
 Chapter 3 provided an overview of the methodology used for this study, which included 
both strategies that worked and strategies that did not work.  A feasibility design was 
recommended for this study.  Chapter 3 was guided by specific aim one - to describe the process 
of conducting a feasibility study for Native Hawaiians with type 2 diabetes and DPN and specific 
aim two - to describe reasons for CAM use, experience of CAM use, and CAM types used by 
Native Hawaiians and Part-Hawaiians with type 2 diabetes and diabetic peripheral neuropathy.  
 The description provided for the conducted feasibility study included the process.  
Starting with a sample of Native Hawaiians and Part-Hawaiians, in a setting in urban medical 
center outpatient clinics, recruitment, and procedures did reveal opportunities for adjustments.  
The instruments selected might have presented limitations in regards to cultural appropriateness 
or participants being unfamiliar with questionnaire terms.  It was recommended that there be 
development of a CAM use tool for Native Hawaiians and Part-Hawaiians.  The opportunity to 
conduct the study with the established procedures might provide insight for future studies.  
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CHAPTER 4. FEASIBILITY STUDY RESULTS 	
In Chapter 4, the results of this feasibility study are presented in the following sequence; 
the challenges experienced during the process of a feasibility study, descriptive characteristics of 
respondents, and results for reasons Native Hawaiians and Part-Hawaiians used CAM for 
diabetes, diabetes complications and general use.  Results are summarized for the first specific 
aim to describe the process of conducting a feasibility study and second specific aim to describe 
reasons of CAM use, experience of CAM use, and CAM types used by Native Hawaiians and 
Part-Hawaiians with type 2 diabetes and DPN self-management. 
Challenges in the Process of a Feasibility Study  
Setting and Sample 
The urban hospital of the two selected outpatient clinics was a familiar teaching facility 
and supportive of research.  The clinics operated on a time sensitive schedule with sometimes 
more than one appointment for a patient in a single day.  The patient waited between 
appointments or had consecutive appointments that provided opportunities to participate in 
research. 
An advantage was the support provided to the researcher from medical center’s office of 
research and development through the Internal Review Board (IRB) process to protect research 
participants and review research procedures.  A disadvantage of doing research in two clinics 
within the same urban medical center was the limited diversity of the study participants.  The 
familiarity of the setting to the nurse research may serve as a bias.  These disadvantages and 
biases may hinder the ability to generalize the findings of this study.   
 Of the patients available, 128 patients with diabetes neuropathy pain met inclusion 
criteria.  Of the 128 eligible patients, 71 patients completed questionnaires.  There were several 
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reasons that 57 potential participants were not recruited.  For example, a participant did not meet 
inclusion criteria by appearing to have limited English capabilities or being completely non-
English speaking when having met in person with researcher (n=11).  Some individuals denied 
having diabetes peripheral neuropathy (n=7).  Others were a no show, rescheduled or cancelled 
rescheduled or cancelled appointment (n=21).  In some cases, individuals had a vacant phone 
number, did not have voice mail, or did not answer phone calls (n=12).  Some chose not to 
participate because their ride came early, they said “no thanks,” “felt shy,” or “too tired” (n=6).  
This dissertation focused on Native Hawaiians and Part-Hawaiians only.  In future dissemination 
efforts of this feasibility study, other ethnicities will be analyzed.  As a result, the sample size 
decreased to N=21. 
Recruitment 
The recruitment process presented challenges for the researcher, due to efforts to 
minimize disruption to the workflow of the clinic.  Methods of recruitment included “phone 
invitation,” “posted brochures,” and “in person, face-to-face invitation.” Disadvantages of phone 
recruitment included participants not having a working phone, having difficulty hearing the 
nurse researcher’s voice over the phone, or not returning messages.  This made it difficult for the 
nurse researcher to confirm if the patient would be interested in participating in the study or be at 
their next scheduled clinic visit.  Study recruitment brochures were posted in the waiting areas of 
the outpatient clinics.  There were no participants recruited through the recruitment brochure 
method.  The advantage to the in person face-to-face approach was that it provided an 
opportunity for the individual to meet the nurse researcher.  The face-to-face method of 
recruitment was advantageous with recruitment, because respondents displayed a level of 
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comfort and acceptance, possibly an indication of wanting to participate in the research study.  
See study recruitment brochure in Appendix D. 
The two clinics had different operational hours. The Queen Emma Clinic provided 
diabetic patient care eight hours a day.  The Wound Care Clinic provided diabetic patient care 
for four to eight hours a day.  This presented limited access to potential participants.  It required 
the nurse researcher to be flexible in time management.  There was a range of one participant to 
nine participants recruited per day.   
Response Rate 
A total of 128 patients were approached and 71 of them were included and completed 
surveys.  The nurse researcher attempted to recruit participant’s in person at clinic appointments 
if prospective participants were not reachable by phone.  The nurse researcher tried to contact 
potential participants not present for clinic visits by calling prospective participants by both main 
phone numbers and alternate phone numbers, which were provided by clinic staff.   
All surveys were completed after consent was obtained and inclusion criteria met. 
Participants met in a face-to-face meeting with the nurse researcher to complete surveys.  A few 
questions were left blank by participants who chose not to provide an answer or did not know the 
answer.  The original study included 71 participants who self-identified as Asian American, 
Pacific Islander, Native Hawaiian, Part-Hawaiian or other races.  This dissertation only focused 
on the Native Hawaiian and Part-Hawaiian individuals (N=21).  Information collected from other 
ethnic groups will be disseminated in the future. 
Quality of Responses 
The quality of responses was an important part of this feasibility study (Morris & 
Rosenbloom, 2017).  The method of face-to-face interviews was referred to as the best method to 
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collect survey data and obtain quality information (Polit & Beck, 2008).  The participants might 
have planned to meet with the nurse researcher at their scheduled clinic visit because of the 
preliminary phone call and verbal confirmation by both the patient and the nurse researchers at a 
planned meeting.  Most were excited to meet, interested in hearing more about the study, and 
ready to participate.  For those who were approached in person at the primary care clinic visit 
concerns about missing a scheduled transportation pick-up and the amount of time it would take 
to participate were mentioned.  These patients might have had multiple appointments scheduled 
on the same day and verbalized being tired.  These reasons might potentially compromise the 
quality of responses.   
Patients at the Wound Care Clinic experienced a longer appointment often requiring them 
to lie on an examination table for more than 30 minutes.  They were interested in having 
someone to talk to during this visit.  Participating in the study might have served as a positive 
distracter during their weekly clinic appointment with potentially quality responses.  The 
advantages were that they had time to answer each question because their appointments were 
scheduled for an hour compared to the primary care clinic visits estimated at approximately 15 
minutes duration.  The participants responded positively to having the nurse researcher 
conducting the interview, because the once-a-week visits required them to lay on the 
examination table.  The wound care staff liked having the nurse researcher interact with the 
patient, so they could do charting and wound care.  The limited space and privacy was a concern 
for the nurse researcher in respect to obtaining quality responses.  The nurse researcher 
collaborated with staff, what times would be best to perform data collection.  
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Instruments 
A disadvantage was that the Hsiao-Yun Annie Chang CAM Use Survey tool was from 
Taiwanese and international literature and designed to be used in Taiwanese diabetic care clinics.  
The length of this survey also presented a challenge for participants.  Some answers used 
unfamiliar terms.  For example, the question “Approximately, how many times have you visited 
DM clinics during the past year?” could be answered using the term, “fortnightly” (pronounced 
fôrtˌnītlē ) meaning every two weeks.  In some cases, this required an explanation.  The sequence 
of questions in the clinical information session was confusing to respondents.  The question 
“Have you been hospitalized due to diabetes condition during the last years,” was followed by 
the question, “How good do you feel is your health condition?”  Respondents were not sure what 
“health condition” referred to and at times referred to their diabetic condition as their health 
condition when answering this question.  An advantage was the assessment of clinical diabetic 
status, individual CAM therapies and practitioners, as well as reasons for CAM use, non-use and 
stopping use.  The reasons for CAM use was at times, complex, and the CAM survey had three 
options: “for diabetes,” “for DM’s complications” and, “for non-DM specific.”  Patients 
pondered the complexities of the questions and multiples answers before answering a question.  
The types of CAM presented in the survey might not represent traditional Hawaiian types of 
CAM.  Those types were cupping, scraping, gua-sa, biofield therapy, kinesiology, reiki, tai chi, 
gi gong, and bioelectromagnetic-based therapies.  A potential bias was the nurse researchers 
explanations of unfamiliar CAM therapies.  The estimated time to complete the CAM survey 
was 20 minutes and might have taken longer if the participant did not understand the questions.  
Despite the lack of clarity and participant understanding of the questions presented in both 
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survey instruments there was a 100% completion range with potential impact on the quality of 
responses.   
The nurse researcher stated questions from the aforementioned surveys during the face-
to-face interaction.  This might be a bias, because the nurse researcher might have used certain 
vocal tones unconsciously or individuals might have responded to the questions with the way 
they thought the nurse researcher wanted them to respond.  For example, for CAM users the 
researcher asked, “What was the advice of the health care professional after you discussed about 
CAM use?”  The respondent might not have disclosed a quality response because a health care 
provider was asking this question.  Another question for CAM users was, “How do you use your 
Western medication when you are using CAM” participants might have chosen, “no change” 
because the care received from this clinic recommended participants to take Western 
medications.  With some individuals the nurse researcher showed them the questions and 
responses if they could not remember the available answer selections.  The approximate 
completion time to complete or of both surveys was 15-30 minutes.  However, it took more than 
30 minutes for patients who did not understand the question and they requested the nurse 
researcher to repeat or explain the question or a word contributed to an interview.  The 
percentage of participants who asked the researcher to repeat questions or clarify words was not 
tallied.  But, an estimate percentage would be about 50% or more participants who requested at 
least one question or word to be clarified. 
 The sequence of questions in the clinical information session was confusing to 
respondents.  The question, “Have you been hospitalized due to diabetes condition during the last 
years” was followed by the question, “How good do you feel is your health condition?”  
Respondents were not sure what health condition the question referred to. As a result, they 
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referred to their diabetic condition as their health condition when answering this question.  An 
advantage of this questionnaire was the assessment of clinical diabetic status, individual CAM 
therapies and practitioners, reasons for CAM use, non-use and stopping use.  The reasons for 
CAM use at times were complex three options “for diabetes”, “for DM’s complications”, and 
“for non-DM specific”.  Participants took time to think about this because of overlapping reasons 
for CAM use.  The types of CAM presented in the survey might not represent types of CAM 
used among the Native Hawaiian or Part-Hawaiian such as cupping, scraping, gua-sa, biofield 
therapy, kinesiology, reiki, tai chi, gi gong, and bioelectromagnetic-based therapies.  Participants 
would ask the nurse researcher what were those types of CAM therapies.  A potential bias was 
the nurse researcher’s explanations of unfamiliar CAM therapies. 
Qualities of the Nurse Researcher 
 In a feasibility study, demonstration of an achievable research design provided 
information for future research processes, resources, management, and science development 
(Morris & Rosenbloom, 2017).  A specific aspect to consider was the qualities of a nurse 
researcher as a resource.  The nurse researcher, being a Native Hawaiian, PhD student, and 
practicing nurse, could have potential positive impact on recruitment of a Native Hawaiian DPN 
population.  Some of these qualities were presented in the scripted introduction during 
recruitment and received favorable feedback.  Participants asked if the nurse researcher was a 
Native Hawaiian nurse and were intrigued to hear, also a PhD in nursing student.  To establish 
rapport, a respectful approach, open to hearing their story, was conveyed.  Participants were 
friendly and willing to participate, at times sharing more than what was asked.  The nurse 
researcher who presented herself in nursing scrub attire similar to clinic nurses as a strategy, 
promoted comfort and an approachable demeanor.  This presentation contrasted a white coat or 
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professional wear that might not be familiar or create resistance.  The qualities of the nurse 
researcher might have worked for this Native Hawaiian and Part-Hawaiian population. 
Descriptive Characteristics of Native Hawaiian Participants 
 A total of 21 participants ranged from 41 to 77 years old with a mean of 57.76 and 
standard deviation of 10.425.  The sample size N=21 represents the Native Hawaiian and Part-
Hawaiian ethnic group. The majority of participants were younger than age 70 (86%).  Of the 
participants, 86% with an education level of high school or above.  Out of the participants, 86% 
were single, widowed, or separated/divorced.  There were 14% who reported being married or 
living with a partner.  Of the respondents, 86% reported living with others.  95% of the 
respondents reported having health insurance. 
Clinical information provided showed that 43% had diabetes for more than ten years.  Of 
all participants, 57% were receiving insulin treatment.  In addition to that, 29% were treated with 
insulin and oral treatment for diabetes.  Diabetes education was attended by 62% of respondents.  
Detailed characteristics of participants are displayed in Table 1. 
Table 1 
Descriptive Characters of the Participants N=21 
 
Descriptive Characters of the Participants-continued 
Total Household Monthly Income 
 Under $1200 n=12 (57%) 
 $1200-2400 n=5 (24%) 
 $2401-3600 n=2 (10%) 
 $3601-4800 n=1 (5%) 
 More than $4800 n=1 (5%) 
Health Insurance 
 No n=1 (5%) 
 Yes n=20 (95%) 
Clinical Information 
How long have you had diabetes? 
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 1 -10 years n=12 (57%) 
 >10-20 years  n=4 (19%) 
 >20-30 years  n=2 (10%) 
 >30-40 years n=2 (10%) 
 >40 years n=1 (4%) 
Do you have any one in your family and relative who has diabetes? 
 No n=1 (5%) 
 Parents/Grandparents n=16 (76%) 
 Brothers or sisters n=14 (67%) 
 Relatives n=11 (52%) 
 Sons or daughters n=3 (14%) 
 Other  
Have you been hospitalized due to diabetes condition during last years? 
 No n=15 (71%) 
 Yes n=6 (28%) 
 If yes, how many times?  
 1 time n=4 (66%) 
 3 times n=1 (33%) 
 4 times n=1 (33%) 
How good do you feel is your health condition? 
 Very poor and poor n=6 (29%) 
 Good and Very good n=15 (71%) 
What current treatment for DM has been prescribed or suggested by your 
physician? (Choose all that apply) 
 Diet + Exercise n=13 (62%) 
 Oral Agent n=14 (67%) 
 Tablets/per day  
 1 tablet/per day n=4 (30%) 
 2 tablets/per day n=7 (50%) 
 3 tablets/per day n=1 (7%) 
 5 tablets/per day n=1 (7%) 
 6 tablets/per day n=1 (7%) 
 Insulin Injection n=12 (57%) 
 Units/per day  
 5 units/per day n=1 (8%) 
 17 units/per day n=1 (8%) 
 18 units/per day n=1 (8%) 
 20 units/per day n=2 (17%) 
 50 units/per day n=1 (8%) 
 55 units/per day n=1 (8%) 
 69 units/per day n=1 (8%) 
 70 units/per day n=1 (8%) 
 125 units/per day n=1 (8%) 
 155 units/per day n=1 (8%) 
 200 units/per day n=1 (8%) 
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 Oral agent and Insulin injection n=6 (29%) 
Have you ever attended a diabetes education program? 
 No n=8 (38%) 
 Yes n=13 (62%) 
What kind of 
education? 
One to one education n=9 (69%) 
 Lecture Education n=8 (61%) 
 Self-education n=0 
 Other: Brochures n=1 (7%) 
Note: Participants could select more than one response. 
 
Reasons and Types of CAM Use 
 
The reasons and types of CAM used by Native Hawaiians and Part-Hawaiians with DPN 
are listed in Table 2 in past 12 months, for diabetes, for diabetes mellitus complications, and for 
non-diabetes mellitus.  DPN is a type of diabetic complication.  The listed CAM types (ie. 
cupping, scraping/gu-sa, biofield therapy, bioelectromagnetic-based therapies, and 
homeotherapy) on the survey might not be familiar to the Native Hawaiian or Part-Hawaiian 
respondent and resulted in low percentages for CAM use. The four highest CAM therapies used 
for diabetes complications by 16 participants out of N=21 were diet modification (31%), 
manipulative based therapy (19%), supernatural healing (19%), and Western herbal medicine 
(19%).  The least used CAM therapies were Chinese herbal medicines (13%), nutritional 
supplements (13%), acupuncture (6%), folk therapies (6%), biofield therapy (6%), aromatherapy 
(6%), and mind-body therapy (12%).  The CAM practitioners used for diabetic mellitus 
complications were traditional Chinese medicine practitioner (12%), herbalist (6%), 
religious/psychic healer (6%), and naturopath practitioner (6%).  CAM therapies and 
practitioners not used for diabetic complications were cupping, scraping (Gu-sa), 
bioelectromagnetic-based therapies (electrotherapy, polarity, magnetic therapy), homeopathy, 
chiropractor, and other CAM therapies reported like carving, talk therapy, and physical therapy. 
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 The highest used CAM therapies in the SF-36 group with self-rated  “health as excellent, 
very good, and good” (38%), were nutritional supplements (multivitamins, fish oil, glucosamine, 
chromium) (50%), and Western herbal medicine (25%).  The least used types of CAM were diet 
modification (13%), manipulative based therapy (chiropractic, osteopathic, kneading (Tui-an)) 
(13%), supernatural healing (absorption frighten, God healing, divination, name change) (13%), 
mind-body therapy (meditation, yoga, hypnosis) (13%), and other CAM therapies like talk 
therapy (13%).  Surprisingly, nutritional supplements were used by (50%) of CAM users with 
perceived excellent, very good, or good health. 
Highest used CAM therapies in the SF-36 group with “none to mild pain” (n=9) were 
nutritional supplements (44%), diet modification (22%), supernatural healing (22%), Western 
herbal medicine (22%), and other CAM therapies (22%).  CAM therapies leased used were 
manipulative-based therapy (11%), mind-body therapy (11%), and religious healer (11%).  Other 
CAM therapies reported by this group included talk therapy and carving hobby therapy.  There 
was high use of nutritional supplements (44%).  The results for CAM use with SF-36 subgroups 
were presented in Table 2. 
Table 2 
Complementary and Alternative Medicine (CAM) Use and Type 2 Diabetes 
 
CAM Users (N=16 ) 
Nutritional Supplements (Multivitamins, fish oil, glucosamine, chromium) 
  
Past 12 months 
 
n=5 (31%) 
 
Why did you use? 
  
For Diabetes 
 
n=3 (19%) 
  
For Diabetes Mellitus 
Complications 
 
n=2 (13%) 
  
For Non-Diabetes Mellitus 
 
n=5 (31%) 
		 53	
Diet Modification (Organic food, special food design, body cleansing diet, 
macrobiotic diet) 
  
Past 12 months 
 
n=6 (38%) 
 
Why did you use? 
  
For Diabetes 
 
n=6 (38%) 
  
For Diabetes Mellitus 
Complications 
 
n=5 (31%) 
  
For Non-Diabetes Mellitus 
 
n=1 (6%) 
Chinese herbal medicines (Ginseng and Limzig) 
  
Past 12 months 
 
n=2 (13%) 
Why did you use? 
  
For Diabetes 
 
n=2 (13%) 
  
For Diabetes Mellitus 
Complications 
 
n=2 (13%) 
  
For Non-Diabetes Mellitus 
 
n=1 (6%) 
Acupuncture (Acupressure) 
  
Past 12 months 
 
n=0 
 
Why did you use? 
  
For Diabetes 
 
n=1 (6%) 
  
For Diabetes Mellitus 
Complications 
 
n=1 (6%) 
 For Non-Diabetes Mellitus n=3 (19%) 
Cupping, Scraping (Gu-sa) 
  
Past 12 months 
 
n=0 
Why did you use? 
  
For Diabetes 
 
n=0 
  
For Diabetes Mellitus 
Complications 
 
n=0 
  
For Non-Diabetes Mellitus 
 
n=1 (6%) 
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Manipulative based therapy (chiropractic, osteopathic, kneading (Tui-am) 
  
Past 12 months 
 
n=4 (25%) 
Why did you use? 
  
For Diabetes 
 
n=3 (19%) 
  
For Diabetes Mellitus 
Complications 
 
n=3 (19%) 
  
For Non-Diabetes Mellitus 
 
n=6 (38%) 
Folk Therapies (Knife therapy, water therapy, fire therapy) 
  
Past 12 months 
 
n=2 (13%) 
 
Why did you use? 
  
For Diabetes 
 
n=3 (19%) 
  
For Diabetes Mellitus 
Complications 
 
n=1 (6%) 
  
For Non-Diabetes Mellitus 
 
n=1 (6%) 
Biofield Therapy 
  
Past 12 months 
 
n=1 (6%) 
Why did you use? 
  
For Diabetes 
 
n=1 (6%) 
  
For Diabetes Mellitus 
Complications 
 
n=1 (6%) 
  
For Non-Diabetes Mellitus 
 
n=1 (6%) 
Supernatural healing (Absorption frighten, God healing, divination, change name) 
  
Past 12 months 
 
n=4 (25%) 
 
Why did you use? 
  
For Diabetes 
 
n=3 (19%) 
  
For Diabetes Mellitus 
Complications 
 
n=3 (19%) 
  
For Non-Diabetes Mellitus 
 
n=4 (25%) 
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Bioelectromagnetic-based therapies (Electrotherapy, Polarity, Magnetic Therapy) 
  
Past 12 months 
 
n=1 (6%) 
 
Why did you use? 
  
For Diabetes 
 
n=0 
  
For Diabetes Mellitus 
Complications 
 
n=0 
  
For Non-Diabetes Mellitus 
 
n=2 (13%) 
Western herbal medicine (bilberry, bitter melon, opuntia, fenugreek seed, and aloe) 
  
Past 12 months 
 
n=3 (19%) 
 
Why did you use? 
  
For Diabetes 
 
n=3 (19%) 
  
For Diabetes Mellitus 
Complications 
 
n=3 (19%) 
  
For Non-Diabetes Mellitus 
 
n=3 (19%) 
Aromatherapy (essential oil) 
  
Past 12 months 
 
n=2 (13%) 
Why did you use? 
  
For Diabetes 
 
n=1 (6%) 
  
For Diabetes Mellitus 
Complications 
 
n=1 (6%) 
  
For Non-Diabetes Mellitus 
 
n=2 (13%) 
Mind-Body Therapy (Meditation, yoga, hypnosis) 
  
Past 12 months 
 
n=3 (19%) 
 
Why did you use? 
  
For Diabetes 
 
n=2 (13%) 
  
For Diabetes Mellitus 
Complications 
 
n=2 (13%) 
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For Non-Diabetes Mellitus n=3 (19%) 
Homeopathy 
  
Past 12 months 
 
n=0 
 
Why did you use? 
  
For Diabetes 
 
n=0 
  
For Diabetes Mellitus 
Complications 
 
n=0 
  
For Non-Diabetes Mellitus 
 
n=0 
Complementary and Alternative Medicine Practitioners 
Traditional Chinese medicine practitioner 
  
Past 12 months 
 
n=2 (13%) 
 
Why did you use? 
  
For Diabetes 
 
n=2 (13%) 
  
For Diabetes Mellitus 
Complications 
 
n=2 (13%) 
  
For Non-Diabetes Mellitus 
 
n=2 (13%) 
Chiropractor 
  
Past 12 months 
 
n=0 
 
Why did you use? 
  
  
For Diabetes 
 
n=0 
  
For Diabetes Mellitus 
Complications 
 
n=0 
  
For Non-Diabetes Mellitus 
 
n=4 (25%) 
Herbalist 
  
Past 12 months 
 
n=1 (6%) 
 
Why did you use? 
  
  
For Diabetes 
 
n=1 (6%) 
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For Diabetes Mellitus 
Complications 
n=1 (6%) 
  
For Non-Diabetes Mellitus 
 
n=1 (6%) 
Religious healer/ Psychic healer 
  
Past 12 months 
 
n=1 (6%) 
 
Why did you use? 
  
  
For Diabetes 
 
n=1 (6%) 
  
For Diabetes Mellitus 
Complications 
 
n=1 (6%) 
  
For Non-Diabetes Mellitus 
 
n=2 (13%) 
 
Naturopath Practitioner 
  
Past 12 months 
 
n=1 (6%) 
 
Why did you use? 
  
  
For Diabetes 
 
n=1 (6%) 
  
For Diabetes Mellitus 
Complications 
 
n=1 (6%) 
  
For Non-Diabetes Mellitus 
 
n=1 (6%) 
Any other CAM therapies 
Carving (Hobby Therapy) “Keeps my sanity.” 
  
Past 12 months 
 
n=0 
 
Why did you use? 
  
  
For Diabetes 
 
n=0 
  
For Diabetes Mellitus 
Complications 
 
n=0 
  
For Non-Diabetes Mellitus 
 
n=1 (6%) 
Talk Therapy 
  
Past 12 months 
 
n=0 
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Why did you use? 
  
For Diabetes 
 
n=0 
  
For Diabetes Mellitus 
Complications 
 
n=0 
  
For Non-Diabetes Mellitus 
 
n=1 (6%) 
Physical Therapy 
  
Past 12 months 
 
n=1 (6%) 
Why did you use?   
  
For Diabetes 
 
n=0 
  
For Diabetes Mellitus 
Complications 
 
n=0 
  
For Non-Diabetes Mellitus 
 
n=1 (6%) 
NOTE: Complementary and Alternative Medicine (CAM) and Type 2 Diabetes 
Participants (N=21) were asked have you ever used a specific CAM therapy in these 
questions.  The numbers here indicate a participant may have answered with 
multiple answers. 
 
Perception of Health 
SF-36 Items for Short Form Survey Instrument 
The disadvantage of this tool was the variable number of responses to each question from 
a two-point to a six-point scale.  Participants had trouble remembering the six available 
responses.  The nurse researcher, who sat next to the patients, read the question and then showed 
them the question.  The questions, “Did you feel full of pep,” “Have you felt so down in the 
dumps that nothing could cheer you up,” and, “Have you felt downhearted and blue,” were 
difficult for some participants to understand.  Specifically the words “pep”, “dumps”, and “blue” 
were not familiar.  The nurse researcher explained the words “pep,” as energy, “dumps,” as a low 
point, and, “blue”, as sad. 
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The assessment of general health status in patients with DPN was obtained through the 
Short Form (36) Health Survey.  The majority of respondents rated their general health as fair 
and poor (62%).  In general, compared to one year ago, 66% respondents rated their health now 
as “much better”, or “somewhat better” than one year ago.  All 21 Native Hawaiian and Part-
Hawaiian respondents stated that they were limited either, “a lot” or, “a little” with vigorous 
activities such as running, lifting heavy objects, or participating in strenuous sports. Climbing 
one flight of stairs, walking more than a mile, and walking several blocks were limited a lot, or a 
little, (67%) and (57%) respectively.  As far as moderate activities, bending/kneeling, stooping or 
walking one block, 52% of respondents were limited either a lot or a little.  The majority, 95% 
did not have limitations with bathing or dressing self. 
 More than 50% of respondents did not have problems with work, regular daily activity, or 
social activities as a result of their physical health or emotional problems in the past four weeks.  
However, there were 57% of respondents with moderate, severe, and very severe bodily pain 
during the past four weeks.  Despite the high reports of pain 71% respondents reported pain 
referring to it with either, “not at all” or “a little bit” and during normal work as, “not at all”, or, 
“a little bit”. 
 During the past four weeks, more than 75% of respondents felt very nervous, down in the 
dumps, that nothing could cheer them up, downhearted, or blue.  They felt as least one of these 
attributes either some of the time, a little of the time, or none of the time.  Of the respondents, 
70% felt calm and peaceful, worn out, or happy all of the time or most of the time, or a good bit 
of the time.  The responses were similar for the question, “Did you feel full of pep?” with a 
percentage that was from all of the time, most of the time, and a good bit of the time at 52%.   
For 47% of the participants, the answer was for some of the time, a little of the time or none of 
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the time. Less than half of respondents reported having a lot of energy (42%), and felt tired 
(47%), some of the time, all of the time, most of the time, or a good bit of the time.  The 
response of mostly false, and definitely false, were selected by more than (60%) of respondents 
for statements, “I seem to get sick a little easier than other people,” “I am as healthy as anybody I 
know,” and, “I expect my health to get worse.”  For the statement, “My health is excellent”, 47% 
of respondents selected, “don’t know.”  In Table 3, detailed information on the results from the 
SF-36 short form survey was presented. 
Table 3 
SF36 Items for Short Form Survey Instrument N=21 
 
In general, would you say your health is: 
Excellent, Very good, Good n=8 (38%) 
Fair and Poor n=13 (62%) 
Compared to one year ago, how would you rate your health in general now? 
Much better and Somewhat better now than one year ago n=14 (66%) 
About the same n=5 (24%) 
Somewhat worse and much worse now than one year ago n=2 (9%) 
Does your health now limit you in these activities If so, how much? 
Vigorous activities, such as running, lifting heavy objects, participating in strenuous 
sports 
Yes, Limited a lot and limited a little 
n=21 (100%) 
No, not limited at all 
Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or 
playing golf 
Yes, Limited a lot and limited a little 
n=11 (52%) 
No, not limited at all 
n=10 (47%) 
Lifting or carrying groceries 
Yes, Limited a lot and limited a little 
n=8 (38%) 
No, not limited at all 
n=13 (62%) 
Climbing one flight of stairs 
Yes, Limited a lot and limited a little  
n=14 (67%) 
No, not limited at all 
n=7 (33%) 
Bending, kneeling, or stooping  
Yes, Limited a lot and limited a little  
n=11 (52.4%) 
No, not limited at all 
n=10 (47%) 
Walking more than a mile 
Yes, Limited a lot and limited a little 
n=14 (67%) 
No, not limited at all 
n=7 (33%) 
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Walking several blocks 
Yes, Limited a lot and limited a little 
n=12 (57%) 
No, not limited at all 
n=9 (42%) 
Walking one block 
Yes, Limited a lot and limited a little 
n=11 (52%) 
No, not limited at all 
n=10 (47%) 
Bathing or dressing yourself 
Yes, Limited a lot and limited a little 
n=1 (5%) 
No, not limited at all 
n=20 (95%) 
During the past 4 weeks, have you had any of the following problems with your 
work or other regular daily activities as a result of your physical health? 
Cut down the amount of time you spent on work or other activities 
 Yes n=9 (42%) 
 No n=12 (57%) 
Accomplished less than you would like 
 Yes n=10 (47%) 
 No n=11 (52%) 
Were limited in the kind of work or other activities  
 Yes n=10 (47%) 
 No n=11 (52%) 
Had difficulty performing the work or other activities (for example, it took extra effort) 
 Yes n=10 (47%) 
 No n=11 (52%) 
During the past 4 weeks, have you had any of the following problems with your 
work or other regular daily activities as a result of any emotional problems (such as 
feeling depressed or anxious)? 
Cut down the amount of time you spent on work or other activities 
 Yes n=7 (33%) 
 No n=14 (66%) 
Accomplish less than you would like 
 Yes n=8 (38%) 
 No n=13 (61%) 
Didn’t do work or other activities as carefully as usual 
 Yes n=5 (23%) 
 No n=16 (76%) 
During the past 4 weeks, to what extent has your physical health or emotional 
problems interfered with your normal social activities with family, friends, 
neighbors, or groups? 
 Not at all and Slightly n=15 (72%) 
 Moderately, quite a bit, and 
extremely 
n=6 (28%) 
 
How much bodily pain have you had during the past 4 weeks? 
 None, Very Mild, and Mild  n=9 (43%) 
 Moderate, Severe, and Very 
Severe 
n=12 (57%) 
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During the past 4 weeks, how much did pain interfere with your normal work 
(including both work outside the home and housework)? 
 Not at all and A little bit n=15 (71%) 
 Moderately, quite a bit, and 
extremely 
n=6 (28%) 
How much of the time during the past 4 weeks... 
Did you feel full of pep?  
 All of the time, most of the 
time, and a good bit of the 
time 
n=11 (52%) 
 
 
 Some of the time, a little of 
the time, and none of the 
time 
n=10 (47%) 
 
 
Have you been a very nervous person? 
 All of the time, most of the 
time, and a good bit of the 
time 
n=0 
 
 
 Some of the time, a little of 
the time, and none of the 
time 
n=21 (100%) 
 
 
Have you felt so down in the dumps that nothing could cheer you up? 
 All of the time, most of the 
time, and a good bit of the 
time 
n=2 (9%) 
 
 
 Some of the time, a little of 
the time, and none of the 
time 
n=19 (90%) 
  
 
Have you felt calm and peaceful? 
 All of the time, most of the 
time, and a good bit of the 
time 
n=16 (71%) 
 
 
 Some of the time, a little of 
the time, and none of the 
time 
n=5 (23%) 
 
 
Did you have a lot of energy? 
 All of the time, most of the 
time, and a good bit of the 
time 
n=9 (42%) 
 
 
 Some of the time, a little of 
the time, none of the time 
n=12 (57%) 
 
 
Have you felt downhearted and blue? 
 All of the time, most of the 
time, and a good bit of the 
time 
n=5 (23.8%) 
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 Some of the time, a little of 
the time, and none of the 
time 
n=16 (76%) 
 
 
Did you feel worn out? 
 All of the time, most of the 
time, and a good bit of the 
time 
n=10 (47%) 
 
 
 Some of the time, a little of 
the time, and none of the 
time 
n=11 (52%) 
 
 
Have you been a happy person? 
 All of the time, most of the 
time, and a good bit of the 
time 
n=15 (71%) 
  
 
 Some of the time, a little of 
the time, and none of the 
time 
n=6 (28%) 
 
 
Did you feel tired? 
 All of the time, most of the 
time, and a good bit of the 
time 
n=10 (47%) 
 
 
 
 
 Some of the time, a little of 
the time, and none of the 
time 
n=11 (52%) 
  
 
During the past 4 weeks, how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting with friends, 
relatives etc.)? 
 All of the time, most of the 
time, and some of the time 
n=6 (28%) 
  
 
 A little of the time and none 
of the time 
n=15 (72%) 
 
I seem to get sick a little easier than other people  
 Definitely true and mostly 
true 
n=4 (19%) 
 
 Don’t Know n=1 (4%) 
 Mostly False and definitely 
false 
n=16 (76%) 
 
I am as healthy as anybody I know 
 Definitely true and mostly 
true 
n=5 (24%) 
 
 Don’t Know n=2 (9%) 
 Mostly false and definitely 
false 
n=14 (67%) 
 
I expect my health to get worse 
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 Definitely true and  
mostly true 
n=7 (33%) 
 
 Don’t Know n=1 (4%) 
 Mostly false and definitely 
false 
n=13 (61%) 
 
My health is excellent 
 Definitely true and mostly 
true 
n=5 (23%) 
 
 Don’t Know n=10 (47%) 
 Mostly false and definitely 
false 
n=6 (28%) 
 
Reasons for Not Using or Stopped Using CAM 	
 Of the 21 participants, six did not use CAM (n=5, 24%) or stopped using CAM (n=1, 
5%).  The respondent that stopped using CAM was also accounted for as a CAM user.  Thus, 
there is an overlap in CAM use and CAM non-use.  The CAM survey instrument asked about 
respondents experience with CAM use, reasons for not using CAM, or stopping use of CAM.  
The CAM survey instrument recognized the respondent that stopped CAM use as a CAM user 
and CAM non-user.  Reasons for not using CAM or stopping the use of CAM included “never 
heard of them,” “do not think they really work,”  “do not know where to purchase CAM (not 
available in my area),” “have heard of stories that CAM is not good for you,” “worried about 
negative side-effects,” and “felt they are too expensive.”  A “no” response was selected by (66%) 
of respondents who also selected, “my health care professionals are opposed to my use of 
CAM,” “do not want to mix up anything with your Western medicine,” “feel they are harmful,” 
and, “are dissatisfied with them.”  Reasons such as “have heard of stories that CAM is not good 
for you,” “worried about negative side-effects,” and “feel they are too expensive,” were 50% yes, 
and 50% no.  See Table 4 for detailed results for not using CAM or stopping use of CAM.   
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Table 4 
Reasons for Not Using CAM or stopping Use of CAM 
 
Reasons for not using CAM or stopping use of CAM 
Why you never use CAM or why you stop using CAM to help you control your 
diabetes? N=6 
No CAM use n=5 (24% of 21 
participants) 
Stopped CAM use n=1 (5%) 
You did not use CAMs because you 
Never heard of them No n=2 (33%) 
 Yes n=4 (66%) 
Do not know where to 
purchase CAM (Not 
available in my area) 
No n=2 (33%) 
 Yes n=4 (66%) 
My health care 
professionals are opposed to 
my use of complementary 
and alternative medicine 
No n=4 (66%) 
 Yes n=2 (33%) 
Do not want to mix up 
anything with your Western 
medicine 
No n=4 (66%) 
 Yes n=2(33%) 
Do not think that they really 
work 
No n=2 (33%) 
 Yes n=4 (66%) 
Have heard of stories that 
CAM is not good for you 
No n=3 (50%) 
 Yes n=3 (50%) 
Worried about negative 
side-effects 
No n=3 (50%) 
 Yes n=3 (50%) 
Feel they are harmful No n=4 (66%) 
 Yes n=2 (33%) 
Feel they are too expensive No n=3 (50%) 
 Yes n=3 (50%) 
Dissatisfied with them No n=4 (66%) 
 Yes n=2 (33%) 
Other:  n=0 
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Experience of CAM Use 	
Out of 21 respondents, a total of 16 (76%) participants reported being CAM users.  One 
respondent was a CAM user and then stopped using CAM.  The two most important reasons for 
CAM use were “recommended by their health care professionals” (44%), and “other reasons,” 
(38%), providing an opportunity to share their personal response such as, “Be at peace with 
one’s self”, “Alternative for stress relief Convenient”, “Pain in back and neck”, “Pain relief, not 
from diabetes”, “Relieve pain”, and, “Parents and Chinese medication” was reported by of 
respondents.  The five least selected reasons for CAM use were “CAM was consistent with their 
culture” (19%), “People around you believe in CAM treatment” (13%), “Believe in CAM for the 
treatment of diabetes” (13%), “Dissatisfaction with Western medicine” (6%), and, “believe 
CAMs are safer than Western medicine (fewer side-effects)” (6%). 
Of the participants, 25% or more reported obtaining CAM use information from friends 
(38%), a physician (31%), partner or family (25%) or a nurse (25%).  The lowest responses for 
obtaining information regarding CAM use were the media, newspapers, magazines (13%), CAM 
practitioners (6%), or medical book or research journal (6%). No respondents selected a 
pharmacist (0%) for obtaining information about CAM use.   
The proportion of respondents who had knowledge of the ingredients in their herbal 
medicine was equal to those who had no idea.  Of the respondents, 25% knew the ingredients of 
their herbal medicine and 25% the ingredients were completely unknown to them.  Other choices 
were, “unknown, but it was from CAM practitioner,” “unknown but it shown on the can,” and 
“other”; none of these were not selected. 
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The majority of CAM users (69%) reported that the type of CAM they should use was 
their decision.  The least selected reasons chosen by respondents were that family decided what 
type of CAM to use (13%), or that a physician recommended prior to back surgery for (6%).  No 
respondents selected “your friend’s decision”, or “your CAM practitioner decision.” 
More than half of respondents reported no change in Western medication when using 
CAM (81%).  Minority (6%) reduced the dose of Western medicines when using CAM.  While 
CAM was used, Western medicine was not used either separately, at different times, or stopped.  
The cost of CAM was assessed, and 88% of respondents paid under $500 per month.  
Out of the respondents, 38% reported health care professionals encouraged them to use 
CAM after discussing CAM use.  A smaller 6% reported health care professionals discouraged 
them from using CAM.  Reponses of why respondents might not discuss CAM use with their 
health care professional included, “I think that the health care professionals do not have adequate 
knowledge of CAM therapies” (50%), “I think it is safe, thus no need to discuss” (38%), “I never 
think of it,” “Health care professional did not ask it,” and “I think that there was not sufficient 
time to discuss” for (19%), as well as, “I think that health care professionals would discourage 
CAM use” for 19%.  One respondent (6%) chose, “other” as selection for CAM use not 
discussed with their health care professional because, “Hard to accept Western model. Cut! Cut! 
Cut! Not a solution to me. Cultural medicine starts with prayer.”  Other comments respondents 
added were, “Educate doctors on other types of alternative medicine,” “Care providers need to 
have aloha,” and “The wound care clinic staff are the best!” See Table 5 for the experience of 
CAM use. 
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Table 5 
Experience of CAM Use 
 
Experience of CAM Use 
Experienced CAM use (includes 
participant with previous CAM use and 
stopped CAM use) 
N=16 (76%) 
What is the most important reason that made you start to use CAM? Note: 
respondents selected multiple responses. 
Dissatisfaction with Western medicine n=1 (6%) 
Believe CAMs are safer than Western medicine (fewer 
side-effects) 
n=1 (6%) 
People around you believe in CAM treatment n=2 (13%) 
CAM is consistent with my culture n=3 (19%) 
Believe in CAM for the treatment of diabetes n=2 (13%) 
Recommended by health care professionals n=7 (44%) 
Other: “Be at peace with ones self.” “Alternative for stress 
relief.  Convenient.” “Pain in back and neck.” “Pain relief, 
not from diabetes.” “Relieve pain.” “Parents and Chinese 
medication.” 
(The selection of other most important reasons reported by 
participants) 
n=6 (38%) 
NOTE: Two participants choose more than one answer 
from the selection.  One participant selected five selections 
and one participant selected two selections.  For the choice 
other there were six participants. 
 
From where did you get the information regarding CAM use? N=16  
Partner & Family No n=9 (56%) 
 Yes n=4 (25%) 
Participants did not answer  n=3 (19%) 
Friends No n=8 (50%) 
 Yes n=6 (38%) 
Participants did not answer  n=2 (13%) 
Physician No n=8 (50%) 
 Yes n=5 (31%) 
Participants did not answer  n=3 (19%) 
Pharmacist No n=13 (81%) 
 Yes n=0  
Participants did not answer  n=3 (19%) 
Nurse No n=9 (56%) 
 Yes n=4 (25%) 
Participants did not answer  n=3 (19%) 
Media, Newspaper, Magazine No n=11 (69%) 
 Yes n=2 (13%) 
Participants did not answer  n=3 (19%) 
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Medical book or research journal No n= 12 (75%) 
 Yes n=1 (6%) 
Participants did not answer  n=3 (19%) 
CAM Practitioners No n=12 (75%) 
 Yes n=1 (6%) 
Participants did not answer  n=3 (19%) 
Do you know the ingredients of your herbal medicine when you used it? 
Know it. n=4 (25%) 
Completely unknown n=4 (25%) 
Unknown, but it was from CAM practitioner n=0 
Unknown, but it shown on the can n=0 
Other: n=0 
Eight participants did not answer this question n=8 (50%) 
Who mostly decides what type of CAM that you should use?  It is: 
Your decision n=11 (69%) 
Your family’s decision n=2 (13%) 
Your friend’s decision n=0 
Your CAM practitioner decision n=0 
Other: “Physician recommended prior to back surgery.” n=1 (6%) 
Two participants did not answer this question n=2 (13%) 
How do you use your Western medication when you are using CAM? 
No Change n=13 (81%) 
Use separately and use at different times  
Reduce the dose of Western medicines n=1 (6%) 
Stopped Western medicines  
Participants did not answer n=2 (13%) 
Approximately, how much money have you paid for CAM (in general per month)? 
$ under 500 n=14 (88%) 
$ 501-1000 n=0 
$1001-1500 n=0 
$1501-2000 n=0 
More than $ _______________ n=0 
Participants did not answer n=2 (13%) 
What was the advice of the health care professional after you discussed about CAM 
use? 
Encourages you to take it n=6 (38%) 
Discourages you from taking it n=1 (6%) 
Feels it’s entirely up to me; has no strong feelings about it n=0 
Warns you of possible side-effects regarding CAM use n=0 
Warns you that some may interfere with your regular 
treatment 
n=0 
Other: n=0 
Participants did not answer n=9 (56%) 
Reasons you may not discuss CAM use with your health care professional 
I never think of it No n=4 (25%) 
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 Yes n=3 (19%) 
Participants did not answer  n=9 (56%) 
Health care professionals did not ask it No n=4 (25%) 
 Yes n=3 (19%) 
Participants did not answer  n=9 (56%) 
I think that there was not sufficient time to 
discuss 
No n=4 (25%) 
 Yes n=3 (19%) 
Participants did not answer  n=9 (56%) 
I think it is safe, thus no need to discuss No n=1 (6%) 
 Yes n=6 (38%) 
Participants did not answer  n=9 (56%) 
I think that the health care professionals would 
discourage CAM use 
No n=4 (25%) 
 Yes n=3 (14%) 
Participants did not answer  n=9 (56%) 
I think that the health care professionals do not 
have adequate knowledge of CAM therapies 
No n=5 (31%) 
 Yes n=8 (50%) 
Participants did not answer  n=3 (19%) 
Others: “Hard to accept Western model. Cut! Cut! 
Cut! Not a solution to me. Cultural medicine 
starts with prayer.” 
 n=1 (6%) 
Do you have any comments you would like to add? 
Educate doctors on other types of alternative medicine. 
Care providers need to have aloha.  The wound care clinic staff are the best! 
 
Percentages of respondents who reported health as excellent, very good or good health 
were 38%, and fair or poor health, 62%. CAM use by a Native Hawaiian DPN group who 
reported in excellent, very good, or good health was 88% (n=8), while others (n=13) who 
reported fair or poor health were (see Table 6).  The duration of diabetes was similar for both 
groups ranging from 1-41 years.  The high CAM users (88%) were from the self-reported 
excellent, very good, or good health group. The excellent, very good, or good health group was 
younger than 67 years old, religious (87%), high school educated (88%), single with a monthly 
household income of more than & $1200 (88%), not employed females (63%) and had health 
insurance and lives with others (100%). They had religious/spiritual beliefs (100%), and lived 
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with others (100%).  Participants who reported “fair or poor” health were the low CAM users.  
The characteristics of this “fair or poor” health group were younger than 78 years old, religious 
(62%), most with a high school education (69%), single (38%), male (62%) with a total 
household income more than $1200 (62%).  Percentages of religious/spiritual beliefs and lived 
with others of these participants were 62% and 77% respectively.  Please see Table 6 for results 
from SF36 perceived general health, CAM use, and descriptive characteristics. 
Table 6 
SF36 Perceived General Health, CAM Use, and Descriptive Characteristics 
In general, would you say your health is: 
 
Excellent, Very good, or 
Good 
 
n=8 (38%) of 21 
respondents 
 
CAM Use 
 
n=7 (88%) 
 
Fair or Poor 
 
n=13 (62%) of 
21 respondents 
 
CAM Use 
 
n=9 (69%) 
General Health is Excellent, Very good, or Good n=8 (38%) CAM User n=7 (88%) 
 
Diabetes Duration 
 
1-41 years 
 
n=8 
 
n=7  
 
1-41 years 
 
Age 
 
41-66 years 
 
n=8 
 
n=7 
 
41-74 years old 
 
Gender 
 
Male 
 
n= 3 (38%) 
 
n=2 (29%) 
  
Female 
 
n=5 (63%) 
 
n=5 (71%) 
 
Education 
 
Middle School 
 
n=1 (12%) 
 
n=1 (14%) 
  
High School 
 
n=7 (88%) 
 
n=6 (86%) 
  
Bachelors 
Degree 
 
n=0 
 
n=0 
  
Graduate School 
 
n=0  
 
n=0 
 
Marital Status 
 
Married 
 
n=1 (13%) 
 
n=1 (14%) 
  
Single 
 
n=5 (62%) 
 
n=4 (57%) 
  
Widowed 
 
n=1 (13%) 
 
n=1 (14%) 
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Separated 
 
n=1 (13%) 
 
n=1 (14%) 
 
Employment 
 
Full-time 
 
n= 1(13%) 
 
n=2 (29%) 
  
Part-time 
 
n=1 (13%) 
 
n=1 (14%) 
  
Retired 
 
n=2 (25%) 
 
n=1 (14%) 
  
Not Working 
 
n=3 (38%) 
 
n=3 (42%) 
 
Religious/Spiritual Beliefs 
 
No 
 
n= 1 (13%) 
 
n=0 
  
Yes 
 
n=7 (88%) 
 
n=7 (100%) 
 
Lives with others 
 
No 
 
n=0 
 
n=0 
  
Yes 
 
n=8 (100%) 
 
n=7 (100%) 
 
Total Household Monthly 
Income 
 
<$1200 
 
n=1 (13%) 
 
n=4 (57%) 
  
$1200-2400 
 
n=5 (63%) 
 
n=2 (28%) 
  
$2401-3600 
 
n=2 (25%) 
 
n=1 (14%) 
  
$3601-4800 
 
n=0 
 
n=0 
  
More than 
$4800 
 
n=0 
 
n=0 
 
Health Insurance 
 
No 
 
n=0 
 
n=0 
  
Yes 
 
n=8 (100%) 
 
n=7 (100%) 
 
General Health is Fair or Poor n=13 (61%) 
 
CAM User n=9 (69%) 
 
Diabetes Duration 
 
1.5-40 years 
 
n=13 
 
n=9 
 
5-40 years 
 
Age 
 
48-77 years 
 
n=13 
 
n=9  
 
52-77 years old 
 
Gender 
 
Male 
 
n=8 (62%) 
 
n=5 (56%) 
  
Female 
 
n=4 (30%) 
 
n=4 (44%) 
 
Education 
 
Middle School 
 
n=2 (15%) 
 
n=1 (11%) 
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High School 
 
n=9 (69%) 
 
n=6 (67%) 
  
Bachelors 
Degree 
 
n=1 (8%) 
 
n=1 (11%) 
  
Graduate School 
 
n=1 (8%) 
 
n=1 (11%) 
 
Marital Status 
 
Married 
 
n=2 (15%) 
 
n=1 (11%) 
  
Single 
 
n=5 (38%) 
 
n=3 (33%) 
  
Widowed 
 
n=3 (23%) 
 
n=2 (22%) 
  
Separated 
 
n=3 (23%) 
 
n=3 (33%) 
 
Employment 
 
Full-time 
 
n=2 (15%) 
 
n=1 (11%) 
  
Part-time 
 
n=0 
 
n=0 
  
Retired 
 
n=5 (38%) 
 
n=3 (33%) 
  
Homemaker 
(working at 
home) 
 
n=1 (8%) 
 
n=1 (11%) 
  
Other: Self 
Employed and 
Disabled. 
 
n=2 (15%) 
 
n=2 (22%) 
  
Not Working 
 
n= 3 (23%) 
 
n=2 (22%) 
 
Religious/Spiritual Beliefs 
 
No 
 
n=5 (38%) 
 
n=3 (33%) 
  
Yes 
 
n=8 (62%) 
 
n=6 (67%) 
 
Lives with others 
 
No 
 
n= 3 (23%) 
 
n=2 (15%) 
  
Yes 
 
n= 10 (76%) 
 
n=7 (78%) 
Total Household Monthly 
Income 
 
<$1200 
 
n=5 (38%) 
 
n= 2 (22%) 
  
$1200-2400 
 
n=8 (62%) 
 
n=6 (67%) 
  
$2401-3600 
 
n=0  
 
n=0 
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$3601-4800 n=0 n=1 (11%) 
  
more than 
$4800 
 
n=0 
 
n=0 
 
Health Insurance 
 
No 
 
n=1 (8%) 
 
n=1 (11%) 
  
Yes 
 
n=12 (92%) 
 
n=8 (88%) 
Note: Total respondents (N=21), CAM Users (n=16), Non-CAM Users n=5 + n=1 Stopped 
using CAM (n=6). The stopped using CAM respondent was counted as a CAM user and 
CAM non-user. 
 
Participants who reported, “none to mild bodily pain” represented 43% of the Native 
Hawaiians and Part-Hawaiians N=21 while others reported a “moderate to severe bodily pain” 
rating represented 57%.  CAM use for those with “none to mild bodily pain”, was 89%, and 67% 
for those with “moderate to very severe pain” (see Table 7).  Descriptive characteristics of the 
group, “none to mild pain”, included diabetes duration of 1-41 years, a wide age range of 41-77 
years, male gender (56%), female gender (44%), and most respondents not employed (66%).  
The education level was at a high school level for 89% of participants.  The “none to mild bodily 
pain” CAM user (n=8) (89%) group who were: single, widowed, or separated, had religious 
beliefs, reported “living with others” and had “a total household income of less than $1200 per 
month”, also reported “having health insurance”.  
The participants reporting “moderate to very severe bodily pain group” used less CAM 
(67%), were younger by five years, and experienced one year less in diabetes duration when 
compared to the group reported “none to mild body pain.”  Gender in the “moderate to severe 
bodily pain group” was predominantly male (58%), with a high school or higher education 
(83%), and reported higher total household monthly income equal to greater than $1200 (41%).  
The majority of participants were not employed (66%), but had health insurance (92%).  The 
“moderate to very severe pain” group reported less religious and spiritual beliefs (58%), and 
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reported a higher percentage of living with others (92%).  Please refer to Table 7 for results on 
SF36 bodily pain and descriptive characteristics. 
Table 7 
SF36 Bodily Pain and Descriptive Characteristics 
 
How much bodily pain have you had during the past 4 weeks? N=21 
   
None to Mild 
Pain 
 
Moderate to 
Very Severe Pain 
 
Participants 
  
n=9 (43%) 
 
n=12 (57%) 
 
CAM Use 
  
n=8 (89%) 
 
n=8 (67%) 
 
Diabetes Duration 
  
1-41 years 
 
1.5 -40 years 
 
Age 
  
41-77 years 
 
50-72 years 
 
Gender 
 
Male 
 
n=5 (56%) 
 
n=7 (58%) 
  
Female 
 
n=4 (44%) 
 
n=5 (41%) 
 
Education 
 
Middle School 
 
n=1 (11%) 
 
n=2 (16%) 
  
High School 
 
n=8 (89%) 
 
n=8 (67%) 
  
Bachelor Degree 
  
n=1 (8%) 
  
Graduate School 
  
n=1 (8%) 
 
Marital Status 
 
Married 
 
n=1 (11%) 
 
n=2 (16%)  
  
Single 
 
n=5 (56%) 
 
n=5 (41%) 
  
Widowed 
 
n=2 (22%) 
 
n=2 (16%) 
  
Separated 
 
n=1 (11%) 
 
n=3 (25%) 
 
Employment 
 
Full-time 
 
n=2 (22%) 
 
n=2 (16%)  
  
Part-time 
 
n=1 (11%) 
 
n=1 (8%) 
  
Retired 
 
n=2 (22%) 
 
n=5 (41%) 
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Homemaker 
(working at 
home) 
n=1 (11%) 
  
Not Working 
 
n=4 (44%) 
 
n=2 (16%) 
  
Other: (self-
employed and 
disabled) 
  
n=2 (16%)  
 
Religious Beliefs 
 
No 
 
n=1 (11%) 
 
n=5 (42%) 
  
Yes 
 
n=8 (88%) 
 
n=7 (58%) 
 
Lives with others 
 
No 
 
n=2 (22%) 
 
n=1 (8%) 
  
Yes 
 
n=7 (78%) 
 
n=11 (92%) 
 
Total Household Monthly 
Income 
 
<$1200 
 
n=5 (56%) 
 
n=7 (58%) 
  
$1200-2400 
 
n=3 (33%) 
 
n=2 (17%) 
  
$2401-3600 
 
n=1 (11%) 
 
n=1 (8%) 
  
$3601-4800 
  
n=1 (8%) 
  
>$4800 
 n=1 (8%) 
Health Insurance  
No 
  
n=1 (8%) 
  
Yes 
 
n=9 (100%) 
 
n=11(92%) 
 
Summary 	
The study results identified 21 participants completing the two standardized tools.  The 
participants consisted of a self-identified Native Hawaiian and Part-Hawaiian sample.  The 
recruitment processes used to seek participation by Native Hawaiian and Part-Hawaiian 
individuals showed that interpersonal connections between the researcher and the stakeholders of 
the research site, as well as the connection between the research and the study populations, were 
the key elements in successfully carrying out the feasibility study. The recruitment process also 
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showed that providing services to the community prior to presenting the research intent was the 
foundation for developing necessary connections. 
 The results for the first specific aim, revealed the challenges experienced while 
conducting a feasibility study for Native Hawaiians and Part-Hawaiians with type 2 diabetes and 
DPN such as respondents availability, clinic schedules, and healthcare provider preferences. The 
second specific aim results described reasons for CAM use, experience of CAM use, and CAM 
types used by Native Hawaiians and Part-Hawaiians with type 2 diabetes and DPN self-
management.  Descriptive statistical analysis frequency results reveal the characteristics of CAM 
users and non-CAM users related to perceived bodily pain and health. 
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CHAPTER 5. DISCUSSION 	
Knowledge of CAM use amongst Native Hawaiian peoples in the literature was limited.  
Lack of CAM use knowledge identified a need for further exploration in Native Hawaiian 
peoples.  There was an opportunity to explore CAM use and potentially gain new knowledge. 
The objective of this feasibility study was to scrutinize the process of recruiting and 
interviewing Native Hawaiians in Hawai'i with DPN and explore reasons these individuals use 
CAM for self-management.   Studies such as this may provide valuable culturally appropriate 
knowledge of the usage of CAM by Native Hawaiians with type 2 diabetes.  This feasibility 
study was presented based on two specific aims: (1) to describe the process of conducting a 
feasibility study for Native Hawaiians with type 2 diabetes and DPN and, (2) to describe reasons, 
experiences, and types of CAM used by Native Hawaiians with type 2 diabetes and diabetic 
peripheral neuropathy.  
Specific Aim 1  
 Specific aim 1 was to describe the process of conducting a feasibility study for Native 
Hawaiians with type 2 diabetes and DPN.  Interpersonal connections were the key elements that 
initiated the process of this feasibility study.  The Native Hawaiian perceived “fictive kin” 
(hoahānau) as family (Ka'opua, 2008).  The concept of “fictive kin” was the social network of 
individuals with informal relationships (Jordan-Marsh & Harden, 2005).   
The setting and sample of this feasibility study selected, showed the importance of 
established community partnerships and the nurse researcher’s service before the research intent.  
In this feasibility study setting, urban hospital outpatient clinics prior relationships was formed 
by the nurse researcher’s employment at the medical center and was familiar to staff.  The nurse 
researcher has had experience with this sample caring for Native Hawaiian patients in the 
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selected urban hospital.  In a Hawaiian Homestead type 2 diabetic study, described partnerships 
between academic and community-based organizations formed over a decade (Townsend et al., 
2016).  These relationships might be preceded by distrust by the Native Hawaiian community. 
The feasibility study revealed the need for culturally appropriate tools to measure CAM 
use in Native Hawaiians.  The literature indicated there were no instruments found for CAM use 
in Native Hawaiians and Part Hawaiians.  The selected CAM survey and SF-36 survey possessed 
limitations in culturally appropriate, unfamiliar terms, and confusing question sequence, possibly 
affecting the quality of response.  To minimize the limitations of selected instruments, the nurse 
researcher sat with each respondent to provide assistance with reading questions, clarifying 
questions, and provided a culturally accepted face-to-face semi-structured interview approach.  
The CAM use survey should not be used for future research with Native Hawaiian population.  A 
culturally appropriate tool providing CAM types previously used and reasons familiar to Native 
Hawaiians is recommended for future research. 
The procedures and processes of this feasibility study were found to be acceptable to the 
Native Hawaiian and Part-Hawaiian community.  The procedures were developed to support the 
sample based on recommendations from the healthcare providers from the outpatient clinics. In 
contrast, direct involvement of community members at the initial phases of research 
development can identify practical challenges and was recommended for research with 
indigenous historically disadvantaged populations (Sharp & Foster, 2002).  Other studies 
describe successful culturally tailored community-based participatory research in the Native 
Hawaiians with type 2 diabetes was documented in the literature (Kaholokula et al., 2014; 
Sinclair et al., 2013; Townsend et al., 2016).   
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There may be a sense of trust between the individual and their health care professional to 
support CAM use.  Trust inhibits the Native Hawaiian’s participation in research and required 
time devoted to build relationships (Townsend et al., 2016).  The nurse researcher established 
rapport through respectful communication to build trust with patients.  Prior to clinic 
appointments, the nurse researcher communicated with participants by telephone or in person 
and established trust with staff through dialogue about the feasibility protocol.  The qualities of 
the nurse researcher such as being a Native Hawaiian may have contributed to the ability to 
recruit participants and conduct research with a Native Hawaiian population.  In comparison to 
another study, Burkett and Morris (2015) recommended nurse researchers to practice the process 
of gradual immersion to develop trusting relationships to ensure truth in results. 
 Factors inclusive of recruitment, response rate, organizational support and patient 
population for this feasibility study are important to consider for a larger study in the future.  In 
this feasibility study an IRB approval and an individualized recruitment process was needed for 
each clinic.  The physicians and directors of the clinics requested specific approaches in addition 
to IRB recommendations.  Accessibility to potential diabetic peripheral neuropathy patients at 
one of the clinics required the clinic director authorizing a DPN list to the nurse researcher 
(provided by a clinic records staff member).  The complexities of working within the 
organizational research department, clinic leadership, staff and patients should be considered and 
descried in the future methodological designs.  Previously established professional relationships 
supported the recruitment research efforts.  The individual patients were difficult to reach by 
phone.  It is discovered during this feasibility study, in-person interaction to recruit study 
participants did positively impact the response rate.  Other recruitment options such as email, 
phone, or mailed survey methods maybe less effective with this population.  Minimization of 
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disruption to clinic appointment time gained clinic administration and staff support.  The 
researcher was required to adjust time and approach based on the priority of the clinic schedule.  
For all factors mentioned there were challenges but the overall response by patients and staff 
were positive. 
 Recommendations for future research would be to have focus groups or “talk story”, a 
potentially useful method to develop a culturally tailored questionnaire of CAM use in this 
population. The “talk story” strategy was used during the recruitment phase to establish rapport 
and trust.  The “talk story” strategy was used during the recruitment phase to establish rapport 
and trust.  In a self-management study to recruit Asian Pacific Islanders in Hawai'i with type 2 
diabetes, a “talk story” approach was implemented (Wong et al., 2015).  A familiar form of 
communication for childhood experienced in the Hawaiian Islands “talk story” was reflective of 
“malama or caring” a Hawaiian value (Wong, et al., 2015).  
Specific Aim 2 
 The Specific Aim 2, the results describe reasons for CAM used by Native Hawaiians with 
type 2 diabetes and diabetic peripheral neuropathy by performing a face-to-face interview to 
collect data.  This feasibility study revealed CAM use for participants with diabetic neuropathy 
pain.  Types of CAM use were nutritional supplements, diet modification, Chinese herbal 
medicine, acupuncture, cupping/scrapping, manipulative-based therapy, folk therapies, biofield 
therapy (kinesiology, reiki, tai chi, Gi gong), supernatural healing, and bioelectromagnetic-based 
therapies.  Western herbal medicine, aromatherapy, mind-body therapy, homeopathy, seeing a 
traditional Chinese medicine practitioner, seeing an herbalist, seeing a religious healer/psychic 
healer, or seeing a naturopath practitioner were also reportedly used. 
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Comparatively, CAM use for those participants with a perception of “excellent, very 
good, or good health” and CAM use for, “fair or poor health” respondents did not use CAM. 
Consistent with another study, Harrigan et al. (2006) reported CAM use higher for respondents 
with a higher health rating.  However, CAM use was higher in lower income and educated 
respondents compared to Harrigan et al. (2006) study on provider CAM use.  The reason for this 
inverse relationship between high CAM use and low income and education was unclear. 
A discrepancy was revealed in respondents perceived health rating.  In the CAM survey 
diabetes clinical information assessment data section, respondents were asked the question “How 
good do you feel is your health condition?”  Respondents felt their health condition was, “good 
and, very good”.  In the SF-36 survey, respondents were asked the question “In general, would 
you say your heath is: excellent, very good, good, fair or poor”.  Most respondents rated their 
health was “excellent, very good, and good”.  CAM survey confusing questions posed 
clarification from respondents for the CAM survey’s question terms “health condition”.  
Although, the question does not refer to diabetes most respondents rated their diabetes condition.  
It may have been the question placement in the diabetes clinical assessment survey sequence of 
questions that contributed to a rating respondent diabetes condition.  People diagnosed with type 
2 diabetes are often diagnosed with other health issues such as obesity, cardiovascular disease, 
and kidney disease.  These other potential diagnosis may contribute to the lower perceived 
general health rating for people with type 2 diabetes. 
For this feasibility study, Native Hawaiian participants were higher CAM users than 
CAM use reported in the general United States Population (NCCAM, 2014).  Respondents who 
reported, “none to mild bodily pain” used CAM at a higher rate.  To compare the groups, low 
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CAM users had, “moderate to very severe pain”.  These findings could not determine if CAM 
use had an effect on bodily pain but, reveal bodily pain characteristics of CAM users. 
Health beliefs and attitudes contribute to CAM use in a type 2 diabetic population 
(Chang, Wallis, & Tiralongo, 2012).  Additional characteristics of a type 2 diabetes CAM user 
suffered more diabetes-related symptom distress, engaged in self-care behaviors, with positive 
attitudes towards CAM and had higher social support (Chang et al., 2012).  The health beliefs 
and attitudes in the Native Hawaiian and Part Hawaiian with type 2 diabetes population, could be 
assessed to describe CAM use. 
The diet modification and supernatural healing were the leading CAM types used by 
Native Hawaiians and Part Hawaiians with type 2 diabetes and DPN.  Individuals with type 2 
diabetes were aware of recommended diet modifications to manage hyperglycemia or 
hypoglycemia.  These recommendations came from by healthcare professionals and participants 
claimed to use it in this feasibility study.  Hsu and colleagues (2012) reviewed the literature and 
found dietary guidelines for Americans, in 2010, applicable to Native Hawaiian when cultural 
adaptations are made.  Food was a cultural factor and should be considered in the management of 
hyperglycemia, hypertension and hyperlipidemia.  
In a CAM utilization study, spiritual and religious individuals are identified as more 
likely to utilize CAM therapies that involve prayer, meditation, and spiritual healing (Ellison, 
Bradshaw, & Roberts, 2012).  Most Native Hawaiian respondents had religious/spiritual beliefs 
and implemented and used supernatural healing as a CAM therapy for diabetic complication self-
management.  Manipulative body therapies, biologically based therapies, and mind-body 
therapies are found as commonly used CAM therapies (Rhee & Harris, 2017).  Individuals with 
chronic diseases are more likely to use CAM (Tindle, Davis, Phillips, & Eisenberg, 2005).  
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Native Hawaiians and Part Hawaiians with type 2 diabetes and diabetic peripheral 
neuropathy responded CAM use was recommended by their health care professional.  
Respondents started to use CAM after discussion with health care professionals on CAM use. 
CAM was encouraged and recommended by health care professionals.  Native Hawaiians 
reported the type of CAM they choose to use was their decision and, “CAM was consistent with 
their culture”.  CAM was used without change to Western medicine.  Native Hawaiians reported 
CAM use was their decision with encouragement to use CAM from their health care 
professionals, and maintained current Western medicine while using CAM. 
Perceptions and attitudes of physicians to CAM use were perceived as not-evidence 
based treatments (Al-Omari, Al-Qudimat, Hmaidan, & Zaru, 2013).  Physicians would like to 
learn more about CAM with the lack of scientific studies on CAM and the widely accepted CAM 
use in patient’s culture (2013).  Nurses have a positive attitude towards CAM use, report CAM 
offered in their facilities, and used CAM for self-care (Jong, Lunqvist, & Jong, 2015).  Based on 
findings in the literature health care professionals have varied perceptions and attitudes of CAM. 
In the literature, there were studies on the prevalence of CAM use and descriptors of 
those who use CAM for specific reasons (Fox, Coughlan, Butler, & Kelleher, 2010; Harris, 
Cooper, Relton, & Thomas, 2012; Tindle et. al, 2005).  Studies that inquired about the most 
important reason an individual started to use CAM are limited.  A qualitative study provided a 
decision-making process approach to reasons for CAM use in a type 2 diabetic sample 
population (Chang, Wallis, Tiralongo, & Wang, 2012). There were four categories that emerged 
from the data; recognizing the need for using CAM, assessing the potential CAM prior to use, 
matching CAM use to personal philosophy, and ongoing evaluation of CAM (Chang et al., 
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2012).  It supports further research into relationships between CAM therapies used with a larger 
sample and it was noted that pain was not the only reason for CAM use. 
Feasibility of Conducting a Larger Study 
 The feasibility study revealed two instruments used which may not be appropriate to gain 
knowledge of CAM use in Native Hawaiians.  These instruments might not be the best fit for a 
Native Hawaiian and Part Hawaiian population.  Thus, would not be recommended in future 
studies with a Native Hawaiian or Part Hawaiian study population.   
Implications for Research, Practice, Education, and Policy 
 The feasibility study indicated the importance of a culturally appropriate instrument of 
CAM use.  The “talk story” strategy for collecting data was used in studies with Native 
Hawaiians and described as culturally acceptable (McEligot, et al., 2010).  In future research, the 
acceptable “talk story” research data collection strategy should be considered with a Native 
Hawaiian population. Native Hawaiians preferred to select “other” as a response for research 
questions (when available) to provide their response in their own words. 
 Based on the findings of this feasibility study CAM was used primarily as a supplement 
to conventional medicine for DPN self-management.  Vinik, Emir, Cheung, and Whalen (2013) 
found conventional treatment for individuals with chronic pain from DPN experienced 
improvement in quality of life related to pain relief, function, and sleep disturbance.  These 
symptoms were difficult to manage despite pharmacological therapeutic modalities for diabetic 
neuropathic pain.  Thus, the result that CAM serves this population as a supplement to 
conventional medicine highlights the complexities and limitations of conventional treatment.  
The result of this feasibility study may reflect the need for CAM use. 
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Practice 
 Health care professionals’ assessment of CAM use on health self-management is 
important because a high number of adults with chronic disease use CAM (Ben-Arye & Frenkel, 
2008).  The use of CAM could affect prescribed treatments and cause adverse effects.  In this 
feasibility study, health professionals recommended the use of CAM. There was specific focus 
on diet modification reported for a diabetic population.  Ben-Arye and colleagues (2008) 
developed a useful tool, in the primary care setting, to consider when referring individuals for 
CAM.  To support future research with Native Hawaiians, a research instrument should be 
developed for CAM use.  Instrument development could assist CAM use assessment by health 
care professionals.  This may improve safe self-management efforts for individuals seeking to 
supplement conventional therapy.  Practitioners could initiate assessment for CAM use and 
become educated on the types of CAM their patients use to coordinate health promotion and 
prevention (Hawk, Ndetan, & Evans, 2012). 
Education 
 Educational programs for health care professionals have the opportunity to expand their 
curriculum to include a course on CAM. CAM use is present in a variety of patient populations.  
It is important for health care professionals to understand the risk of harm to patients if CAM is 
incompatible with conventional treatment.  The first step is educating health care professionals in 
the area of CAM therapies, and encouraging open communication about CAM use with patients 
for their safety.  CAM use could serve in health prevention and wellness education. 
Policy 
 Policy development to investigate the safety of CAM could be considered.  The 
availability for a variety of CAM was present.  There was concern for the safety of the general 
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public accessing CAM and conventional therapies.  Healthcare professionals could be an active 
voice in needed policies to promote safe CAM therapies and regulate potentially unsafe use of 
CAM.  A collaborative effort between researchers, practitioners, educators, and policy 
developers are critical in a new emerging prominence of CAM use. 
Limitations 
 There are several limitations of this feasibility study.  There was a bias with a 
convenience sample type, and inclusive of Native Hawaiians and Part-Hawaiians.  The study 
exposed barriers for recruitment.  For example, patients did not have a phone or did not come to 
their clinic visit.  Additionally, the self-reporting structure of the interview could have been a 
bias.  The recruitment process method was started prior to clinic appointment for one group and 
was challenging when clinic patients did not show up for scheduled appointments. Individuals in 
this setting had limited access to receiving telephone calls.  Some individuals were shy, did not 
have the time or were tired and not able to participate.  Other variables that could have impacted 
feasibility of research in these settings are the concerns related to having multiple appointments 
scheduled on the day, limiting time to participate in research or transportation pick-up times.  
Participants were often accompanied by a family member and did not drive to their appointment, 
creating a sense of dependence on others, limiting time to participate and could have affected the 
quality of responses.   
 The in-person meeting was supportive of survey completion for most participants.  The 
setting was two outpatient clinics, possibly limiting presented data because the survey is not 
representative of other settings.  Limited results may be improved with a larger sample. These 
findings may not be generalized to all people with DPN. 
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Conclusion 
In conclusion, this feasibility study provided challenges in implementation, descriptive 
findings for demographic characteristics of a Native Hawaiian and Part Hawaiian with type 2 
diabetes and DPN population in Hawai'i that differed by education, and income level (when 
compared to other CAM studies).  The key finding of this feasibility study was a process with 
healthcare professionals initiating assessment of CAM use in a Native Hawaiian and Part- 
Hawaiian with type 2 diabetes and DPN population in Hawai'i.  The research procedure should 
include culturally tailored instruments and data collection methods such as, “talk story” in the 
future. The standardized tools contained structured questions used in this feasibility were not 
culturally appropriate.  However, the open-ended questions allowed participants to verbalize 
what types of CAM they used.  Some participants have not had a healthcare provider ask about 
their CAM practices and appreciated the opportunity to discuss what CAM practices were 
helpful to their health self-management.  CAM therapies were used for general use and diabetic 
use.  The population studied used a variety of CAM types and independently decided to use 
CAM based on healthcare provider recommendations. CAM use was present and health care 
providers should devote time to learning more about types of CAM used, reasons for CAM used, 
and implications for CAM users to adjust, research, practice, educate and change policy. 
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APPENDIX A 
CAM treatment for DPN Studies 
Studies selected met the following inclusion criteria: (1) research that implemented a 
form of alternative therapy intervention for diabetic peripheral neuropathy pain management in 
adults; (2) written in English; and (3) conducted within the last 10 years.  Exclusion criteria 
eliminated non-English text, published more that 10 years ago, and non-research based studies. 
A literature search was conducted via the PUBMED MED-LINE, CINAHL, and 
COCHRANE databases from 2002-2012.  The search option selected was Boolean/phrase with 
selected limitations such as full text, English language, research article, and peer reviewed. To 
maximize search “MM” exact major subject heading and “MH” exact subject heading were used 
with selected search terms.  The search terms were (MM “Diabetic Neuropathies+”),  (MM 
“Pain”), (MM ”Diabetes Mellitus+”) or (MM “Diabetes Patients”), (MM “Peripheral Nervous 
System Diseases+”) and (MM “Alternative Therapies”).  The plus sign next to a subject heading 
means there are narrower subjects within the general subject search. 
The search resulted in 150 citations from the disciplines of medicine, nursing, and 
psychology.  After the review of the citations, there were 11 articles that met the inclusion 
criteria.  Articles were reviewed to ensure a sufficient sample.  Each database was searched on 
several different occasions before the 11 articles were selected.  The papers selected for the 
sample were read and key data was entered into a matrix method according to Garrard (2007). 
See Appendix B for a summary of CAM treatment studies for DPNP.  The data consisted of 
author, publication year, purpose, alternative therapy studied, sample size, research study design, 
and instrument.  The designs of the studies were: pretest-posttest experimental design (N=5), 
randomized control trials (N=2), placebo-controlled single blinded randomized study (N=1), 
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randomized double blind (N=1), experimental (N=1) and randomized double-blind crossover 
(N=1).  All studies were conducted on adult participants.  The geographic location varied from 
four studies conducted in the United States, one in the Republic of Slovenia, one in the United 
Kingdom, one in China, two in Germany and two in Italy.  Two of the studies incorporated 
examination of other neuropathy types.  
CAM treatment themes identified for DPN 
 Alternative therapies and complementary and alternative medicine (CAM) studied to 
reduce diabetic peripheral neuropathy pain (DPNP) in adults were mind-body medicine, natural 
products and other CAM therapies.   There were no studies in CAM group manipulative and 
body-based practices (National Center for Complementary and Alternative Medicine, 2012).  
Acupuncture (3 studies) and meditation (2 study) represent the mind and body medicine for 
studies to reduce DPNP.  There were studies on the effect of natural products (4 studies), 
Neuragen PN, NGX-4010, topical capsaicin cream and acetyl-L-carnitine on DPNP.  Natural 
products were researched to determine efficacy on DPNP relief.  Neuragen PN (Li, 2010), 
categorized as a natural product, is a mixture of six homeopathic substances and five plant based 
oils.  The NGX-4010 is an 8% capsaicin patch and is the active ingredient of capsicum peppers 
(Forst et al., 2002).  Acetyl-L-carnitine (DeGrandis & Minardi, 2002) is a natural dietary 
supplement, which assists with increased glucose and phospholipid metabolism.  Other CAM 
and alternative therapies studied to reduce DPNP were transcutaneous electrical neuropathy 
stimulation (TENS) (two studies) and frequency-modulated electromagnetic neural stimulation 
(FREMS) (one study).  One study reported participants maintain a diary to document use of pain 
medication with alternative therapies (Ahn, Bennani, Freeman, Hamdy, & Kaptchuck, 2007). 
Mind-Body Medicine 
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Acupuncture 
Acupuncture is a meridian-based therapy with a focus to insert needles at precise body 
points to achieve a select therapeutic action (Tong et al., 2010).   It is one of the oldest forms of 
alternative medicine used in Traditional Chinese Medicine (TCM) over the past 2500 years 
(Tong et al., 2010).  There is evidence of DPNP reduction in several acupuncture studies. 
Acupuncture was studied as an adjunct therapy to conventional diabetes therapy (diet 
treatment, hypoglycemic agents, insulin and hypotensive agents) to relieve DPNP (Tong, Guo, & 
Han, 2010).  Traditional acupuncture had significant improvement in motor and sensory nerve 
function measures, improvement in lower extremity numbness, spontaneous pain, temperature 
perception and rigidity in upper extremities (Tong et al., 2010).  In all three studies, acupuncture 
was statistically significant in reducing DPNP (Ahn et al., 2007, Green & McClennon, 2006, & 
Tong et al. 2010).  Acupuncture in the traditional form was more effective on DPNP relief than 
other types of acupuncture such as sham (Tong et al., 2010) and Japanese Kiiko-Matsumoto 
acupuncture (Ahn et al., 2007). 
Meditation 
There are different types of meditation such as transcendental meditation (TM) a 
repetition method focuses on a word, phrase, or sound and zazen mindful meditation is practiced 
formally while in a sitting position (Teixeira, 2010).  Mindfulness meditation is an Eastern 
cultural practice traced to Buddhism.  In Western culture, there is the non-secular form of 
mindfulness meditation to end suffering through self-transcendence and enlightenment.  It is 
used in clinical practice and research to promote clinical relaxation and overall health.  A pilot 
study was conducted to examine the efficacy of a mindful meditation on quality of life (QOL), 
pain relief, and sleep quality in adults with chronic DPN (Teixeira, 2010).  The effect of mindful 
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meditation was not statistically significant for QOL, neuropathic pain relief, and sleep quality.  
Despite the lack of statistical significance, a positive relationship was identified between pain 
severity and sleep quality.  Thus, participants with increased pain severity experienced decreased 
sleep quality (Teixeria, 2010).   
Natural Products 	
Complementary medicine natural product category includes herbal medicines or 
botanicals, vitamins, minerals, and other natural products (NCCAM, 2012).   Neuragen PN, a 
blend of homeopathic substances and essential oils (Li, 2010), NGX-4010, 8% capsaicin patch 
(Webster, Peppin, Murphy, Tobias, & Vanhove, 2012), topical capsaicin cream (Forst et al., 
2002) and Acetyl-L-carnitine, a natural biochemical (DeGrandis & Minardi, 2002) are four 
natural products studied to promote DPN pain relief.  Neuragen PN (Li et al., 2010), NGX-4010 
(Webster et al., 2012), and topical capsaicin cream (Forst et al., 2002) studies were conducted in 
the United States and Acetyl-L-carnitine (DeGrandis et al., 2002) conducted in Italy. 
Neuragen PN 
Neuragen PN (Li, 2010) application resulted in a significant reduction in peripheral 
neuropathy pain.  The McGill Pain Questionnaire and Visual Analog Scale (VAS) was presented 
on a personal digital assistant (PDA) with the Purdue Momentary Assessment Tool (PMAT, 
Bangstate, Inc.) to assess participant’s pain reduction (Li, 2010).  Participants reported 
significant pain reduction (93.3%) within 30 minutes of Neuragen PN topical application and up 
to eight hours post treatment.  There were 18 diabetic participants and 94% reported pain 
reduction within 30 minutes of treatment as compared to 11% in the placebo group (2010).  
According to researchers, Neuragen PN is recommended as a safe and effective alternative to 
conventional treatment for temporary peripheral neuropathy pain relief. 
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NGX-4010 8% Capsaicin Patch 
 NGX-4010, 8% capsaicin patch (Webster et al., 2012) and capsaicin cream (Forst, et al., 
2002) were topical interventions studied for DPNP relief.   The NGX-4010 was applied after one 
of three topical anesthetics to assist in patch tolerability and participants used additional 
pharmacological analgesics (Webster et al., 2012).  The average pain score reported on the 
Numeric Pain Rating Score was 5.4-5.9 with a zero score represents no pain and a 10 score is the 
worst possible pain.  There was an overall decrease in pain by 30% in all groups with a pain 
relief up to 12 weeks after a single application (Webster et al., 2012).  The capsaicin (0.05%) 
cream study (Forst et al., 2002) treated one foot and left the other participant’s foot untreated.  A 
total symptom score was obtained from four ten point scales to assess pain, dysesthesia, 
hypesthesia, and muscle weakness at baseline, four weeks and eight weeks.  There was a 
decrease in the total symptom score with improvement specific to hypesthesia and warmth 
perception threshold.  Evidence of adverse reaction to sensory nerve fiber function or 
neurovascular control was not present during the eighth week treatment period.  Overall, the 
investigators concluded there is a beneficial effect of topical capsaicin cream treatment for 
symptomatic diabetic neuropathy (Forst et al., 2002). 
Acetyl-L-carnitine, a natural biochemical (DeGrandis et al., 2002) was administered in an 
intramuscular form for 10 days and an oral form for 355 days to determine the efficacy and 
tolerability for the treatment of diabetic neuropathy.  There was statistical significance with 
patient reported nerve conduction velocity (p <0.01) and visual analogue scale (p<0.0) 
significantly decreased after 12 months of treatment.  There was good tolerability of Acetyl-L-
carnitine and minimal adverse reactions but, primarily related to gastrointestinal.  
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diabetic neuropathy progression (DeGrandis et al., 2002).  Acetyl-L-carnitine is a safe and 
tolerable option for DPNP relief.  
Other CAM and Alternative Therapies  
In other CAM and alternative therapies group, there were two studies found in the 
literature that utilize Transcutaneous Electrical Neuropathy Stimulation (TENS) (Moharic & 
Burger, 2010) (Grossrau et al., 2011) and one study evaluated Frequency-modulated 
Electromagnetic Neural Stimulation (FREMS) (Bosi et al., 2005).  There was no other CAM and 
alternative therapies found in the literature to represent Eastern and Western movement-based 
therapies, traditional healers, energy fields, or whole medical systems. 
Transcutaneous Electrical Neuropathy (TENS). 
 Other CAM and alternative therapies found in the literature included two forms of 
electrical and electromagnetic stimulation.  TENS affect on painful diabetic neuropathy had a 
significant effect on sensory thresholds by increased cold pain and decreased heat pain from 
baseline in a non-stimulated thenar or base of the thumb (Moharic et al., 2010).  There was no 
change in the lower extremities where the TENS was applied (Moharic et al., 2010).  However, 
the second study had no statistical significance with micro-TENS application to lower 
extremities (Grossrau et al., 2011).  In the placebo group 25% responded to therapy compared to 
23% responded in the treatment group.  There may have been decreased efficacy because of the 
micro level of current administered compared to conventional TENS that use electrical 
stimulation measured in milliamps (Grossrau et al., 2011).  Both studies view TENS as a safe 
alternative method to neuropathy pain relief. 
Frequency-modulated Electromagnetic Neural Stimulation (FREMS) 
Frequency-modulated Electromagnetic Neural Stimulation (FREMS) is different from 
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TENS with sequences of modulated electrical stimuli change automatically in pulse frequency, 
duration, and voltage amplitude (Bosi et al., 2005).  Bosi and colleagues studied the efficacy of 
FREMS as a novel treatment for painful diabetic neuropathy (2005).  In a sample of 31 
participants with the group divided to form a FREMS group and a placebo group of 15 and 16 
participants there was statistical significance in the FREMS group.  Daytime pain (p=0.0025) 
and night-time pain (p=0.0107) VAS score was significantly decreased in the FREMS group.  
There was statistical significance with an increase in sensory tactile perception with 
monofilament assessment (p=0.0077) and decreased foot vibration perception threshold 
(p=0.001).  At the four-month follow-up, all parameters were tested and resulted in statistically 
significant outcomes.  It was concluded that FREMS is a safe and effective therapy for diabetic 
peripheral neuropathy pain (Bosi et al., 2005). 
Review of the types of CAM treatments for DPNP and implications for use in the Native 
Hawaiian population was summarized (see appendix C).  These researched treatments have little 
significance on management of DPN.  Acupuncture from the CAM mind-body modality 
provided significant improvement in motor and sensory nerve function measures, improvement 
in lower extremity numbness, spontaneous pain, temperature perception and rigidity in upper 
extremities (Tong et al., 2010).  Utilization of these researched CAM DPNP treatments may be 
difficult to access because of cost and availability.  Cultural acceptance may not support 
utilization of particular CAM treatments.  But with support, knowledge, and understanding from 
healthcare providers a collaborative treatment plan for DPNP to include conventional and 
complementary and alternative medicine could be accessed and utilized. 
Analysis of Cochrane Database CAM DPN Studies  
There is limited research about the reasons people use CAM (Chang, Wallis, & 
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Tiralongo, 2010).  The Cochrane Database reviewed the effects of vitamin B for treating 
generalized peripheral neuropathy, the beneficial and harmful effects of acupuncture therapy for 
symptomatic diabetic neuropathy, and Chinese herbal medicine for people with diabetic 
peripheral neuropathy (Ang et al., 2008; Chen, Zhang, Xinxue, Yang, & Liu, 2013; Zhao, Zhang, 
& Zhao, 2006).   Based on the Cochrane Database reviews there is a gap in knowledge and an 
opportunity to conduct studies on reasons people use CAM for DPN.  The CAM DPNP studies 
are limited to providing information on types of CAM to manage DPNP.  The studies do not 
provide information if these CAM treatments are selected and used by DPNP patients.  The 
evaluations of CAM treatments do not provide recommendations for use on patients outside of 
the research study. 
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CAM Treatment Studies for Diabetic Peripheral Neuropathy Pain 	Authors,	Year	 Purpose	 Subjects	 Data	 Relevant	Results		 	 #	of	Subjects	&	Characteristics	 	Design	 	Source	or	Instrument	 	
Mind-Body	Medicine	
Acupuncture	Ahn,	Bennani,	Freeman,	Hamdy,	&	Kaptchuck	(2007)	
To	assess	the	feasibility	of	studying	two	acupuncture	styles,	Traditional	Chinese	Medicine	(TMC)	and	Japanese	Kiiko-Matsumoto	style	acupuncture.	To	obtain	preliminary	data	for	the	clinical	and	mechanistic	effects	of	acupuncture	on	diabetic	neuropathy.	
n=7		 Randomized	Control	Trial	
Weekly	acupuncture	treatments	over	a	period	of	10	weeks.	An	11	point	Likert	Scale	daily	pain	severity	score	was	recorded	4	times	a	day.	A	diary	was	used	to	record	pain,	sleep	interference	due	to	nocturnal	pain,	glucose	control,	use	of	pain	medication,	Profile	of	Mood	States	scores,	the	pain	rating	index	portion	of	SF-MPQ,	SF36	Quality	of	Life	Questionnaire,	and	blood	tests	(CBC,	Crt,	and	HgbA1C).	
• Pain	scores	were	lower	for	the	Japanese	Acupuncture	group	initially.	
• Sensation	improved	for	the	TCM	group.	
• The	Pain	Rating	Index	of	the	SF-MPQ	noted	a	decrease	in	pain	for	both	groups.	
• For	both	groups	there	were	no	changes	in	mood	or	blood	test	results.		
• This	study	was	unable	to	determine	the	clinical	and	mechanistic	effects	for	physiological	response	to	diabetic	peripheral	neuropathy	pain.	
Green	&	McClennon(2006)	 To	determine	the	effectiveness	of	acupuncture	on	peripheral	diabetic	neuropathy.	
n=88	 Pre-test	posttest	Experimental	design	
1	hour	initial	appointment	includes	health	and	pain	assessment.	Completion	of	short	form	McGill	questionnaire	in	week	1	and	week	6.	Each	participant	received	6	acupuncture	sessions	once	a	week	for	6	weeks.	
• Results	were	analyzed	using	the	student	t-tests.	
• Pre	acupuncture	scores	were	20.1	and	post	acupuncture	scores	were	10.7.	
• There	were	67	participants	with	reduced	pain.	
• Monthly	‘top	up’	acupuncture	continued	for	29	participants.	
• At	the	end	of	the	acupuncture	course	10	participants	reduced	or	stopped	peripheral	diabetic	neuropathy	medication.	
• There	12	participants	who	reported	no	pain	reduction.	Tong,	Guo,	&	Han	(2010)	 To	investigate	the	effects	of	acupuncture	on	diabetic	peripheral	neuropathy.	
n=63	Diabetic	Peripheral	Neuropathy	patients	between	age	35-52.	
Pre-test		Posttest	Experimental	Design	
42	cases	treated	with	acupuncture.		21	cases	exposed	to	sham	acupuncture	The	difference	between	acupuncture	and	sham	acupuncture	was	needle	manipulation.	A	2:1	ratio	used	to	determine	randomization	for	groups.	All	patients	participated	
• No	statistical	significance	in	glycemic	control.	
• Statistical	significance	present	in	nerve	function.	
• In	the	acupuncture	group,	three	of	the	six	measures	in	
• motor	nerves	demonstrated	significant	improvement	
• (p	<	0.05)	over	the	15-day	treatment	period.	
• There	were	no	significant	improvement	in	the	sham					acupuncture	group.	
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in	one	session	per	day	lasting	30	minutes	for	15	days.		The	method	to	measure	nerve	function	was	electromyography	and	the	vibration	perception	
threshold	was	measured	on	the	medial	malleolus	in	the	lower	extremities	using	a	hand-held	biothesiometer.	A	standardized	questionnaire	was	used	to	assess	subjective	data.	
The	two	measures	of	sensory	function,	forearm	and	distal	sensory	nerve	conduction	velocity	were	improved	in	the	acupuncture	group.	-	The	vibration	perception	threshold	was	significantly	different	between	the	groups.	
• Subjective	symptoms	over	time.	-	In	the	acupuncture	group,	participants	reported	improvement	on	numbness	of	lower	extremities,	spontaneous	pain	in	lower	extremities,	rigidity	in	upper	extremities,	and	alteration	in	temperature	perception	in	lower	extremities.		
Meditation	Teixeira	(2010)	 To	evaluate	the	effect	of	mindfulness	meditation	on	QOL	among	adults	with	diabetes	living	with	symptomatic	(pain,	numbness,	and/or	reduced	feeling	in	1	or	more	extremity)	DPN.		Also,	to	highlight	the	cost	effectiveness	of	mindful	meditation	and	low	risk.		Hypotheses	*Mindfulness	meditation	will	have	a	positive	effect	on	QOL	in	adults	with	PDPN	as	measured	by	scales	from	the	Neuropathy-Specific	Quality	of	Life	Tool	(NeuroQOL).	*There	will	be	
n	=	20	n	=	10	Group	A	was	given	meditation	instructions	and	satisfaction	log.		This	group	used	a	meditation	CD	5	days	a	week.	n	=	10	Group	B	placebo	control	group	received	nutrition	class	and	maintained	a	4	week	diet	log.	A	convenience	sample	of	type	2	diabetic	adults	living	with	chronic	PDPN.		The	DPN	symptoms	pain	and/or	numbness	experienced	for	>	6	months	for	a	male	or	female	50-92	years	of	age.	
Pretest-Posttest	Experimental	Design		
Baseline	and	week	4	data	were	collected	with	the	Demographic	Form,	Neuropathic	Pain	Scale	(NPS),	NeuroQol,	and	the	Pittsburgh	Sleep	Quality	Index	(PSQI).	
• Hypothesis	1	–	No	significant	difference	between	the	groups.		The	adjusted	mean	score	for	the	pain	QOL	was	4	points	less	compared	to	the	control	group.	Comparison	on	Means	Using	NeuroQol	Constructs																																		
N Unadjusted		Mean	(SD)	 Adjusted	Mean		(SD)	
Overall QOL    
Group B 
(Placebo)10 
Group A 
(Intervention)10  
 
2.90 (0.88)  
3.50 (0.53) 	  3.02 (0.63)  3.39 (0.63)	
Symptom-
related QOL 
Group B 
(Placebo) 10  
Group A 
(Intervention)10  
 
2.40 (1.47)  
2.20 (1.40)	 	2.44 (0.74) 2.16 (0.74) 	
Pain QOL 
Group B 
(Placebo) 
10  
Group A 
(Intervention)10  
 
24.70 (20.89)  
22.30 (11.91)	 	25.38 (11.42) 21.62 (11.42) 	
Emotion QOL 
Group B 
(Placebo) 
10  
Group A 
(Intervention) 
10 
 
13.40 (12.12)  
13.50 (7.49)	  13.65 (8.92) 13.25 (8.92)	
Sensory/ 
motor QOL 
Group B 
(Placebo)10  
Group A 
(Intervention)10  
 
19.4 (12.87)  
18.2 (9.89)	  18.10 (7.17)  19.51 (7.17)	
	
• Hypothesis	2	–	No	statistical	significance	between	the	groups	for	post-intervention	pain	intensity.	
 
Comparison of Pain Scores From Neuropathic 
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a	decrease	in	DPN	pain	severity	with	the	use	of	mindfulness	meditation.	*There	will	be	an	inverse	relationship	between	DPN	pain	severity	and	sleep	quality.	
Pain Scale 
 
N Unadjusted 
Mean (SD) 
Adjusted Mean (SD) 
Pain intensity 
Group B 
(Placebo) 10 
Group A 
(Intervention)
10 
 
2.89 (1.96) 
4.80 (3.12) 
 
3.09 (0.63) 
4.62 (0.63) 
Pain 
Unpleasantn
ess 
Group B 
(Placebo) 10 
Group A 
(Intervention)
10 
 
2.40 (1.47) 
2.20 (1.40) 
 
2.44 (0.74) 
2.16 (0.74) 
 
• Hypothesis	3	–	No	statistical	significant	improvement	noted	for	pain	severity	between	groups.		However,	there	was	a	positive	relationship	between	pain	severity	and	sleep	quality.		N=16	 PSQI	 Mean	(SD)	Pain-	NeurQol	PSQI	 0.531	 23.5	(16.6)	6.9	(4.8)	
	
Natural	Products	
Neuragen	PN	Li	(2010)																													
To	investigate	the	effect	of	Neuragen	PN		(a	mixture	of	six	homeopathic	substances	and	five	plant	based	oils)	on	neuropathic	pain	reduction.	
n=60	Individuals	with	peripheral	neuropathy.	n=18	Diabetic	induced	peripheral	neuropathy.	
Pre-test	posttest	Experimental	design		
n=30	treatment	(Neuragen	PN)	n=30	placebo	McGill	Pain	Questionnaire	and	Visual	Analogue	Scale	(VAS).		These	assessment	tools	were	administered	at	specific	time	points	(2,3,4,5,6,7,8,&	9	hr)	using	a	PDA	software	system.	Each	participant	received	two	sessions.	
• There	was	significant	pain	reduction	reported	using	the	VAS	between	the	treatment	group	and	placebo	group.			
• Within	30	minutes	of	receiving	treatment	the	Neuragen	PN	60	(93.3%)	participants	reported	pain	reduction	and	in	the	placebo	group,	21	(35%)	reported	pain	reduction.	
• Out	of	the	18	diabetic	participants	94%	in	the	Neuragen	PN	reported	pain	reduction	within	30	minutes	compared	to	11%	in	placebo	group.	
• There	was	50%	maximum	pain	relief	reported	in	the	Neuragen	PN	group	compared	to	3%	in	the	placebo	group.	
• Pain	relief	was	statistically	significant	up	to	8	hrs.		
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NGX-4010	8%	Capsaicin	Patch	Forst,	Pohlmann,	Kunt,	Goitom,	Schulz,	Lobig,	Engelbach,	Beyer,	&	Pfutzner	(2002)	
To	investigate	the	impact	of	topical	capsaicin	cream	application	on	small	nerve	fiber	function	and	neurovascular	control.	
n=13		n=10	completed	the	study,	2	participants	discontinued	due	to	adverse	events	and	1	was	eliminated	due	to	inadherence	to	study	protocol.	
Pre-test	Post-test	experimental	design.	
*	Capsaicin	applied	to	one	foot	and	the	participant’s	other	foot	was	left	untreated. *	Total	“symptom	score”	based	on	sum	of	four	10	point	scales	to	assess	pain,	dysesthesia	(abnormal	sensation),	hypesthesia	(reduced	sensation),	and	muscle	weakness	were	assessed	at	baseline,	week	4,	&	week	8.	*	Peripheral	large	nerve	assessment	was	done	at	the	metatarsophalangeal	joint	of	the	great	toe	with	vibration	perception	threshold	at	the	measurement	with	biothesiometry	(Vibra	Tester	100,	PHYWE,	Gottingen,	Germany).	*	Small	nerve	fiber	function	was	measured	by	the	determination	of	cold,	heat,	and	pain	perception	threshold	at	the	dorsum	of	the	foot	with	a	marstock	stimulator	(path-Tester,	PHYE,	Gottingen,	Germany).	*	Blood	sample	obtained	to	measure	substance	P	levels.	*	A	laser	Doppler	fluxometry	(LDF,	MBF	3D,	Moor	Instruments,	Devon,	UK)	was	used	to	measure	microvascular	blood	flow	response	to	heat	stimulus	and	acetylcholine.	*	Venous	blood	sample	measured	HbA1c.	
• No	change	in	blood	sugar	control	as	evidence	by	HgbA1c.	
• Total	symptom	score	was	decreased	in	the	capsaicin-treated	foot.		The	specific	symptom	improvement	was	for	hypesthesia.	
• No	adverse	affects	on	tested	sensory	nerve	fiber	functions.	
• Blood	flow	response	to	heat	stimulus	revealed	no	significant	change	but	in	capsaicin-treated	feet	there	was	a	slight	decline	in	acetylcholine.	
• Serum	P	levels	(a	neuropeptide	and	functions	as	a	neurotransmitter	with	peripheral	pain	sensation)	increased	significantly	in	the	4	week	for	the	local	capsaicin	treatment	and	decreased	in	the	following	weeks.	
Webster,	Peppin,	Murphy,	Tobias,	&	Vanhove	(2012)	
To	assess	safety,	tolerability,	and	preliminary	efficacy	of	NGX-4010,	a	capsaicin	8%	patch,	after	one	of	three	topical	anesthetics.		
n=	117	post-herpetic	neuralgia,	HIV-associated	distal	sensory	polyneuropathy	or	painful	diabetic	neuropathy.	
Randomized	Control	Trial	
*	Randomized	to	receive	pre-treatment	from	one	of	three	topical	anesthetic	and	receive	a	60	or	90	minute	NGX-4010	patch	treatment	for	12	weeks.	*	Numeric	Pain	Rating	Scores	(NPRS)	for	“pain	now”	and	“average	pain	for	the	past	24hours”	recorded	at	9pm	in	a	diary	at	baseline	and	from	2	to	12	weeks.	*	Patient	Global	Impression	of	Change	(PGIC)	and	investigator-rated	Clinical	Global	Impression	of	Change	(CGIC)	were	assessed	at	weeks	2,	6,	&	
• Majority	of	patients	were	white,	male	with	PDN.			
• Average	pain	scores	were	5.4	to	5.9	on	the	average	Numeric	Pain	Rating	Scale	(NPRS).		A	0	score	signifies	no	pain	and	a	10	score	signifies	the	worst	possible	pain	on	the	NPRS.	
• At	baseline,	more	than	half	of	patients	were	receiving	concurrent	neuropathy	treatment.	
• At	least	one	adverse	effect	from	pretreatment	was	reported	by	50-59%	of	participants	in	all	three	
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12.	 groups.	
• The	“pain	now”	NPRS	score	on	the	day	of	treatment	decreased	after	pretreatment	and	slightly	increased	after	patch	application.	
• Dermal	irritation	was	minimal	with	a	maximum	dermal	assessment	score	of	2	out	of	7.	
• A	27.2%-34.3%	patient	reported	pain	reduction	between	weeks	2	to	12.		
• A	45%-50%	of	patients	responded	to	treatment	based	on	a	>	30%	mean	decrease	in	pain	from	baseline.	
• No	significance	in	type	of	topical	analgesic	pretreatment	or	patch	application	time	of	60	minutes	or	90	minutes.	
• At	week	12,	the	PGIC	analysis	revealed	58%-71%	patients	reported	improvement	as	slightly,	much,	or	very	much	and	35%-42%	reported	much	or	very	much	improved.		Similar	findings	present	in	the	CGIC.	
Acetyl-L-Carnitine	DeGrandis	&	Minardi	(2002)	 To	assess	the	efficacy	and	tolerability	of	acetyl-L-carnitine	(Levacecarnine;	LAC)	versus	placebo	in	treatment	of	diabetic	neuropathy.	
n=20	multicenter	n=333	patients	
Randomized,	double	blind,	placebo	controlled,	parallel-group	study	
*	LAC	or	placebo	IM	1000mg/day	dose	for	10	days	and	daily	2000mg	oral	dose	for	355	days.	*	Nerve	conduction	velocity	(NCV)	and	amplitude	in	sensory	(ulnar,	sural,	and	median)	and	motor	(median,	ulnar	and	peroneal)	*	Visual	analogue	scale	(VAS)	
• Statistical	significance	reported	in	patients	treated	with	LAC	for	mean	NVC	and	amplitude	compared	to	placebo	(p	<0.01).	
• The	mean	VAS	significantly	decreased	after	12	months	of	treatment	by	39%	from	baseline	in	LAC	treated	patients	(p<0.0)	as	compared	to	a	decrease	of	8%	in	placebo	patients.	Other	CAM	and	Alternative	Therapies	
Transcutaneous	Electrical	Neuropathy	Stimulation	(TENS)	
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Moharic	&	Burger	(2010)	 To	determine	whether	TENS	improves	small	fiber	function	diminished	because	of	painful	diabetic	neuropathy.		
n	=	46	Painful	Diabetic	Neuropathy	(PDN)	6	months	or	longer	reports	of	neuropathic	symptoms	affecting	primarily	the	lower	limbs.	
Experimental	design	 Michigan	Neuropathy	Screening	Instrument	(MNSI),	Marstock	method	for	thermal	and	pain	threshold	assessment,	Thermal	stimulator	(TSA	2001	Thermal	Sensory	Analyser,	Medoc	Ltd,	Ramat	Yishai,	Israel),	VSA	3000	Vibratory	Sensory	Analyser	(Medoc	Ltd.,	Ramat	Yishai,	Israel),	von	Frey’s	hair		(Aesthesiometer,	Somedic,	Sweden).	
• Statistically	significant.	
• Thenar	Cold	Pain	P	=	0.0001	Heat	Pain	P	=	0.0001	
• TENS	significantly	influenced	the	sensory	threshold	with	the	increase	of	cold	pain	from	baseline	and	heat	pain	decreased	from	baseline	at	thenar.	
• TENS	application	to	lower	extremities	for	three	hours	daily	for	three	weeks.	
• Improved	heat	pain	and	cold	pain	thresholds	in	non-stimulated	areas	up	to	a	month	after	treatment.	Grossrau,	Wahner,	Kuschke,	Konrad,	Reichmann,	Wiedemann,	Sabatowski.	(2011)	
To	assess	the	effect	of	micro-TENS	in	reducing	neuropathic	pain	in	patients	with	PDN.	
n	=	41	n	=	22	Verum	group	n	=	19	Placebo	group	European	Diabetics	with	PDN	
Placebo-controlled,	single	blinded	randomized	study	
Standardized	questionnaires	(Pain	Disability	Index	[PDI],	neuropathic	pain	score					[NPS],	Center	for	Epidemiologic	Studies	Depression	Scale	[CES-D])	assessed	pain	intensity,	pain	disability,	as	well	as	quality	of	life.	
• No	statistical	significance.	
• 6	out	of	21	(23%)	in	the	treatment	group	responded	to	therapy.	
• 10	out	of	19	(25%)	in	the	placebo	group	responded	to	therapy.	
• Number	of	pain	attacks,	patients’	general	condition,	and	patients’	depression	score	do	not	respond	to	micro	–	TENS.	
• Before	treatment	and	after	4	week	treatment.	Pain	attacks/day		P	=	>0.07	Patients’	general	condition	P	=	>0.5	Patients’	depression	score	P	=	>0.3		
Frequency-modulated	Neural	Stimulation	(FREMS)	Bosi,	Conti,	Vermigli,	Cazzetta,	Peretti,	Cordoni,	Galimberti,	&	Scionti	(2005)	
To	evaluate	the	efficacy	of	frequency-modulated	electromagnetic	neural	stimulation	(FREMS)	as	a	novel	treatment	for	painful	diabetic	neuropathy.	
n=31	Painful	diabetic	neuropathy	patients.	
Randomized	double-blind	crossover	study		
Sequence	1	n=15	Sequence	2	n=	16	(FREMS	group	&	Placebo	group)	Daytime/Night-time	pain	measured	by	0-100	VAS,	tactile	sensation	measured	by	Semmes-Wienstein	monofilament	test,	foot	vibration	perception	threshold	measured	with	biothesiometer	(Bio-Medical	Instrument	Company,	Newbury,	OH,	USA),	and	motor	nerve	conduction	velocity	(MNCV)	and	sensory	nerve	conduction	velocity	(SNCV)	measured	by	Micromed	System	98	(Myoquick,	Treviso,	Italy)	in	Milan,	and	in	Perugia	Medlelec	Premier	
• FREMS	significantly	reduced	daytime	(p=0.0025)	and	night-time	(p=0.0107)	VAS	pain	score	(all	p<0.02).	
• FREMS	significantly	increased	sensory	tactile	perception	with	monofilament	assessment	(p=0.0077),	MNCV	(p=0.0019)	and	decreased	foot	vibration	perception	threshold	(p=0.0001).	
• No	significant	changes	in	placebo	group.	
• Baseline	data	was	not	significantly	different	between	groups.	
• At	the	4	month	follow-up	results	were	statistically	significant	in	all	parameters	
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Plus	(TECA,	NY,	USA)	was	used.	 (daytime	pain	score	p<0.01,	night-time	pain	score	p<0.01,	vibration	perception	threshold	p<0.05,	sensory	perception	assessed	by	monofilament	p<0.001,	MNCV	p<0.05	modified	by	FREMS	during	treatment	and	overall	quality	of	life.	
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APPENDIX B 	
Types of CAM (NCCAM, 2012) CAM	Group	 Samples	of	CAM	Types	Natural	Products	 Herbal	medicine,	vitamins,	minerals,	and	probiotics.	Mind-Body	Medicine	 Meditation,	yoga,	acupuncture,	deep-breathing	exercising,	guided	imagery,	hypnotherapy,	progressive	relaxation,	qi	gong,	and	tai	chi.	Manipulative	and	Body-Based	Practices	
Spinal	manipulation	(chiropractic/osteopathic)	and	massage	therapy.	
Other	CAM	Practices	 Eastern	and	Western	Movement-based	therapies	(Feldendrais	method,	Alexander	technique,	pilates,	rolfing	structural	integration,	and	trager	pshychophysical	integration),	traditional	healers	(Native	American	healer/medicine	man),	energy	fields	(magnet	therapy,	light	therapy,	qi	gong,	Reiki,	and	healing	touch),	and	whole	medical	systems	(Ayurvedic	medicine	and	traditional	Chinese	medicine).		
National Center for Complementary and Alternative Medicine.  What is Complementary and 
Alternative Medicine? 2012.  Available from: http://nccam.nih.gov/health/whatiscam 
accessed July 27, 2014. 
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APPENDIX C 	
CAM DPNP Treatment Implications for Native Hawaiians 
Theme Implications for Native Hawaiians with 
DPNP 
                   Mind-Body Medicine 
Native Hawaiians practice lomi (massage) 
a form of mind-body medicine to achieve 
healing. 
Acupuncture Native Hawaiians may consider this useful 
to achieve a select therapeutic action such 
as pain reduction.  As a method of Eastern 
medicine, the insertion of needles may be 
more acceptable. 
Meditation It is inexpensive and can be done as an 
individual or with others.  Native 
Hawaiians may consider outdoor venues to 
meditate to support connection between 
mind, body, and spirit. 
Natural Products Native Hawaiians obtain natural products 
from the 'āina (land) or kahakai (seashore) 
for sustenance and health maintenance. 
Neuragen PN The cost of the natural product is not 
mentioned and therefore could present a 
concern.  Native Hawaiians are consumers 
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of affordable natural products.   
NGX-4010 8% Capsaicin Patch The reports of burning sensation side 
effects may not be tolerable for Native 
Hawaiians.  But, the beneficial pain 
reduction may outweigh the initial side 
effect. 
Acetyl-L-Carnitine Native Hawaiians may not prefer this 
method of intramuscular injections and oral 
doses of Acetyl-L-Carnitine.  It is a natural 
biochemical and administered in a 
traditional pharmacological manner. 
Other CAM and Alternative Therapies Native Hawaiians may prefer holistic CAM 
treatments such as religious healing/prayer, 
vitamins/supplements, and 
massage/bodywork. 
Transcutaneous Electrical Neuropathy 
(TENS) 
The administration of electrical current for 
pain relief may not be the preferred CAM 
therapy for Native Hawaiians.  Electricity 
is a Western form of therapy that may 
disrupt the balance between body, mind, 
and spirit. 
Frequency-modulated Electromagnetic 
Neural Stimulation (FREMS) 
Although this is different from TENS with 
sequences of modulated electrical stimuli 
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alterations, Native Hawaiians may not 
connect with these forms of CAM therapy.  
There is a question to cost and accessibility 
to FREMS treatment not presented in the 
literature. 
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APPENDIX D 	
Recruitment Brochure Complementary	and	Alternative	Medicine	Study	
	
	
Do	you	have	diabetes	peripheral	neuropathy?		You	may	be	eligible	to	be	a	part	of	
this	study.		It	is	voluntary,	confidential,	and	you	may	withdraw	at	anytime	from	
the	study.		There	is	a	one	time	15-30	minute	meeting	with	a	researcher.		
Purpose:	To	determine	how	many	people	use	Complementary	and	Alternative	
Medicine	(CAM)	and	different	types	of	CAM	for	diabetes	peripheral	neuropathy.			Principle	Investigator:	Mahealani	Suapaia,	MS,	RN,				If	you	have	questions	contact	Queen’s	Medical	Center,	Office	of	Research	and	Development, The	
Queen's	Medical	Center 1301	Punchbowl	Street, Honolulu,	HI		96813, 808-691-4106	office, 808-691-
7897	fax 	
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APPENDIX E 
 
 THE	QUEEN’S	MEDICAL	CENTER	HONOLULU,	HAWAII		
INFORMED	CONSENT	TO	TAKE	PART	IN	A		
CLINICAL	RESEARCH	STUDY	
		Title	of	Study:	Exploration	of	Complementary	and	Alternative	Medicine	Use		for	Management	of	Diabetic	Peripheral	Neuropathy:	A	Multivariate	Approach		Principal	Investigator:	Mahealani	Suapaia,	MS,	RN	
Address	2528	McCarthy	Mall,	Webster	Hall,	Honolulu,	Hawaii	96822	
	 Phone	808-236-5829		Sub-investigator(s):	Dr.	Chen-Yen	Wang		Sponsor:	N/A.		INFORMED	CONSENT		 You	are	being	asked	to	take	part	in	this	research	study	because	you	have	diabetes	
peripheral	neuropathy.	This	is	a	research	study	that	will	explore	the	types	of	
Complementary	and	Alternative	Medicine	used	by	those	with	diabetes	peripheral	
neuropathy.		
Before you decide whether or not to take part in this study, you must understand the 
purpose, how it may help, any risks, and what you have to do.  This process is called 
informed consent.  The researcher(s) will talk with you about the study and the informed 
consent form.  The consent also gives you information about what health information will 
be collected as part of the research study and how that information will be used or 
disclosed.   Once you understand the study, and if you agree to take part, you will be 
asked to sign this consent form.  If you sign this form you are agreeing to take part in this 
study and to allow the use and disclosure of your medical records and health information 
collected in connection with your part in this study.  You will be given a signed copy to 
keep. If you do not sign this consent form, you may continue to receive care, but not as 
part of this study.” 	 Before	you	learn	about	the	study,	it	is	important	that	you	know	the	following:	
• Taking	part	in	this	study	is	of	your	own	free	will.	
• You	may	decide	not	to	take	part	in	the	study	or	stop	being	in	the	study	at	any	time	without	it	making	any	difference	to	your	care	now	or	in	the	future,	or	to	any	benefits	that	you	are	allowed.	
		 111	
• If	the	study	changes	in	any	way	which	could	make	a	difference	to	your	taking	part,	you	will	be	told	about	the	changes	and	may	be	asked	to	sign	a	new	consent	form.		PURPOSE	OF	THE	STUDY			 This	research	study	is	being	done	to:	1) Describe	types	of	Complementary	Alternative	Medicine	(CAM)	used	to	manage	
Diabetes	Peripheral	Neuropathy.		PROCEDURES		
Screening If	you	decide	to	take	part	in	this	study,	you	will	be	asked	to	sign	this	consent	form.			1. You	will	be	asked	to	complete	three	questionnaires.	One	of	questionnaires	will	be	a	short	interview.	A	researcher	will	be	available	to	assist	you	with	the	questionnaires.	 			RISKS	
	 1. There	may	be	a	risk	of	psychological	stress	by	taking	part	in	this	study.		BENEFITS		 Taking	part	in	this	study	may	help	you	feel	better	but	no	guarantee	can	be	made	and	it	is	possible	that	no	good	response	will	happen.		Knowledge	gained	from	this	study	may	help	other	people	in	the	future.		OTHER	TREATMENT		You	may	choose	to	not	take	part	in	this	study	without	it	making	a	difference	in	the	care	that	you	get	now	or	in	the	future.				CONFIDENTIALITY	
	
Federal	Privacy	Regulations	provide	safeguards	for	privacy,	security,	and	
authorized	access	to	health	information.			The	confidentiality	of	all	study-related	records	will	be	kept	according	to	all	applicable	laws.		Information	gained	during	this	study	and	information	known	about	you	will	be	confidential	(private)	to	the	extent	permitted	by	state	and	federal	law.			The	results	of	this	research	may	be	presented	at	meetings	or	in	publications;	however,	your	identity	will	not	be	disclosed.					USE	AND	DISCLOSURE	(RELEASE)	OF	YOUR	HEALTH	INFORMATION		
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By	signing	this	form	you	are	authorizing	the	collection,	use	and	release	of	your	personal	health	information	in	medical	records	and	diagnostic	imaging	and	any	health	information	gathered	about	you	as	part	of	this	study.		Your	information	will	only	be	used/disclosed	as	described	in	this	consent	form	and	as	permitted	by	state	and	federal	laws.		Your	personal	health	information	is	health	information	about	you	that	could	be	used	to	identify	you.		This	information	may	include	information	about	AIDS	or	HIV	infection,	treatment	for	alcohol	and/or	drug	abuse,	or	mental	health	or	psychiatric	services.	
 The	purposes	of	releasing	your	protected	health	information	are	to	collect	the	data	needed	to	complete	the	research,	to	properly	monitor	(watch)	how	the	study	is	done,	and	to	answer	research	questions	related	to	this	study.		
There is no expiration date to this authorization.   	Who	may	receive,	use	or	release	information:	Your	medical	records	and	any	health	information	related	to	this	study	may	be	used	or	released	in	connection	with	this	research	study	to	the	following:	
• Mahealani	Suapaia	and	Dr.	Chen-Yen	Wang	and	his/her	research	staff	for	the	purposes	of	conducting	this	research	study.	
• The	Research	and	Institutional	Review	Committee	of	QMC	and	staff	members	of	the	Research	Regulatory	Office	for	purposes	of	overseeing	the	research	study	and	making	sure	that	your	ethical	rights	are	being	protected.	
• Providers	and	other	healthcare	staff	of	QMC	involved	in	your	care.		Who	may	receive	the	information	by	the	above	groups:	
The individuals or groups named above may release your medical records, this consent form and 
the information about you created by this study to: 
• The	sponsor	of	this	study	and	their	designees	(N/A)	
• Federal,	state	and	local	agencies	having	oversight	over	this	research,	such	as	The	Office	for	Human	Research	Protections	in	the	U.S.	Department	of	Health	and	Human	Services,	Food	and	Drug	Administration,	the	National	Institutes	of	Health,		
• Representatives	of	outside	groups	hired	by	QMC	Research	Department	for	audits	to	make	sure	studies	are	done	as	required.	
• Dr.	James	Davis,	Biostatistician,	University	of	Hawaii	School	of	Medicine	
• University	of	Hawai‘i	at	Manoa		There	is	a	possibility	that	your	information	may	be	released	again	by	the	sponsor	of	the	study	or	governmental	agencies	described	above	and	no	longer	covered	by	federal	privacy	rules.		
Right to Withdraw or Stop Taking Part in the Study 
You may refuse to sign this authorization.  If you refuse to sign the authorization, you will not be 
able to take part in this study.  If you choose not to be in the study, or choose to withdraw from 
the study, or if you refuse to sign the authorization, it will not make a difference in your usual 
treatment, or your payment, and it will not change your eligibility for any health plan or health 
plan benefits that you are allowed.   
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If you decide to end your taking part in the study or you are removed from the study by the 
researcher (study doctor), you may revoke (take away) your authorization.  In order to take away 
this authorization, you must send a letter/notice to the researcher in charge of this study.  Send 
the written notice to the researcher to the address listed on the original consent form. 
If you take away your authorization, your part in the study will end and the study staff will stop 
collecting medical information from you and about you.  The researchers and sponsor will 
continue to use information that has already been collected, but no new information about you 
will be collected unless the information is about an adverse event (a bad side effect) related to 
the study or to keep the scientific integrity of the study.  If an adverse event happens, we may 
need to review your entire medical record. 	Access	to	Your	Information	As	is	usually	the	case,	you	may	see	the	information	in	your	medical	record;	however,	the	records	and	information	related	only	to	the	study	are	kept	separately	will	not	be	available	to	you	until	the	study	is	finished.		If	you	wish	to	review	your	study	records	after	the	completion	of	the	study,	you	should	request	this	from	the	principle	investigator.					
For Certificate of Confidentiality, This	research	study	is	covered	under	a	Certificate	of	Confidentiality	given	by	the	Department	of	Health	and	Human	Services.		The	Certificate	protects	the	researchers	(study	doctors,	and	staff)	from	being	forced	to	release	any	research	information	(data)	in	which	you	are	identified,	even	under	court	order	or	subpoena,	for	criminal	(related	to	a	crime),	administrative,	or	legislative	proceedings.		The	information	can	be	released	if	you	or	your	guardian	requests	it	in	writing.		This	protection	is	not	absolute.		It	does	not,	for	example,	apply	to	any	state	requirements	to	report	certain	communicable	diseases,	or	to	release	information	in	cases	of	medical	necessity.		The	researcher(s)	must	report	cases	of	suspected	child	or	elder	abuse	to	the	appropriate	authorities.					COSTS		 1. There	is	no	cost	to	the	participant.	2. Participant	volunteers	to	take	part	in	the	study.	
	 Any	procedure	or	test	related	only	to	this	research	study	and	not	normally	be	done	will	be	explained	to	you,	and	is	explained	in	this	consent	form.		All	costs	for	doctors	fees,	medication	(including	drugs	to	treat	any	side	effects),	laboratory	tests,	x-rays	or	scans,	and	hospital	costs	will	be	charged	to	you	as	if	you	were	not	part	of	this	study.		The	sponsor	of	this	study	and	the	study	doctor	do	not	have	any	funding	(money)	to	pay	for	any	of	these	costs.		Your	insurance	company	may	not	pay	for	some	(or	all)	of	these	tests	and	procedures	because	this	is	a	research	study.		If	your	medical	insurance	does	not	cover	any	of	these	costs,	you	will	be	responsible	for	
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payment.		Because	these	costs	can	be	very	high,	you	should	talk	about	the	kind	of	insurance	coverage	you	have	with	your	doctor	and	insurance	company	before	you	decide	to	take	part	in	this	study.		You	can	have	financial	counseling	to	go	over	your	insurance	coverage	and	get	an	estimate	of	your	share	of	the	cost.		TREATMENT	AND	COMPENSATION	FOR	INJURY			 If	you	are	injured	as	a	result	of	being	in	this	study,	you	will	get	immediate	medical	care	and	treatment.		No	money	will	be	given	to	patient	to	cover	these	expenses.		Your	medical	costs	will	be	paid	by	you	or	through	medical	insurance	and/or	other	forms	of	medical	coverage.		Please	contact	PI	Mahealani	Suapaia	in	case	of	research	related	injury.	
	 If	you	have	an	injury	or	illness	(get	sick)	as	a	result	of	being	in	this	study,	immediate	emergency	medical	care	and	treatment	that	may	be	needed	will	be	available	at	the	usual	charge.		The	sponsor	of	the	study	and	the	study	doctor	do	not	have	any	funding	(money)	to	pay	for	treating	the	injury	or	illness.		Your	insurance	company	may	not	pay	for	some	(or	all)	of	the	treatment	of	the	injury	or	illness	as	a	result	of	being	in	this	study.		If	your	medical	insurance	does	not	pay	for	these	medical	costs,	you	alone	will	be	responsible	for	payment.		There	is	no	way	of	knowing	what	the	costs	will	be.		You	should	talk	about	the	kind	of	insurance	coverage	you	have	with	your	doctor	and	insurance	company	before	you	decide	to	take	part	in	this	study.	You	can	have	financial	counseling	to	go	over	your	insurance	coverage.		 If	you	are	injured	or	become	sick	directly	from	taking	part	in	this	study,	you	will	pay	for	the	reasonable	costs	of	medical	treatment	for	your	injuries.			You	must	be	sure	to:	1) Talk	with	study	doctor	or	the	study	nurse	of	the	injury	right	away,	and	2) Carefully	follow	all	study	directions.		 If	your	illness	or	injury	did	not	result	from	the	study	treatment(s)	or	study	procedures,	the	study	researchers	will	not	pay	for	your	treatment.		Your	insurance	company	may	not	pay	for	some	(or	all)	of	the	treatment	of	the	injury	or	illness.		If	your	medical	insurance	does	not	pay	for	these	medical	treatments,	you	alone	will	be	responsible	for	payment.		 The	Queen’s	Medical	Center	and	the	study	researchers	have	not	set	aside	any	other	kind	of	compensation	(payment)	for	lost	wages	or	other	damages	or	losses	resulting	from	any	injury	that	you	may	get	from	taking	part	in	this	study.		REMOVAL	FROM	THE	STUDY		 You	take	part	in	this	study	of	your	own	free	will.		You	may	be	taken	off	the	study	without	your	consent	for	any	of	the	following	reasons:		
- Unable	to	follow	researchers	instructions.		
WHO TO CONTACT 
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If you feel that you have been injured as a result of taking part in this study, Mahealani Suapaia 
principle investigator, 808-236-5829. 	If	you	have	any	questions	about	your	treatment,	your	rights	as	a	volunteer	or	any	other	matter	relating	to	this	study,	you	may	call	Mahealani	Suapaia	at	808-236-5829	and	talk	about	any	questions	that	you	might	have.				If	you	cannot	get	satisfactory	answers	to	your	questions	or	you	have	comments	or	complaints	about	your	treatment	in	this	study,	you	may	contact:		 	 Research	&	Institutional	Review	Committee		 	 The	Queen’s	Medical	Center		 	 1301	Punchbowl	Street		 	 Honolulu,	HI		96813		 	 Phone:	(808)	691-4512		
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AGREEMENT	TO	TAKE	PART	AND	CERTIFICATION	and	AUTHORIZATION	OF	PROTECTED	
HEALTH	INFORMATION	–		 I,	or	my	legally	authorize	representative	(the	legal	person	who	cares	for	me)	have	read	and	understand	the	description	of	this	study	such	as	the	purpose	and	nature	of	this	study,	its	expected	length,	the	procedures	to	be	done,	reasonably	known	risks	and	discomforts,	benefits	to	expect,	other	treatments	I	may	have,	release	of	my	medical	records,	payment	and	medical	treatment	for	injury,	and	removal	without	my	consent	for	this	research	study.			 I	am	taking	part	in	this	study	of	my	own	free	will.	I	may	withdraw	(stop	taking	part)	and/or	withdraw	my	authorization	for	use	and	release	of	protected	health	information	at	any	time	after	signing	this	consent	form	without	it	making	a	difference	to	my	care	now	or	in	the	future	or	any	loss	of	benefits	that	I	am	allowed.			My	consent	does	not	take	away	my	legal	rights	in	case	of	carelessness	or	negligence	of	anyone	connected	with	this	study.					My	signature	means	that	I	have	read	the	information	above	or	that	it	has	been	read	to	me,	my	questions	have	been	satisfactorily	answered,	and	at	any	time	I	have	other	questions,	I	can	contact	the	researcher	listed	on	the	first	page.		
Specially	Protected	Health	Information	I	agree	to	the	release	of	the	following	information	should	it	be	contained	in	my	medical	records:		Acquired	Immune	Deficiency	Syndrome	(AIDS	or	HIV),	alcohol	and/or	drug	abuse	treatment,	or	behavioral	or	mental	health	services.		cc:	 Signed	copy	of	consent/authorization	form	to	patient		________________________	_________________________	 ___________	Subject’s	Name	(Print)	 	 Subject’s	Signature	 	 	 Date/	Time		________________________	_________________________	 ___________	Witness’	Name	(Print)	 	 Witness’	Signature	 	 	 Date/	Time	(Witnessing	Signature	Only)	 	 *****************		I	have	explained	this	research	to	the	above	subject.		In	my	judgment	the	subject	is	voluntarily	and	knowingly	giving	informed	consent	and	has	the	legal	capacity	to	give	informed	consent	to	take	part	in	this	research	study.		________________________	_________________________	 ___________	Investigator’s	Name	(Print)	 	 Investigator’s	Signature	 	 Date/	Time	(Individual	obtaining	Subject’s	consent)			(Investigator:	fax	a	copy	of	this	signed	page	to	Research	Regulatory	Office	at	691-7897	within	24	hours	of	signing.)	
[Please	leave	2	inches	at	the	bottom	of	this	page	blank.		This	is	reserved	for	the	RIRC	stamping.]		
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CONSENT	TO	TAKE	PART	and	AUTHORIZATION	OF	PROTECTED	HEALTH	
INFORMATION	–	IF	SUBJECT	IS	UNABLE	TO	CONSENT:	As	a	legally	authorized	representative	of	the	subject,	my	signature	indicates	that	I	have	read	this	form,	or	it	has	been	read	to	me,	I	have	had	the	study	explained	to	me,	I	have	had	answers	to	my	questions,	and	I	am	satisfied	with	the	information	that	I	have	been	given.		I	am	giving	consent	for	the	subject	listed	below	to	take	part	in	this	study	and	authorize	the	use	and	release	of	their	protected	health	information.		I	can	withdraw	(stop	taking	part)	and	or	take	away	the	authorization	for	the	use	and	release	of	protected	health	information	at	any	time	after	signing	this	for	without	it	making	a	difference	to	the	subject’s	care	now	or	in	the	future	or	any	loss	of	benefits	that	I	am	allowed.		My	consent	does	not	take	away	legal	rights	in	care	of	carelessness	or	negligence	of	anyone	connected	with	this	study.		I	will	be	given	a	signed	copy	of	this	consent	form.			Specially	Protected	Health	Information	I	agree	to	the	release	of	the	following	information	if	it	is	in	the	subject’s	medical	records:		Acquired	Immune	Deficiency	Syndrome	(AIDS	or	HIV),	alcohol	and/or	drug	abuse	treatment,	or	behavioral	or	mental	health	services.		______________________________________		is	not	able	to	consent	Name	of	the	Subject	(print)		_______________________________________	 	 ____________________________	Name	of	Legal	Representative	(print)	 	 	 	 Signature	of	Legal	Representative			______________________________________________	 	 ________________	Description	of	legal	authority	to	act	on	behalf	of	subject	 	 Date/	Time		________________________	_________________________	 ___________	Witness’	Name	(Print)	 	 Witness’	Signature	 	 	 Date/	Time	(Witnessing	signature	only)	 *****************	Based	on	my	clinical	judgment,	this	subject	is	not	able	or	is	incompetent	to	independently	consent	to	participate	in	this	research	study.		________________________	_________________________	 ___________	Investigator’s	Name	(Print)	 	 Investigator’s	Signature	 	 Date/	Time	(Individual	obtaining	the	Legally	Authorized	Representative’s	consent)			(Investigator:		Fax	a	copy	of	this	signed	page	to	Research	Regulatory	Office	at	691-7897	within	24	hours	of	signing.)	
[Please	leave	2	inches	at	the	bottom	of	this	page	blank.		This	is	reserved	for	the	RIRC	stamping.]		 page	#	10	and	version	date	10-15-14	
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Addendum	to	Consent	Form	
	
Authorization	to	Use	and	Release	Personal	Health	Information	(PHI)	for		Researchers/Investigators/Study	Doctor:	Mahealani	Suapaia,	MS,	RN	and	Dr.	Chen-Yen	
Wang		Study	Title:	Exploration	of	Complementary	and	Alternative	Medicine	Use	for	Management	of	Diabetic	Peripheral	Neuropathy:	A	Multivariate	Approach		The	federal	government	has	created	a	new	privacy	rule	called	the	Health	Insurance	Portability	and	Accountability	Act	of	1996	(HIPAA).		It	gives	you	the	right	to	decide	who	can	use	and	release	your	personal	health	information	(also	called	“protected	health	information”	or	PHI).		This	form,	called	an	“Authorization”,	explains	your	rights	and	how	your	health	information	will	be	used	and	released	for	this	study.		Description	and	purpose	of	information	to	be	released:	By	signing	this	form,	you	will	be	allowing	or	“authorizing”	the	use	and	release	of	your	personal	health	information	in	medical	records	and	diagnostic	imaging	and	any	health	information	gathered	about	you	at	as	part	of	this	study.		Your	personal	health	information	is	health	information	about	you	that	could	be	used	to	identify	you.		This	information	may	include	information	about	AIDS	or	HIV	infection,	venereal	disease,	treatment	for	alcohol	and/or	drug	abuse,	or	mental	health	or	psychiatric	services.		The	purposes	of	releasing	your	protected	health	information	are	to	collect	the	data	needed	to	complete	the	research,	to	properly	monitor	(watch)	how	the	study	is	done,	and	to	answer	research	questions	related	to	this	study.		Who	may	receive,	use	or	release	information:	Your	medical	records	and	any	health	information	related	to	this	study	may	be	used	or	released	in	connection	with	this	research	study	to	the	following:	
• Mahealani	Suapaia,	MS,	RN	and	Dr.	Chen-Yen	Wang	and	his/her	research	staff	for	the	purposes	of	conducting	this	research	study.	
• The	Research	and	Institutional	Review	Committee	of	QMC	and	staff	members	of	the	Research	Regulatory	Office	for	purposes	of	overseeing	the	research	study	and	making	sure	that	your	ethical	rights	are	being	protected.	
• Providers	and	other	healthcare	staff	of	QMC	involved	in	your	care.		Who	may	receive	the	information	by	the	above	groups:	
The individuals or groups named above may release your medical records, this consent form and the 
information about you created by this study to: 
• The	sponsor	of	this	study	and	their	designees	(N/A)	
• Federal,	state	and	local	agencies	having	oversight	over	this	research,	such	as	The	Office	for	Human	Research	Protections	in	the	U.S.	Department	of	Health	and	Human	Services,	Food	and	Drug	Administration,	the	National	Institutes	of	Health,		
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• Dr.	James	Davis,	University	of	Hawaii	at	Manoa	John	A.	Burns	School	of	Medicine	
Biostatistician.	There	is	a	possibility	that	your	information	may	be	released	again	by	the	sponsor	of	the	study	or	governmental	agencies	described	above	and	no	longer	covered	by	federal	privacy	rules.	You	will	not	be	identified	by	name	in	any	published	reports,	or	scientific	publications,	or	meetings.			
Right to Withdraw or Stop Taking Part in the Study 
You may refuse to sign this authorization.  If you refuse to sign the authorization, you will not be 
able to take part in this study.  If you choose not to be in the study or if you refuse to sign the 
authorization, it will not make a difference in your usual treatment, or your payment, and it will 
not change your eligibility for any health plan or health plan benefits that you are allowed.   
 
If you decide to end your taking part in the study or you are removed from the study by the 
researcher (study doctor), you may revoke (take away) your authorization.  In order to take away 
this authorization, you must send a letter/notice to the researcher in charge of this study.  Send 
the written notice to the researcher to the address listed on the original consent form. 
If you take away your authorization, your part in the study will end and the study staff will stop 
collecting medical information from you and about you.  The researchers and sponsor will 
continue to use information that has already been collected, but no new information about you 
will be collected unless the information is about an adverse event (a bad side effect) related to 
the study or to keep the scientific integrity of the study.  If an adverse event happens, we may 
need to review your entire medical record. 	Access	to	Your	Information	You	may	not	be	allowed	to	see	or	get	copies	of	certain	information	in	your	medical	records	collected	as	part	of	this	research	study	while	the	research	is	going	on.		Once	the	research	is	completed,	you	will	be	able	to	access	or	get	copies	of	the	information.			
 
 
 
 
 
 
 
 
 
 
 
 
 
There is no expiration date to this authorization.   	You	will	get	a	signed	copy	of	this	consent	form	to	keep.	
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	________________________	____________________________________	Subject’s	Name	(Print)	 	 Subject’s	Signature	 	 	 Date/	Time	
	
If	subject	unable	to	sign:		________________________	_________________________	 ___________	Representative’s	Name	(Print)	 Representative’s	Signature	 	 Date/	Time	
If signed by a personal representative of the subject, a description of the representative’s legal 
authority to act on behalf of the subject must be stated below: 	_________________________________________________________________	 		________________________	_________________________	 ___________	Witness’	Name	(Print)	 	 Witness’	Signature	 	 	 Date/	Time	*****************	I	have	explained	this	authorization	to	the	above	subject.		In	my	judgment	the	subject	is	voluntarily	and	knowingly	giving	authorization	and	has	the	legal	capacity	to	give	authorization	to	take	part	in	this	research	study.		________________________	_________________________	 ___________	Investigator’s	Name	(Print)	 	 Investigator’s	Signature	 	 Date/	Time	(Individual	obtaining	Subject’s	consent)		________________________	_________________________	 ___________	Translator’s	Name	(if	appropriate)	Translator’s	Signature	 	 Date/	Time	(Print)		
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APPENDIX F 	
Hsiao-Yun Annie Chang CAM Use Survey Instrument Interview	schedule	
Thank you for participating in this research. This research is to understand your 
experience of diabetes and your usage of complementary and alternative medicine 
(CAM). There is no right or wrong answer. The information that you provide is very 
valuable which will become a reference for when we care for patients with diabetes. Any 
information obtained will be kept strictly confidential and your name will not be 
associated with it. I’ll expect the interview to take about 20 minutes to complete. Have 
you got any question you would like to ask before I start this interview survey?   
Now I’d like to begin by asking you some general questions about your diabetes. 
 
A. Clinical information  
1	 How	long	have	you	had	diabetes?		 ____________months	or	___________yrs	
2.	 Do	you	have	any	one	in	your	
family	and	relative	who	has	
diabetes?	
o0			No	
o1		Parents/Grandparents			
o2	Brothers	or	sisters	
o3		Relatives	
o4		Sons	or	daughters	
o5		Other____________ 
3.	 Approximately,	how	many	times	
have	you	visited	DM	clinics	
during	the	past	year?	
o0		At	least	fortnightly	
o1		At	least	monthly	
o2		At	least	3	month	
o3		At	least	yearly	
o4		Other__________________________________	
4.	 Have	you	been	hospitalised	due	
to	diabetes	condition	during	the	
last	years?	
o0		No	
o	Yes→	How	many	times?	_________(used	as	data)	
5.	 How	good	do	you	feel	is	your	
health	condition?	
o0		Very	poor	
o1		Poor	
o2		Good	
o3		Very	good	
6.	
	
What	current	treatment	for	DM	
has	been	prescribed	or	suggested	
by	your	physician?		
o6.1		Diet	+Exercise		 How	many…?	
o6.2		Oral	agent		 o6.21	_____tablets/per	day	
o6.3		Insulin	injection	 o6.31_____	units/	per	day	
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	 o6.4		Other:______________________________	
5.	 Have	you	ever	attended	a	
diabetes	education	program?		
Yes→	What	kind	of	education?	 o0	No		o		Yes→	o1		One	to	one	education																	o2		Lecture	education																	o3		Self-education	 																	o4		Other____________________	
	
Now I am going to run though a list of medicines and therapies. I would like you to tell 
me whether you have ever used these medicines and therapies before you were 
diagnosed with Type 2 diabetes, or after you were diagnosed with Type 2 diabetes, and 
during the past 12 months?	(Please	tick	the	box	if	participants	have	been	used)	
D. CAM checklist 
Have	you	ever	used	 Before	
diabetes		
After	
diagnosis	
12Ms	 Why	did	you	use?	(28.3-41.3)	
28
.	
Nutritional	supplements	(multivitamins,	fish	oil,	glucosamine,	chromium)	 28	 28.1	 28.2	
o0		For	diabetes	
o1		For	DM’s	complications		
o2		For	non-DM	specific	
29
.	
Diet	modification		(organic	food,	special	food	design,	body	cleansing	diet,	macrobiotic	diet) 
29	 29.1	 29.2	 o0		For	diabetes	
o1		For	DM’s	complications		
o2		For	non-DM	specific	
30
.	
Chinese	herbal	
medicines	(Ginseng,	Limzig	)	
30	 30.1	 30.2	 o0		For	diabetes	
o1		For	DM’s	complications		
o2		For	non-DM	specific	
31
.	
Acupuncture		(acupressure)	 31	 31.1	 31.2	 o0		For	diabetes	o1		For	DM’s	complications		
o2		For	non-DM	specific	
32
.	
Cupping,	Scraping		(Gua-sa)	 32	 32.1	 32.2	 o0		For	diabetes	o1		For	DM’s	complications		
o2		For	non-DM	specific	
33
.	
Manipulative	based	
therapy	(chiropractic,	osteopathic,	kneading	(Tui-an))	
33	 33.1	 33.2	 o0		For	diabetes	
o1		For	DM’s	complications		
o2		For	non-DM	specific	
34
.	
Folk	therapies	(Knife	therapy,	water	therapy,	fire	therapy)	
34	 34.1	 34.2	 o0		For	diabetes	
o1		For	DM’s	complications		
o2		For	non-DM	specific	
35
.	
Biofield	therapy	(Kinesiology,	Reiki,	Tai	chi,	Gi	gong)	 35	 35.1	 35.2	 o0		For	diabetes	o1		For	DM’s	complications		o2		For	non-DM	specific	
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Have	you	ever	used	 Before	
diabetes		
After	
diagnosis	
12Ms	 Why	did	you	use?	(28.3-41.3)	
36
.	
Supernatural	healing		(Absorption	frighten,		God	healing,	divination,	change	name)	
36	 36.1	 36.2	 o0		For	diabetes	
o1		For	DM’s	complications		
o2		For	non-DM	specific	
37
.	
Bioelectromagnetic-
based		therapies	(Electrotherapy,	Polarity,	Magnetic	therapy)	
37	 37.1	 37.2	 o0		For	diabetes	
o1		For	DM’s	complications		
o2		For	non-DM	specific	
38
.	
Western	herbal	
medicine	(bilberry,	bitter	melon,	opuntia,	fenugreek	seed,	and	aloe)		
38	 38.1	 38.2	 o0		For	diabetes	
o1		For	DM’s	complications		
o2		For	non-DM	specific	
39
.	
Aromatherapy	(essential	oil)		 39	 39.1	 39.2	 o0		For	diabetes	o1		For	DM’s	complications		
o2		For	non-DM	specific	
40
.	
Mind-body	therapy			(Meditation,	yoga,	hypnosis)	 40	 40.1	 40.2	 o0		For	diabetes	o1		For	DM’s	complications		
o2		For	non-DM	specific	
41
.	
Homeopathy		(homeopathic	medicine)	 41	 41.1	 41.2	 o0		For	diabetes	o1		For	DM’s	complications		
o2		For	non-DM	specific	
 
Now I am going to run though a list of variety of CAM practitioners. I would like you to 
tell me whether you have ever consulted any of those practitioners before you were 
diagnosed with Type 2 diabetes, or after you were diagnosed with Type 2 diabetes, and 
during the past 12 months? (Please	tick	the	box	if	participants	have	been	used)	
E. A checklist of CAM practitioners  
Have	you	ever	seen	a	 Before	
diabetes	
After	
diabetes	
12Ms	 Why?	(42.3-46.3)	
42
.	
Traditional	Chinese	
medicine	practitioner	
42	 42.1	 42.2	 o0		For	diabetes	
o1		For	DM’s	complications		
o2		For	non-DM	specific	
43	 Chiropractor	 43	 43.1	 43.2	 o0		For	diabetes	
o1		For	DM’s	complications		
o2		For	non-DM	specific	
44	 Herbalist		 44	 44.1	 44.2	 o0		For	diabetes	
o1		For	DM’s	complications		
o2		For	non-DM	specific	
45	 Religious	healer	 45	 45.1	 45.2	 o0		For	diabetes	
o1		For	DM’s	complications		
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Have	you	ever	seen	a	 Before	
diabetes	
After	
diabetes	
12Ms	 Why?	(42.3-46.3)	
/Psychic	healer	 o2		For	non-DM	specific	
46
.	
Naturopath	practitioner		 46	 46.1	 46.2	 o0		For	diabetes	
o1		For	DM’s	complications		
o2		For	non-DM	specific	
Except for the therapies just mentioned, have you used any others, please feel free to 
let me know. It is very important to me to have all the information. For example, urine 
therapy, colon irrigation. (Please fill the therapy in the next page) 
Have	you	ever	seen	 Before	
diabetes	
After	
diabetes	
12Ms	 Why	you	used	it?	
	 	 	 	 	 o1		For	diabetes	
o2		For	DM’s	complications		
o3		For	non-DM	specific	
	 	 	 	 	 o1		For	diabetes	
o2		For	DM’s	complications		
o3		For	non-DM	specific	
	 	 	 	 	 o1		For	diabetes	
o2		For	DM’s	complications		
o3		For	non-DM	specific	
	 	 	 	 	 o1		For	diabetes	
o2		For	DM’s	complications		
o3		For	non-DM	specific	
	 	 	 	 	 o1		For	diabetes	
o2		For	DM’s	complications		
o3		For	non-DM	specific	
 
Now I’d like to know why you never use CAM or why you stop using CAM to help you 
control of your diabetes. The answer is either yes or no. 
F. The reasons for not using CAM or stopping the use of CAM  
You	did	not	use	CAMs	because	you	
47.	 Never	heard	of	them	 0No	 1Yes	
48.	 Do	not	know	where	to	purchase	CAM	(Not	available	in	
my	area)	
0No	 1Yes	
49.	 My	health	care	professionals	are	opposed	to	my	use	of	
complementary	and	alternative	medicine		
0No	 1Yes	
50.	 Do not want to mix up anything with your Western 
medicine 
0No	 1Yes	
51.	 Do	not	think	that	they	really	work	 0No	 1Yes	
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52.	 Have	heard	of	stories	that	CAM	is	not	good	for	you	 0No	 1Yes	
53.	 Worried	about	negative	side-effects		 0No	 1Yes	
55.	 Feel	they	are	harmful	 0No	 1Yes	
56.	 Feel	they	are	too	expensive		 0No	 1Yes	
57	 Dissatisfied	with	them	 0No	 1Yes	
Other:	______________________________________________________________		If	patient	never	use	CAMs,	please	go	to	page	7	and	question	78.		
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Next I’d like to understand your experience of CAM use. The questions are an important 
part of the study, so please answer as accurately as you can.  
H. CAM survey  
58.	 What	is	the	most	
important	reason	
that	made	you	start	
to	use	CAM?	
 
o1.1  Dissatisfaction with Western medicine 
o1.2 Believe CAMs are safer than Western medicine(fewer 
side-effects) 
o1.3 People around you believe in CAM treatment 
o1.4 CAM is consistent with my culture 
o1.5 Believe in CAM for the treatment of diabetes  
o1.6	Recommended	by	health	care	professionals		
o1.7	Other:	____________________________	
From	where	did	you	get	the	information	regarding	CAM	use?	(Please	tick	the	box	)	
59.	 Partner&	Family	 0No	 1Yes	 60. Friends 0No	 1Yes	
61.	 Physician	 0No	 1Yes	 62. Pharmacist  0No	 1Yes	
63.	 Nurse		 0No	 1Yes	 64. Media, Newspaper, 
Magazine  
0No	 1Yes	
65.	 Medical	book	or	
research	journal		
0No	 1Yes	 66. CAM	
Practitioners 
0No	 1Yes	
 Others: 
67	 Do	you	know	the	
ingredients	of	your	
herbal	medicine	
when	you	used	it?	
o0  Know it.                                     
o1  Completely unknown 
o2  Unknown, but it was from CAM practitioner 
o3  Unknown, but it shown on the can 
o4		Other:_______________________	
68	 Who	mostly	decides	
what	type	of	CAM	
that	you	should	use?	
It	is	:	
o0  Your decision                                        
o1  Your family’s decision 
o2  Your friend’s decision  
o3  Your CAM practitioner decision 
o4		Other:_______________________	
70.	 How	do	you	use	
your	Western	
medication	when	
you	are	using	CAM?	
o0  No change 
o1  Use separately and use at different times  
o2  Reduce the dose of Western medicines 
o3  Stopped Western medicines 
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o4  Others 
69.	 Approximately,	how	
much	money	have	
you	paid	for	CAM	(in	
general	per	month)?	
 
o0  $ under 500  
o1  $501-1000  
o2  $1001-1500  
o3  $1501-2000  
o4		More	than	$________________	
71.	 Have	you	told	your	
doctor	or	nurse	
about	your	use	of	
CAM?		
o0  Yes à Go to Q 71  
o1		No		à	Go	to	Q	72	
o2		Did	not	use	Western	medicine	at	that	time.	
72.	 What	was	the	advice	
of	the	health	care	
professional	after	
you	discussed	about	
CAM	use?		
o0  Encourages you to take it  
o1  Discourages you from taking it  
o2  Feels it’s entirely up to me; has no strong feeling about it 
o3  Warns you of possible side-effects regarding CAM use 
o4  Warns you that some may interfere with your regular 
treatment 
o5		Other	:	____________________________________________	
The	following	statements	give	possible	reasons	for	the	fact	that	you	may	not	discuss	
CAM	use	with	your	health	care	professionals.	The	answer	is	either	yes	or	no.	
73.	 I	never	think	of	it	 0No	 1Yes	
74.	 Health	care	professionals	did	not	ask	it	 0No	 1Yes	
75.	 I think that there was not sufficient time to discuss 0No	 1Yes	
76.	 I think it is safe, thus there is no need to discuss 0No	 1Yes	
77.	 I think that the health care professionals would discourage CAM 
use  
0No	 1Yes	
78	 I think that the health care professionals do not have adequate 
knowledge of CAM therapies  
0No	 1Yes	
	 Others:	___________________________________________________________________	
 
We are almost finished with the interview. In the final part, I’d like to ask you some 
general questions about yourself. 
P. Demographic variable  
124	 Sex	 o0	Male		
o1	Female	
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125.	 How	old	are	you?	 _________yrs.	
126.	 What	is	your	highest	level	of	
education?	
	
o0		No	schooling		
o1		Elementary	school	
o2		Middle	school	
o3		High	school	
o4		Bachelor	degree	
o5		Graduate	school	
127.	 What	is	your	martial	status?	
	
o0	Married	(Living	with	a	partner)	
o1	Single	(never	married)	
o2	Widowed	
o3	Separated	(Divorced)	
128.	 What	statement	best	describes	
your	employment	status?	
	
o0	Full-time	
o1	Part-time	
o2	Homemaker	(working	at	home)	
o3	Retired	
o4		Not	working	
o5	Other_______________________	
129.	 Do	you	have	religious/spiritual	
beliefs?	
o0		No	
o1		Yes		
130.	 What	is	your	race?		
	
o0	Native	Hawaiian	
o1	Part-Hawaiian	
o2	Other	Pacific	Islander	
o3	Asian	
o4	Other____________	
131.	 Do	you	live	with	others?		
		
o0	No	
o1	Yes	
132.	 How	much	is	your	total	household	
income	monthly?	
	
o0 $ under 1200 
o1 $1200-2400  
o2 $2401-3600 
o3 $3601-4800 
o4 more than $4800 
133.	 Do	you	have	health	insurance?	 o0	No	
o1 Yes 
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This completes our interview. Thank you for taking the time to answer these questions. 
Do you have any comments you would like to add?  
 
Thank you for taking the time to complete this questionnaire. Your opinion is highly 
valued.  	Chang,	H.-Y.A.,	Wallis,	M.,	&	Tiralongo,	(2011).		Use	of	complementary	and	alternative	medicine	among	people	with	type-2	diabetes	in	Taiwan:	A	cross-sectional	survey.	Evidence	
Based	Complementary	and	Alternative	Medicine,	Article	ID	983792.	
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APPENDIX G 
	
36-Item Short Form Survey Instrument 
 
 
Circle one number for questions below: 
1. In general, would you 
say 
your health is: 
Excellent 1 
Very good  2 
Good 3 
Fair 4 
Poor 5 
2. Compared to one year ago, 
how would your rate your health in general 
now? 
Much better now than one year ago 1 
Somewhat better now than one year ago 2 
About the same 3 
Somewhat worse now than one year ago 4 
Much worse now than one year ago 5 
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The following items are about activities you might do during a typical day. Does your health now limit you in 
these activities? If so, how much? 
(Circle One Number on Each Line) 
 
Yes, 
Limited a 
Lot  
Yes, 
Limited a 
Little  
No, Not 
limited at 
All  
3. Vigorous activities, such as running, 
lifting heavy objects, participating in 
strenuous sports 
[1]  [2]  [3]  
4. Moderate activities, such as moving a 
table, pushing a vacuum cleaner, bowling, 
or playing golf 
[1]  [2]  [3]  
5. Lifting or carrying groceries [1]  [2]  [3]  
6. Climbing several flights of stairs [1]  [2]  [3]  
7. Climbing one flight of stairs [1] [2] [3] 
8. Bending, kneeling, or stooping [1] [2] [3] 
9. Walking more than a mile [1]  [2]  [3]  
10. Walking several blocks  [1]  [2]  [3]  
11. Walking one block [1] [2] [3]  
12. Bathing or dressing yourself [1] [2] [3] 
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During the past 4 weeks, have you had any of the following problems with your work or 
other regular daily activities as a result of your physical health? 
(Circle One Number on Each Line) 
 Yes  No  
13. Cut down the amount of time you spent on work or other activities 1  2  
14. Accomplished less than you would like 1  2  
15. Were limited in the kind of work or other activities  1  2  
16. Had difficulty performing the work or other activities (for example, it 
took extra effort)  
1  2  
During the past 4 weeks, have you had any of the following problems with your work or 
other regular daily activities as a result of any emotional problems (such as feeling 
depressed or anxious)? 
(Circle One Number on Each Line) 
 Yes No 
17. Cut down the amount of time you spent on work or other activities 1  2  
18. Accomplished less than you would like 1  2  
19. Didn't do work or other activities as carefully as usual 1  2  
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20. During the past 4 weeks, to what extent has your physical health or emotional 
problems interfered with your normal social activities with family, friends, neighbors, or 
groups? 
(Circle One Number) 
Not at all 1 
Slightly 2 
Moderately 3 
Quite a bit 4 
Extremely 5 
21. How much bodily pain have you had during the past 4 weeks? 
(Circle One Number) 
None 1   Very mild 2   Mild 3   Moderate 4   Severe 5   Very severe 6 
22. During the past 4 weeks, how much did pain interfere with your normal work 
(including both work outside the home and housework)? 
(Circle One Number) 
Not at all 1  A little bit 2  Moderately 3  Quite a bit 4  Extremely 5 
These questions are about how you feel and how things have been with you during the 
past 4 weeks. For each question, please give the one answer that comes closest to the 
way you have been feeling. 
How much of the time during the past 4 weeks . . .(Circle One Number on Each Line) 
 
All of 
the 
Time 
Most 
of the 
Time 
A Good 
Bit of 
the 
Time 
Some 
of the 
Time 
A Little 
of the 
Time 
None 
of the 
Time 
23. Did you feel full of 
pep? 
1  2  3  4  5  6  
24. Have you been a 
very nervous person? 
1  2  3  4  5  6  
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25. Have you felt so 
down in the dumps 
that nothing could 
cheer you up? 
1  2  3  4  5  6  
26. Have you felt calm 
and peaceful? 
1  2  3  4  5  6  
27. Did you have a lot 
of energy? 
1  2  3  4  5  6  
28. Have you felt 
downhearted and 
blue? 
1  2  3  4  5  6  
29. Did you feel worn 
out? 
1  2  3  4  5  6  
30. Have you been a 
happy person? 
1  2  3  4  5  6  
31. Did you feel tired?  1  2  3  4  5  6  
32. During the past 4 weeks, how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting with friends, 
relatives, etc.)? 
(Circle One Number) 
All of the time 1 
Most of the time 2  
Some of the time 3  
A little of the time 4 
None of the time 5 
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How TRUE or FALSE is each of the following statements for you. 
(Circle One Number on Each Line) 
 Definitely 
True 
Mostly 
True  
Don't 
Know  
Mostly 
False  
Definitely 
False  
33. I seem to get sick a 
little easier than other 
people  
1  2  3  4  5  
34. I am as healthy as 
anybody I know  
1  2  3  4  5  
35. I expect my health to 
get worse  
1  2  3  4  5  
36. My health is excellent  1  2  3  4  5 
 This	survey	was	reprinted	with	permission	from	the	RAND	Corporation.	Copyright©	the	RAND	Corporation.	RAND's	permission	to	reproduce	the	survey	is	not	an	endorsement	of	the	products,	services,	or	other	uses	in	which	the	survey	appears	or	is	applied. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
		 136	
APPENDIX H 
 
		 137	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
		 138	
REFERENCES 	
Adejoh, S. O. (2014).  Diabetes knowledge, health belief, and diabetes management among the 
Igala, Nigeria. Sage Open, April-June:1-8. http://sgo.sagepub.com accessed June 30, 
2014. doi: 10.1177/2158244014539966 
Ahn, A. C., Bennani, T., Freeman, R., Hamdy, O., & Kaptchuk, T. J. (2007).  Two styles of 
acupuncture for treating painful diabetic neuropathy: A pilot randomised control trial.  
Acupuncture in Medicine, 25(1-2), 11-17. 
Al-Omari, A., Al-Quidmat, M., Hmaidan, A. A. (2013). Perception and attitude of Jordanian
 physicians towards complementary and alternative medicine (CAM) use in oncology. 
Complementary Therapies in Clinical Practice. 19(2), 70-76. 
http://dx.doi.org/10.1016/j.ctcp.2013.01.002 
Aluli, E., Jones, K., Reyes, P., Brady, K., Tsark, J., & Howard, B.  (2009).  Diabetes and 
cardiovascular risk factors in Native Hawaiians.  Hawai‘i Medical Journal. 68(7), 152-
157. 
American Association of Diabetes Educators. (2008). AADE statement diabetes and public 
health, The Diabetes Educator, 34(1), 45-48. 
American Diabetes Association. (2007). Standards of medical care in diabetes-2007. 
Diabetes Care, 30 (Suppl. 1), S4-S41. https://doi.org/10.2337/dc07-S004 
Argoff, C. E., Backonja, M., Belgrage, M. J., Bennett, G. J., Clark, M. R., Cole, B. E., . . . 
McLean, M. J. (2006).  Consensus guidelines: treatment planning and options.  Mayo 
Clinic Proceedings, 81(4, Suppl.), S12-S25. 
Bair, M. J., Robinson, R. L, Katon, W., & Kroenke, K. (2003). Depression and pain 
comorbidity: a literature review. Archives of Internal Medicine, 163, 2433-2445. 
		 139	
Barrett, A. M., Lucero, M., Le., T., Robinson, R. L., Dworkin, R. H., & Chappell, A. S. 
(2007).  Epidemiology, public health burden, and treatment of diabetic peripheral 
neuropathic pain: A review.  Pain Medicine, 8(S2), S50-S62. doi:10.1111/j.1526-
4637.2006.00179.x 
Bartlett, E. (1986). Historical glimpses of patient education in the United States. Patient  
 Education Counsel, 8, 135-149.  
Ben-Arye, E., & Frenkel, M. (2008). Referring to complementary and alternative 
medicine: A possible tool for implementation. Complementary Therapies in Medicine. 
16, 325-330. doi:10.1016/j.ctim.2008.02.008 
Benbow, S. J., Wallymahmed, M. E., MacFarlane, I. A. (1998). Diabetic peripheral 
neuropathy and quality of life. Quarterly Journal of Medicine: An International Journal 
of Medicine. 91, 733-737. 
Boren, S. (2007). AADE7™ Self-care behaviors: systematic reviews. The Diabetes 
Educator, 33(6), 866-871. DOI: 10.1177/0145721707309662 
Bosi, E., Conti, M., Vermigli, C., Cazzetta, G., Peretti, E., & Cordoni, M. C., et al. 
(2005). Effectiveness of frequency-modulated electromagnetic neural stimulation in the 
treatment of painful diabetic neuropathy. Diabetologia, 48, 817-823. 
Brunk, D. R., Taylor, A. G., M. L, Clark, Williams, I. C., Cox, D. J. (2017). A culturally 
appropriate self-management program for Hispanic adults with type 2 diabetes and low 
health literacy skill. Journal of Transcultural Nursing, 28(2), 187-194.  
doi: 10.1177/1043659615613418 
Burkett, K.W., & Morris, E. J. (2015).  Enabling trust in qualitative research with culturally 
diverse participants.  Journal of Pediatric Health Care, 29(1), 108-112. 
		 140	
http://dx.doi.org/10.1016/j.pedhc.2014.06.002 
Canaway, R., & Manderson, L. (2013).  Quality of life, perceptions of health and illness, 
and complementary therapy use among people with type 2 diabetes and cardiovascular 
disease.  The Journal of Alternative and Complementary Medicine. 19(11), 882-890. 
doi: 10.1089/acm.2012.0617 
Casken, J. (2001).  Improved health status for Native Hawaiians. Wicazo Sa Review: A 
 Journal of Native American Studies, 16(1), 75-89. 
Centers for Disease Control and Prevention. National Diabetes Statistics Report: 
Estimates of Diabetes and Its Burden in the United States, (2014). Atlanta, GA: 
Department of Health and Human Services. 
Centers for Diseases Control and Prevention, (2014), Take charge of your diabetes:  A  
guide for care. 4th ed. Retrieved from 
http://www.cdc.gov/diabetes/library/reports/prevention.html 
Center for the Advancement of Health: Essential Elements of Self-Management 
Interventions (2002). Washington, DC: Center for the Advancement of Health. 
Chang, H. Y., Wallis, M., & Tiralongo, E. (2011).  Use of complementary and 
alternative medicine with type 2 diabetes in Taiwan: A cross-sectional survey.  
Evidence-Based Complementary and Alternative Medicine 2013, 11, 1-8. 
doi:10.1155/2011/983792 
Chang, H. Y., Wallis, M., & Tiralongo, E. (2012). Predictors of complementary and 
alternative medicine use by people with type 2 diabetes. Journal of Advance Nursing, 
68(6), 1256-1266. doi: 10.1111/j.1365-2648.2011.05827.x 
Chang, H. Y., Wallis, M., Tiralongo, E. & Wang, H. L. (2012). Decision-making related to 
		 141	
complementary and alternative medicine with type 2 diabetes: A qualitative study. 
Journal of Clinical Nursing. 21, 3205-3215. doi: 10.1111/j.1365-2702.2012.04339.x 
Chen, W., Zhang, Y., Xinxue, L., Yang, G. & Liu, J. P. (2013). Chinese herbal medicine 
for diabetic peripheral neuropathy.  Cochrane Database of Systematic Reviews, 
10, 1-107. 
Chlebowy, D. O., Hood, S., & LaJoie, A. S. (2010).  Facilitators and barriers to self-management 
of type 2 diabetes among urban African American adults. The Diabetes Educator, 36(6), 
897-905. doi: 10.1177/0145721710385579 
Cook, P. F., Larsen, K. R., Sakraida, T. J., & Pedro, L. (2012).  A novel quantitative 
 
approach to concept analysis: The internomological network, Nursing Research, 61(5),  
369-378. doi:10.1097/NNR.0b013e318250c199 
Crowe, M., Whitehead, L., Bugge, C., Carlyle, D., Carter, J., & Maskill, V. (2017). Living 
withsub-optimal glycaemic control: the experiences of type 2 diabetes diagnosis and  
education.  Journal of Advanced Nursing, 73(3), 612-621. doi:10.1111/jan.13145 
DeGrandis, D., & Minardi, C. (2002). Acetyl-L-Carnitine (Levacecarnine) in the treatment of 
diabetic neuropathy.  Drugs R&D. 3(4), 223-231. 
DeSisto, C. L., Kim, S. Y., & Sharma, A. J. (2014). Prevalence estimates of gestational 
diabetes mellitus in the United States, pregnancy risk assessment monitoring system 
(PRAMS), 2007-2010. Preventing Chronic Disease, 11, 1-9. 
http://dx.doi.org/10.5888/pcd11.130415 
Dunford, B., Andrews, L., Ayau, M., Honda, L., Williams, J. (2013). Hawaiians of Old. 
Honolulu, HI: Bess Press Inc. 
Ellison, C. G., Bradshaw, M., Roberts, C. A. (2012). Spiritual and religious identities predict the 
		 142	
use of complementary and alternative medicine among US adults. Preventative Medicine, 
54(1), 9-12. doi:10.1016/j.ypmed.2011.08.029 
Forst, T., Pohlmann, T., Kunt, T., Goitom, K., Schulz, G., Lobig, M., Engelbach, M., 
Beyer, J., Pfutzner, A. (2002).  The influence of local capsaicin treatment on small nerve 
fibre function and neurovascular control in symptomatic diabetic neuropathy.  Acta 
Diabetol, 39:1-6. 
Fox, P., Coughlan, B., Butler, M., & Kelleher, C. (2010). Complementary alternative 
medicine (CAM) use in Ireland: A secondary analysis of SLAN data. Complementary 
Therapies in Medicine, 18, 95-103. doi:10.1016/j.ctim.2010.02.001 
Funnell, M. M., & Anderson, R. M. (2004). Empowerment and self-management of diabetes. 
 Clinical Diabetes, 22(3), 123-127.  
Garrard, J. (2007).  Health sciences literature review made easy.  Sudbury, 
Massachusetts: Jones and Bartlett. 
Galer, B. S., Gianas, A., Jensen, M. P. (2000).  Painful diabetic polyneuropathy: 
epidemiology, pain description, and quality of life. Diabetic Research and Clinical 
Practice, (47), 123-128. 
Giess, L. S., Wang, J., Cheng, Y. J., Thompson, T. J., Barker, L., Li, Y., ... Gregg, E. W. (2014). 
Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, 
United States, 1980-2012. Journal of the American Medical Association, 312(12), 1218-
1226.  doi:10.1001/jama.2014.11494 
Gilron, I., Watson, P. N., Cahill, C. M., & Moulin, D. E. (2006). Neuropathic pain: A 
practical guide for the clinician. Canadian Medical Association Journal, 173(3), 265-275.  
Gore, M., Dukes, E., Rowbotham, D. J., K. Tai, Leslie, D. (2007).  Clinical characteristics 
		 143	
and pain management among patients with painful peripheral neuropathic disorders in 
general practice settings. European Journal of Pain, 11(6), 652-664. 
doi:10.1016/j.ejpain.2006.10.004 
Grandinetti, A., Chang, H. K., Mau, M. K., Curb, J. D., Kinney, E., Sagum, R., & Arakaki, 
R. F. (1998).  Prevalence of glucose intolerance among Native Hawaiians in two rural 
communities: Native Hawaiian Health Research (NHHR) Project.  Diabetes Care, 21(4), 
549-554. 
Grandinetti, A., Kaholokula, J., Chang, H., Chen, R., Rodriquez B., Melish, J., & Curb, 
 J. (2002).  Relationship between plasma glucose concentrations and Native  
Hawaiian ancestry: The Native Hawaiian health research project.  International 
Journal of Obesity, 26, 778-782. 
Grandinetti, A., Kaholokula, J.K., Mau, M.K., & Chow, D.C., (2010).  Detecting 
cardiometabolic syndrome using World Health Organization public health actions points 
for Asian Pacific Islanders. Ethnic Disparity Journal, (20), 123-128. 
Grandinetti, A., Kaholokula, J.K., Theriault, A.G., Mor, J.M., Chang, H.K., & Waslien, 
C. (2007).  Prevalence of diabetes and glucose intolerance in an ethnically diverse rural 
community of Hawaii.  Ethnic Disparity Journal, 17, 250-255. 
Green, J. & McClennon, J. (2006). Acupuncture: An effective treatment for painful diabetic
 neuropathy. The Diabetic Foot, 9(4), 182-190. 
Grossrau, G., Wahner, M., Kuschke, M., Konrad, B., Reichmann, H., Wiedemann, B., & 
Sabatowski, R. (2011).  Microcurrent transcutaneous electric nerve stimulation in painful 
diabetic neuropathy: A randomized placebo-controlled study. Pain Medicine, 12, 953-
960. doi: 10.1111/j.1526-4637.2011.01140.x 
		 144	
Haddad, N. S., Istepanian, R., Philip, N., Khazaal, F. A., Hamdan, T. A., Pickles, T., . . . 
Gregory, J. W. (2014). A feasibility of mobile phone text to support education and 
management of type 2 diabetes in Iraq. Diabetes Technology & Thereapeutics, 16(7), 
454-459. doi:10.1089/dia.2013.0272. 
Harrigan, R., Nnenna, M., Efird, J.T., Easa, D., Shintani, T., Hammatt, Z., Perez, J., & 
Shomaker, T.S. (2006). Use of provider delivered complementary and alternative 
therapies in Hawai‘i: Results of the Hawai‘i health survey.  Hawaii Medical Journal, 
65(5), 130-151. 
Harris, P. E., Cooper, K. L., Relton, C., & Thomas, K. J. (2012). Prevalence of complementary 
and alternative medicine (CAM) use by the the general population: A systematic review 
and update. The International Journal of Clinical Practice, 66(10), 924-939. 
doi: 10.1111/j.1742-1241.2012.02945.x 
Hartemann, A., Attal, N., Bouhassira, D., Dumont, I., Gin, H., Jeanne, S., Said, G., J. L., 
Richard. (2011).  Painful diabetic neuropathy:  Diagnosis and management.  Diabetes & 
Metabolism.  37, 377-388. doi:10.1016/j.diabet.2011.06.003 
Hawai'i State Department of Health. (2004). Hawai'i Diabetes Report. (pp 1-24). 
Honolulu, HI: Community Health Division, Chronic Disease Management, and Control 
Branch. 
Hawk, C., Ndetan, H., Evans, M., (2012).  Potential role of complementary and 
alternative healthcare providers in chronic disease prevention and health promotion: An 
analysis of National Health Interview survey data. Preventative Medicine. 54,18-22. 
doi:10.1016/j.ypmed.2011.07.002 
Hegney, D. G., Patterson, E., Eley, D. S., Mahomed, R., & Young, J. (2013). The feasibility, 
		 145	
acceptability, and sustainability of nurse-led chronic disease management in Australian 
general practice: The perspectives of key stakeholders. International Journal of Nursing 
Practice, 19(1), 54-59. doi: 10.1111/ijn.12027 
Hoerger, Gregg, Segel, Saaddine, (2008).  Is glycemic control improving in U.S. Adults? 
Diabetes Care, 31(1), 81-86. 
Hsu, W. C., Boyko, E. J., Fujimoto, W. Y., Kanaya, A., Karmally, W., Karter, A., . . . 
Arakaki, R., (2010).  Pathophysiologic differences among Asians, Native Hawaiians and 
other Pacific Islanders and treatment implications.  Diabetes Care, 35, 1189-1198. 
Humphry, J., Jameson, L., & Beckham, S. (1997).  Overcoming social and cultural 
barriers to care for patients with diabetes.  Western Journal of Medicine, 167(3), 138-144. 
Ing, C. T., Zhang, G., Dillard, A., Yoshimura, S. R., Hughes, C., Palakiko, D., . . . Kaholokula, J. 
K. (2016). Social support groups in the maintenance of glycemic control after 
community-based intervention.  Journal of Diabetes Research, 2016, 1-8. Retrieved from 
http://dx.doi.org/10.1155/2016/7913258 
Jong, M., Lundqvist,V., Jong, M. C. (2015). A cross-sectional study on Swedish licensed nurses’ 
use, practice, perception and knowledge about complementary and alternative medicine. 
Scandinavian Journal of Caring Sciences, 29(4), 642-650. doi: 10.1111/scs.12192 
Jordan-Marsh & Harden (2005), Fictive kin friends as family supporting older adults as 
they age.  Journal of Gerontological Nursing, 31(2), 24-31. 
Kaholokula, J. K., Wilson, R. E., Townsend, C. K. M., Zhang, G. X., Chen, J., Yoshimura, 
S. R., . . . Mau, M. K. (2014).  Translating the diabetes prevention program in Native 
Hawaiian and Pacific Islander communities: The PILI ʻOhana Project. Translational 
Behavioral Medicine, 4(2), 149-159. 
		 146	
Kaltman, S., Serrano, A., Talisman, N., Magee, M. F., Cabassa, L. J., Pulgar-Vidal, O., &  
Peraza, D. (2016). Type 2 diabetes and depression a pilot trial of an integrated self-
management intervention for Latino immigrants. The diabetes educator, 42(1), 87-95.  
doi: 10.1177/0145721715617536 
Ka'opua, L. S. (2008).  Developing a culturally responsive breast cancer screeing 
promotion with Native Hawaiian women in churches.  Health & Social Work, 33(3), 169-
177. 
Kawi, J. (2012).  Self-management support in chronic illness care: A concept analysis. 
Research Theory for Nursing Practice: An International Journal, 26(2), 108-125. 
http://dx.doi.org/10.1891/1541-6577.26.2.108 
Kent, N. (1983). Islands under the influence. New York: Monthly Review Press. 
King, G., McNeely, M., Thorpe, L., Mau, M., Ko, J., Liu, L., Sun, A., Hsu, W., & Chow, 
E. (2012).  Understanding and addressing unique needs of diabetes in Asian Americans, 
native Hawaiians, and Pacific Islanders. Diabetes Care, 35, 1181-1188. 
doi: 10.2337/dc12-0210 
Leake, A. R. (2003). Self-management by uninsured Filipino immigrants with type 2 
diabetes (Doctoral Dissertation). Retrieved from University of Hawai‘i, Proquest UMI 
Dissertation Publishing (3110020). 
Li, L. (2010). The effect of Neuragen PN on neuropathic pain: A randomized, double 
blind, placebo controlled clinical trial.  BMC Complementary & Alternative Medicine, 
10:22.  Retrieved from http://www.biomedcentral.com/1472-6882/10/22 
Lindsay, T., Rodgers, B. C., Savath, V., & Hettinger, K. (2010).  Treating diabetic 
peripheral neuropathic pain.  American Academy of Family Physicians, 82(2), 
		 147	
151-158. 
Lorig, K. R., & Holman, H. R. (2003).  Self-management education: history, definition, 
outcomes, and mechanisms. Annals of Behavior Health Medicine, 26(1), 1-7. 
Maskarinec, G. (1997). Diabetes in Hawai'i: Estimating prevalence from insurance claims data. 
American Journal of Public Health, 87(10), 1717-1720. 
Maskarinec, G., Shumay, D. M., Kakai, H., & Gotay, C. C. (2000).  Ethnic differences in 
complementary and alternative medicine use among cancer patients.  The Journal of 
Alternative and Complementary Medicine, 6(6), 531-538. 
Mau, M. K., Sinclair, K., Saito, E. P., Baumhofer, K. N., Kaholokula, J. K. (2009). 
Cardiometabolic health disparities in native Hawaiians and other Pacific Islanders. 
Epidemiologic Reviews, 31, 113-129. 
McDermott, A.M., Toelle, T. R., Rowbotham, D.J., Schaefer, C. P., Dukes, E. M. (2006). The 
burden of neuropathic pain: Results from a cross-sectional survey. European Journal of 
Pain, 10, 127-135. doi:10.1016/j.ejpain.2005.01.014 
McEligot, A. J., McMullin, J., Pang, K., Bone, M., Winston, S., Ngewa, R., & Tanjasiri, 
S.P. (2010). Diet, psychosocial factors related to diet and exercise, and cardiometabolic 
conditions in southern Californian Native Hawaiians.  Hawai'i Medical Journal, 
69(Suppl 2), 16-20. 
McHorney, C. A., Ware, J. E., Lu, R., & Sherbourne, C. D. (1994). The MOS 36-item 
short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and 
reliability across diverse patient groups. Medical Care, 32(1), 40-66. 
Miller, W. R., Lasiter, S., Ellis, R. B., & Buelow, J. M. (2015). Chronic disease self- 
management: A hybrid concept analysis.  Nursing Outlook. 63(2), 154-161.  
		 148	
doi: http://dx.doi.org/10.1016/j.outlook.2014.07.005 
Moharic, M., & Buger, H. (2010).  Effect of transcutaneous electrical nerve stimulation 
sensation thresholds in patients with painful diabetic neuropathy: an observational study.  
International Journal of Rehabilitation on Research, 33, 211-217. 
doi: 10.1097/MRR.0b013e3283352151 
Morris, N. S. & Rosenbloom, D. A. (2017). Defining and understanding pilot and other 
feasibility studies. American Journal of Nursing, 117(3), 38-45. 
Nes, A., Eide, H., Krisjánsdóttir, O. B. & van Dulmen, S. (2013). Web-based, self-management 
enhancing interventions with e-diaries and personalized feedback for persons with 
chronic illness: A tale of three studies. Patient Education & Counseling, 93(3), 451-458.  
http://dx.doi.org/10.1016/j.pec.2013.01.022 
National Center for Complementary and Alternative Medicine (2008).  The use of 
 complementary and alternative medicine in the United States. Available from: 
http://nccam.nih.gov/sites/nccam.nih.gov/files/camuse.pdf accessed October 8, 2014. 
National Center for Complementary and Alternative Medicine (2012).  What is Complementary 
and Alternative Medicine? Available from: http://nccam.nih.gov/health/whatiscam 
accessed July 27, 2014. 
National Center for Complementary and Integrative Health (2014). NIH complementary and 
integrative health agency gets new name. https://nccih.nih.gov/news/press/12172014 
Office of Hawaiian Affairs, (1998).  Native Hawaiian Databook. Honolulu, HI: Office of  
Hawaiian Affairs, Planning and Research Office. 
Oneha, M. (2001). Ka mauli o ka 'oina a he mauli kanaka: an ethnographic study from an 
 Hawaiian sense of place.  Pacific Health Dialog, 8(2), 299-311. 
Pobutsky, A., Balabis, J., Nguyen, D-H, & Tottor, C. (2010).  Hawai'i Diabetes Report 
		 149	
2010.  Honoulu: Hawai'i State Department of Health, Chronic Disease Management and 
Control Branch, Diabetes Prevention and Control Program. 
Polit, D. F., & Beck, C. T. (2008). Nursing Research Generating and Assessing Evidence for 
Nursing Practice, 8th ed.  Philadelphia, PA: Lippincott Williams & Wilkins. 
Ramadas, A., Chan, C. K. Y., Oldenburg, B., Hussien, Z., & Quek, K. F. (2015). A web-based 
dietary intervention for people with type 2 diabetes: development, implementation, and 
evaluation. International Journal of Behavioral Medicine, 22(3), 365-373. 
doi:10.1007/s12529-014-9445-z  
Rasmussen, G. S., Maindal, H. T., & Lomborg, K. (2012).  Self-management in daily life 
with psoriasis: An integrative review of patient needs for structured education. Nursing 
Research and Practice, 2012, 1-19. doi:10.1155/2012/890860 
Richard, A. A. & Shea, K. (2011).  Delineation of self-care and associated concepts.  
Journal of Nursing Scholarship. 43(3), 255-264. doi: 10.1111/j.1547-5069.2011.01404.x 
Rhee, T. G., & Harris, I. M. (2017). Gender differences in the use of complementary and 
alternative medicine and their association with moderate mental distress in U.S. adults 
with migraines/severe headaches. Headache The Journal of Head and Face Pain, 57(1), 
97-108. doi: 10.1111/head.12986 
Rodgers, B., & Knalf, K. (2000). Concept development in nursing foundations, 
techniques, and applications. (2nd ed.).  Philadelphia, PA: Saunders. 
Rothenberger, C.D. (2011). Chronic illness self-management in prediabetes: A concept 
analysis.  Journal of nursing and Healthcare of Chronic Illness, 3, 77-86.  
doi: 10.1111/j.1752-9824.2011.01092.x 
Savage, C., Xu, Y., Richmond, M. M., Corbin, A., Falciglia, M., & Gillespie, G. (2014). A pilot 
		 150	
study: retention of adults experiencing homelessness and feasibility of CDSM diabetes 
program. Journal of Community Health Nursing, 31(4), 238-248. 
http://dx.doi.org/10.1080/07370016.2014.958406  
 
Sell, K. A. (2013). Disease self-management and health behavior change attitudes in older 
adults: the feasibility of mixed-methods design (Doctoral Dissertation). Retrieved from 
CINAHL. (Accession Number 109864470) 
Sharp, R. R., & Foster, M. W. (2002).  Community involvement in the ethical review of genetic 
research: Lessons from American Indian and Alaska Native Populations. Environmental 
Health Perspectives, 110(suppl2), 145-148. 
Sinclair, K. A., Thompson, C., Makahi, E. K., Shea-Solatorio, C., Yoshimura, S. R., Townsend, 
C. K. M., & Kaholokula, J. K. (2013). Outcomes from a diabetes self-management 
intervention for Native Hawaiians and Pacific People: partners in care. Annals of 
Behavior Medicine, 45(1), 24-32. doi:10.1007/s12160-012-9422-1 
Skinner, T., Carey, M., Cradock, S., Daly, H., Davies, M., Doherty, Y., . . . Oliver, L. (2006). 
 Diabetes education and self-management for ongoing and newly diagnosed 
(DESMOND): Process modelling of pilot study. Patient Education and Counseling, 64, 
369-377. 
Teixeria, E. (2010).  The effect of mindfulness meditation on painful diabetic peripheral 
neuropathy in adults older than 50 years.  Holistic Nursing Practice, 24(5), 277-283. 
doi: 10.1097/HNP.0b013e3181f1add2 
Thorne, S., Paterson, B., & Russell, C. (2003).  The structure of everyday self-care 
decision making in chronic illness, Qualitative Health Research, 13(10), 1337-1352.  
doi: 10.1177/1049732303258039 
Thorne, S., Paterson, B., Russell, C., & Schultz, A. (2002).  Complementary/alternative 
		 151	
medicine in chronic illness as informed self-care decision making. International Journal 
of Nursing Studies, 39, 671-683. 
Tindle, H. A., Davis, R. B., Phillips, R. S., & Eisenberg, D.M. (2005). Trends in use of 
complementary and alternative medicine by US adults: 1997-2002. Alternative Therapies 
in Health and Medicine, 11(1), 42-49. 
Tong, Y., Guo, H., & Han, B. (2010).  Fifteen-day acupuncture treatment relieves 
diabetic peripheral neuropathy.  Journal of Acupuncture and Meridian Studies. 3(2), 95-
103. 
Townsend, C. K. M., Dillard, A., Hosoda, K. K., Maskarinec, G. G., Maunakea, A. K., 
Yoshimura, S. R. ... Kaholokula, J. K. (2016).  Community-based participatory research 
integrates behavioral and biological research to achieve health equity for Native 
Hawaiians.  International Journal of Environmental Research and Public Health. 13(4), 
1-10. doi:10.3390/ijerph13010004 
United States Department of Health and Human Services, Centers for Disease Control and 
Prevention, (2011). National diabetes fact sheet: national estimates and general 
information on diabetes and prediabetes in the United States.  Available from 
http://www.cdc.gov/diabetes/pubs/factsheet11.htm   
United States Department of Health & Human Services (2017).  Poverty guidelines used to 
determine financial eligibility for certain federal programs. Retrieved from 
https://aspe.hhs.gov/poverty-guidelines 
United States Public Law 103-150, 103d Cong. Joint Res. 107 STAT. 1510 (1993), To 
		 152	
acknowledge the 100th anniversary of the January 17, 1893 overthrow of the Kingdom of 
Hawai'i, and to offer an apology to Native Hawaiians on behalf of the United States for 
the overthrow of the Kingdom of Hawai'i.  
Udlis, K. A., (2011).  Self-management in chronic illness: concept and dimensional analysis, 
Journal of Nursing and Healthcare of Chronic Illness: An International Journal. 3,130-
139. doi:10.1111/j.1752-9824.2011.01085.x 
Van Acker, K., Bouhassira, D., De Bacquer, D., Weiss, K. Matthys, H., Raemen, H., Mathier, C., 
& Collin, I. M. (2009).  Prevalence and impact on quality of life of peripheral neuropathy 
with or without neuropathic pain in type 1 and type 2 diabetes patients attending hospital 
outpatients clinics.  Diabetes & Metabolism, 35(3), 206-213. 
doi:10.1016/j.diabet.2008.11.004 
Vinik, A., Birol, E., Cheung, R., & Whalen, E. (2013).  Relationship between pain 
relief and improvements in patient function/quality of life in patients with painful diabetic 
peripheral neuropathy or postherpetic neuralgia treated with pregabalin.  Clinical 
Therapeutics, 35(5), 612-623. Retrieved from 
http://dx.doi.org/10.1016/j.clinthera.2013.03.008 
Ware, J. E., Snow, K. K., Kosinski, M. (1993). Health survey manual and interpretation 
 guide. Boston: The Health Institute, New England Medical Center Hospitals. 
Webster, L. R., Peppin, J., Murphy, F. T., Tobias, J. K., & Vanhove, G. F. (2012). 
Tolerability of NGX-4010, a capsaicin 8% patch, in conjunction with three topical 
anesthetic formulations for the treatment of neuropathic pain.  Journal of Pain Research, 
5, 7-13. 
		 153	
Wieland, M. L., Njeru, J. W., Hanza, M. M., Boehm, D. H., Sing, D., Yawn, B. P., . . . Sia, I. G.
 (2017). Pilot feasibility study of a digital storytelling intervention for immigrant and 
refugee adults with diabetes. The Diabetes Educator, 43(4), 349-359. 
doi:10.1177/0145721717713317 
Wilkinson, A., & Whitehead, L. (2009).  Evolution of the concept of self-care and 
implications for nurses: A literature review, International Journal of Nursing Studies, 46, 
1143-1147. doi:10.1016/j.ijnurstu.2008.12.011  
Wong, L., Ribeiro, M., Vasquez-Brooks, M., Estrella, D., Wang, C., Arakaki, R., & Inouye, J. 
(2015).  Recruitment of Asians and Pacific Islanders with type 2 diabetes into clinical 
research trial of enhancing diabetes self-management.  Journal of Cultural Diversity, 
22(4), 142-147. 
Wu, C., Sung, H., Chang, A. M., Atherton, J., Kostner, K., & McPhail, S. M. (2017). Cardiac 
diabetes self-management program for Australians and Taiwanese: A randomized 
blocked design study. Nursing & Health Sciences, 19(3), 307-315.  
doi: 10.1111/nhs.12346 
Zhao, T., Zhang, R., & Zhao, H. (2006).  Acupuncture for symptomatic treatment of 
diabetic peripheral neuropathy.  Cochrane Database of Systematic Reviews, 4,1-6. 
DOI: 10.1002/14651858.CD006280 
 
